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Chapter 1 
Introduction and aim of the thesis 
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INTRODUCTION 
Coronary flow reserve 
Basic research over the past 50 years has provided the clinician with important 
concepts for understanding human coronary physiology. One such tool is the determination 
of coronary blood flow reserve. Defined as the ratio of maximal to resting coronary flow, 
flow reserve may be helpful in assessing the need for revascularization in selected patients 
(1), as well as providing insight into pathophysiological states involving small arterial vessels 
(2-4). Many methodologies have been developed for measuring myocardial blood flow in 
patients, however most are limited by poor spatial resolution, the need for prolonged 
sampling periods or inherent inaccuracies with the measurements (5). 
Two invasive techniques have recently shown promise in the determination of 
coronary flow reserve in patients. Ultrasonic Doppler catheters have become small and 
steerable and can accurately assess changes in coronary blood flow velocities following 
infusions of vasodilators such as papaverine and adenosine. The technique has gained 
widespread acceptance for use in the catheterization laboratory, particularly to evaluate the 
success of interventions such as percutaneous trans luminal coronary angioplasty ( 6). Another 
invasive modality combines videodensitometry and digital subtraction angiography. This 
method uses a measurement of contrast density at two different vessel locations to 
determine the transit time and together with vascular volume can provide measurements of 
coronary blood flow (7). Both of these techniques are safe and show good results when 
validated against other accepted techniques. The major disadvantage however is that neither 
absolute blood flow nor transmural flow distributions can be measured. 
Positron emission tomography (PET) is non-invasive, and thus does not theoretically 
alter baseline flows such as might occur with an intracoronary catheter. Positron emitting 
tracers such as H20
15 are administered either intravenously or as inhaled C02
15 and are 
rapidly extracted by the myocardium. With the use of high resolution, rapid tomographic 
scanners, one can measure time activity curves in the left ventricular chamber and the 
myocardial regions of interest. Using tracer kinetic principles, total and regional myocardial 
blood flows can be accurately quantitated. The results correlate well with flow 
measurements obtained from radiolabeled microspheres in dogs, over a wide range of flows 
(8). Because of the short half-lifes of the tracers, sequential measurements can be made to 
evaluate multiple interventions. 
Limitations of coronary flow reserve measurements: Abnormally low coronary flow reserve 
values may be important for the diagnosis and management of specific diseases. However, 
the maximal coronary flow response to infusions of vasodilators depend upon multiple 
factors, including the driving coronary perfusion pressure in diastole, coronary venous 
pressure, and transmural compressive forces (e.g. contractility). Thus coronary flow reserve 
measurements may be influenced by a number of hemodynamic variables independent of 
changes in coronary vasoreactivity. Likewise, when baseline coronary flow is altered, flow 
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reserve ratios may also vary, not necessarily reflecting changes in the coronary vasculature. 
Therefore, absolute coronary flow reserve measurements in the capacity of the vasculature 
to maximally vasodilate. Maximal coronary flow-pressure relationships more accurately 
characterize the coronary vasculature and are less influenced by changes in systemic 
hemodynamics (9). By obtaining multiple flow-pressure points over a wide range of 
perfusion pressure, one can accurately determine coronary pressure-flow lines during 
maximal vasodilation. Alterations in the capacity of the vasculature to vasodilate may be 
indicated by changes the slopes or flow-intercepts of the relationships. The tool allows for 
more accurate measures of altered flow reserve even in the presence of interventions which 
may cause modest changes in systemic hemodynamics factors such as heart rate, preload, 
or contractility. 
Another means of assessing the response of vasodilators on the vasculature is the use 
of relative flow reserve (10). This is obtained from the ratio of maximal coronary flow 
during a known stenosis to the maximal coronary flow without a stenosis. Like maximal 
flow-pressure lines, relative flow reserve is less affected by changes in systemic 
hemodynamics. This concept has been applied to coronary flow reserve measurements with 
PET, where the vasodilator response in a region of myocardium supplied by a stenosed 
vessel is compared with a region supplied by normal coronary arteries. Thus PET 
measurements of flow reserve are more relative than absolute, and thereby offer a more 
theoretical approach to studying flow reserve in patients. 
Regulation of coronary blood flow 
Autoregulation: During a constant metabolic state, the myocardium like other vascular beds, 
exhibits the capacity to adjust its resistance in order to maintain coronary blood flow 
constant, despite increases or decreases in perfusion pressure (11). This phenomenon, 
termed autoregulation is depicted in figure 1. In response to abrupt changes in coronary 
pressure, coronary flow is initially altered, but rapidly returns to normal within seconds to 
minutes. The mechanism of this phenomenon is not completely understood, but probably 
involves a combination of myogenic and metabolic factors. In regards to the latter, such 
mediators as oxygen, carbon dioxide, and other biproducts of ischemia have all been shown 
to provide endogenous vasodilation for the maintainance of coronary blood flow (12). 
During ischemia: In pathophysiological states such as coronary artery disease or ventricular 
hypertrophy, the balance between myocardial oxygen supply and demand may be disrupted. 
In such situations, coronary pressure may fall below a critical level where the capacity to 
autoregulate flow is exhausted and further reductions in perfusion pressure result in 
reductions in blood flow and oxygen delivery. This "break point" is illustrated in figure 1 as 
the onset of the descending limb of the autoregulatory curve. This can occur anywhere 
between 40 and 70 rom Hg, depending upon such factors as the animal model, the kind of 
anesthesia used, or systemic hemodynamics (13,14). A two fold increase in heart rate, for 
instance, increases the breakpoint of the autoregulatory curve from 40 mm Hg to 60 rom Hg 
in awake dogs (15). The capacity to autoregulate flow is also dependent on extravascular 
compressive forces, and thus the subendocardial regions of the myocardium are more 
Correction: the second sentence on page 10 should read: 
"Therefore, absolute coronary flow reserve is not a specific measurement 
of the capacity of the vasculature to maximally vasodilate." 
3 
0 
_j 
5.0 
lL 3.0 
>-0::: 
<( 
z 
0 
0::: 
0 
u 
1.0 
... 
r: 
t: 
I i 
I i 
I i 
, I 
I • 
I J 
I i 
/ l.K"""'"Fiow Reserve 
I j 
Maximum ,' 1 
Vasodilat~/ \ 
I 
I 
I 
,' i 
I 
I 
I 
I 
I 
I 
,'..__Autoregulatory 
,' Range 
I 
/~----+-~, 
, 
/ , 
, 
, 
, 
, 
, 
CORONARY PRESSURE 
11 
Figure 1. Steady-state relationship between coronary flow and coronary arterial pressure in the 
left ventricle. The solid line depicts the normal relationship. At a constant level of myocardial 
metabolic demand, coronary flow is maintained constant over a wide range of coronary pressure, 
between the bounds qf maximum coronary vasodilation and constriction (dashed lines). The 
solid circle represents the normal operating point under basal conditions; the solid triangle is the 
flow observed at the same pressure during maximum vasodilation. Flow reserve, the ratio of flow 
during vasodilation to that measured before vasodilation, is in this case 5.0. Pra = right atrial 
pressure; Pf=o = "back pressure" opposing coronary flow (from Klocke (45) with permission). 
vulnerable to ischemia than the subepicardium (16,17). 
Below the autoregulatory ''breakpoint", reductions in perfusion pressure, blood flow 
and transmural function have been shown to correlate well with one another. 
In awake dogs, relative reductions in either segment length or wall thickening at constant 
levels of global oxygen demand are linearly related to graded reductions in coronary 
pressure (14). In anesthetized preparations, Verdouw and others have shown a similar 
relationship between function and flow once total coronary blood flow is reduced by 20% 
(18,19-21). This correlation between reductions in flow and transmural function during 
ischemia is even more significant when subendocardial blood flow is considered, thus 
emphasizing the importance of subendocardial flow to transmural function (16,17). 
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In addition to the coronary blood flow-function relationship, changes in flow and 
metabolism have been investigated during graded reductions in coronary perfusion pressure. 
In most animal species, coronary blood flow and oxygen consumption are closely coupled 
over a broad range of flow .reductions (22). The maintainance of normal oxygen delivery to 
the myocardium during reduction in perfusion pressure are provided by the capacity to 
autoregulate blood flow. Once blood flow begins to fall during ischemia, some metabolic 
reserve does exist to enhance energy production. For example, myocardial oxygen extraction 
can increase during graded levels of ischemia (23). In addition, the amount of ATP 
production via fatty acid metabolism is drastically limited during ischemia but is partially 
compensated for by enhanced glycolysis. Thus, metabolic byproducts of anaerobic glycolysis, 
such as lactate and H + increase relative to the degree of flow reductions, although the 
correlation has only been shown to be weakly linear (24 ). In addition to enhanced glycolysis, 
other metabolic changes may occur relative to the degree of ischemia. In anesthetized dogs 
and swine, transmural changes in phosphocreatine and inorganic phosphate levels as 
measured by nuclear magnetic resonance are sensitive to changes in blood flow over a broad 
range of ischemic perfusion pressures during ischemia (25,26). 
The above studies help characterize the relationships between coronary blood flow, 
perfusion pressure, transmural function and metabolism beyond the point when 
autoregulation of blood flow by the myocardium is exhausted. It is apparent that this 
capacity of the myocardium to autoregulate blood flow during reductions in perfusion 
pressure is the most important reserve for maintaining normal function and metabolism. 
Once this fails, some metabolic reserve during ischemia does exist however, this is limited. 
Exogenous vasodilator reserve during myocardial ischemia: Traditionally, it has been assumed 
that the descending limb of the pressure-flow relationship during endogenous vasodilation 
overlaps that observed during pharmacological vasodilation (27). On the basis of recent 
studies however, this does not seem to be the case. In anesthetized swine, Pantely et al 
induced myocardial ischemia by lowering perfusion pressure to 45 mm Hg, and showed that 
coronary blood flow increased in all myocardial layers during an intracoronary infusion of 
adenosine (28). These results have been repeated by two other groups in anesthetized dogs 
(29,30), thus confirming the hypothesis that pharmacologically recruitable reserve exists 
despite moderate ischemia at a time when endogenous vasodilation is maximal. The reason 
for this discrepancy is speculative. Perhaps the myocardial vasculature loses the capacity to 
release potent endogenous endothelial vasodilators such as the "Endothelium Derived 
Relaxing Factor" (EDRF) leaving such vasoconstrictors as endothelin unopposed. It is also 
possible that the myocardial release of biochemical mediators of vasodilation are attenuated 
over time. Interestingly, none of these studies could show that the recruitment of this 
pharmacological vasodilator reserve had any beneficial effect on either function or 
metabolism. These results suggest that during myocardial ischemia, coronary blood flow may 
not be the only regulator of function and metabolism. Such factors as intracellular levels of 
calcium or lactate may also be important determinants of myocardial performance during 
ischemia. 
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Myocardial stunning 
Over the past 15 years, basic cardiovascular research has focused on myocardial 
injury incurred following ischemia and reperfusion. In anesthetized dogs, Heyndrickx et al 
showed that 15 minutes of coronary occlusion followed by reperfusion induces transient 
reductions in function, despite the return in coronary blood flow and the absence of necrosis 
(31). This entity, referred to as "myocardial stunning" is clinically relevant in light of the 
current emphasis on early reperfusion of ischemic syndromes with thrombolytic agents, 
percutaneous transluminal coronary angioplasty and bypass surgery (32). Even though days 
to weeks may be required for the complete normalization of this post-ischemic function, 
infusion of inotropic agents such as epinephrine or the induction of post-extra systolic beats 
can recruit function (33,34). It is not understood why myocardial function remains depressed 
following ischemia and reperfusion, despite the presence of normal functional reserve. Once 
this is delineated, interventions that improve post-ischemic ventricular dysfunction in 
patients following reperfusion can be applied most effectively. 
Coronary blood flow and stunning: Although sustained abnormalities in transmural blood flow 
are not the cause of stunning, it has become apparent that many abnormalities in the 
coronary vasculature may be associated with the functional abnormalities. In both awake and 
anesthetized dogs, subendocardial blood flow has been shown to be abnormally low 
following 15 minutes of complete occlusion and 3-4 hours of reperfusion (35,36). The 
mechanism of this abnormally low blood flow has not been well elucidated, but may involve 
capillary obstruction from edema formation (37) or microvascular plugging by leukocytes 
(38). The endothelial cell may also undergo changes that could alter reflow following 
stunning. For example, after one hour of occlusion and reperfusion in dogs, several 
morphological changes occur, including focal injury and partial detachment from the 
underlying cell matrix (39). In addition to these anatomical changes, the endothelial cells 
may lose the ability to release vasodilating factors such as EDRF, as shown by an attenuated 
response to known stimulators of EDRF release with ATP, bradykinin, serotonin and 
acetylcholine ( 40,41 ). 
Even when basal coronary flow returns to normal following stunning, the capacity to 
maximally vasodilate may be altered. The degree of reactive hyperema following 30 seconds 
of coronary occlusion, for example, has been shown to be lower following myocardial 
stunning induced by 15 minutes of ischemia and reperfusion ( 42). This may not be a specific 
finding for changes in the coronary vasculature because of other factors which are altered 
following the stunning process. These include reductions in either myocardial oxygen 
demand during a brief period of occlusion or the concentrations of endogenous vasodilators 
such as ATP, both of which could explain the lower reactive hyperemia. Other studies 
however, have shown altered vasoreactivity to exogenous vasodilators. Following ischemia 
and reperfusion in anesthetized dogs, the coronary flow response to maximal doses of 
intravenous adenosine has been reported to be lower than prior to stunning (36). Contrary 
to these results, others have shown no alterations in coronary vascular reactivity during 
infusions of maximal doses of adenosine (43,44). 
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Several reasons may exist for the inconsistencies among these studies. First of all, the 
term myocardial stunning has been loosely applied to many models of ischemia and 
reperfusion, some of which involve prolonged ischemic times which also induce necrosis. It 
is not surprising that flow reserve in these infarcted areas is lower than in stunned but viable 
regions. Secondly, intravenous infusions of vasodilators may induce systemic effects on left 
ventricular pressure, heart rate and contractility and thus may not vasodilate to the same 
degree as compared with maximal doses of intracoronary infusions. Finally, because of the 
steep pressure-flow relationship during maximal vasodilation as shown in figure 1, small 
changes in perfusion pressure may induce large changes in coronary flow with the potential 
for error in comparisons between interventions. Thus, coronary vascular resistance is better 
characterized by maximal coronary flow-pressure relationships, defined by their slopes and 
flow-intercepts ( 45). 
It is clear that the coronary vasculature may undergo a number of changes following 
ischemia and reperfusion that are important even though they may not be the primary 
causes of the contractile abnormalities. Further work needs to identify those factors involved 
with "vascular stunning" that are independent of known alterations in the vasculature such 
as "edema" or necrosis. Clinically, these questions are important regarding the efficiency of 
the vasculature to support increased myocardial demand following stunning. It is also 
interesting that enhanced blood flow following reperfusion may correct some of the 
functional abnormalities following reperfusion ( 46). Understanding these problems may give 
a better appreciation of the mechanisms behind stunning and in turn, provide more 
therapeutic applications. 
Myocardial metabolism and stunning: In addition to the coronary vasculature, the metabolic 
state of the myocardium undergoes several changes following ischemia and reperfusion that 
may be associated with the functional abnormalities. The uptake of substrates utilized by the 
myocardium for energy production, for instance, are different, as measured by positron 
emission tomography (PET). In chronically instrumented dogs, 3 hours of coronary occlusion 
followed by reperfusion cause sustained abnormalities in the clearance of C-11 labeled 
palmitate (a marker of fatty acid metabolism). At the same time, uptake of the glucose 
analog F-18 deoxyglucose is enhanced implying that the reperfused myocardium 
preferentially utilizes carbohydrates rather than fatty acids for ATP production (47). This 
new imaging tool allows the researcher a means to quantitate changes in the uptake of 
myocardial substrates following reperfusion ( 48). It also affords the clinician a tool to 
identify the extent of post-ischemic myocardium in patients following exercise or reperfusion 
therapies ( 49). Although the technology has great potential, more basic research on the 
energy needs of the reperfused myocardium is needed before interpreting the results. For 
instance, the tracers used for PET only measure uptake of the substrates, and may 
inaccurately assess their overall utilization (50). 
Following brief periods of ischemia and reperfusion in anesthetized dogs, ATP and 
other nucleotides have been shown to be persistently depressed (51). Because the time 
course of their recovery coincide with that of the functional abnormalities (52), it has been 
hypothesized that a reduced high-energy phosphate pool is the cause of stunning. Based on 
the results of further studies however, the relationship between post-ischemic function and 
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reductions in ATP is not causal. For example, providing substrate to increase myocardial 
A TP stores to normal values following reperfusion has not been shown to improve the 
contractile abnormalities (53). More importantly, the presence of normal contractile reserve 
suggests that a defect in the resynthesis of ATP is not the primary cause of stunning. The 
capacity for the mitochondria to phosphorylate appears to be intact as indicated by normal 
or elevated levels of pho~phocreatine (54,51), thus leading some investigators to postulate 
that the lower ATP represents an energy drain following stunning. In support of this, 
myocardial oxygen consumption in regionally stunned myocardium may be unchanged, 
despite the reductions in regional function and thus oxygen demand (55). This "oxygen 
waste" theory suggests that the energy consumption of the myocardium is inefficiently high 
following reperfusion compared with the amount of measured work. 
The relationship between oxygen consumption and post-ischemic ventricular function 
is of great interest, but has not yet been well characterized. Part of the problem is accurately 
measuring oxygen extraction, which has been shown to be heterogenous following 
reperfusion (55). Secondly, it is difficult to relate oxygen consumption and contractility 
following reperfusion because changes in coronary blood flow in regionally stunned 
myocardium may depend upon many determinants of oxygen demand other than thickening 
or shortening. Finally, different models of stunning report variable degrees of functional 
changes, thus confounding the interpretation of coronary blood flow, oxygen consumption 
and function following reperfusion. 
Mechanism of myocardial stunning: The mechanism of myocardial stunning is not well 
understood but probably involves multiple processes that could potentially contribute to the 
mechanical dysfunction. A leading hypothesis suggests that free oxygen metabolites such as 
superoxide anion (02-), hydrogen peroxide (H20 2) and hydroxyl radical (OH-) are 
generated during early reperfusion and cause damage to membranes, contractile structures 
or the sarcoplasmic reticulum (56). Potential sources of these free radicals include the 
activation of neutrophils (57) and the increased activity of the enzyme xanthine oxidase (58). 
In support of this oxyradical theory, several investigators have shown in anesthetized dogs 
that superoxide dismutase (an enzyme that converts 0 2- to 0 2 and H20 2) and catalase (an 
enzyme that reduces H20 2 to 0 2 and H20) significantly attenuate the degree of myocardial 
stunning following ischemia and reperfusion (59,60). Further proof is provided by the fact 
that these agents reduce the level of free radicals produced following reperfusion as 
detected by spin trap and electron paramagnetic resonance spectroscopy (61). 
An equally important component in the evolution of myocardial stunning involves 
intracellular calcium homeostasis or altered myofibrillar sensitivity to the anion. Several 
studies suggest that "calcium overload" occurs during reperfusion, thus inducing contractile 
abnormalities. For example, isolated hearts exposed to 15 minutes of ischemia and 
reperfusion demonstrate less myocardial stunning when the perfusate contains low calcium 
concentrations (54). In isolated ferret hearts, intracellular levels of calcium ("calcium 
transients") as measured by the fluorinated calcium indicator 5F-BAPTA and nucleur 
magnetic resonance spectroscopy (NMR) are elevated following ischemia and reperfusion 
at a time when contractile function is reduced (62). Although calcium levels may be elevated 
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only briefly during reperfusion, this transient excess may be enough to damage intracellular 
organelles responsible for contraction. 
Another hypothesis links calcium abnormalities and stunning by proposing that the 
sensitivity of the myofilaments for calcium is reduced. In experiments with isolated 
reperfused ferret hearts using NMR, "calcium transients" are elevated but maximal 
calcium-activated pressure is decreased suggesting a lowered responsiveness to calcium by 
the contracile proteins (63). Contrary to these studies, in a canine model of post-ischemic 
dysfunction produced by multiple 5-minute occlusions and 10 minute reperfusions, isolated 
sarcoplasmic reticulum demonstrate a decrease in the ability to transport calcium, along with 
a reduction in the activity of calcium-magnesium-ATPase (64). This would suggest that the 
myofilament sensitivity is intact, but that the defect lies in the inability of the sarcoplasmic 
reticulum to deliver calcium to the contractile proteins. This theory is attractive in that it 
might explain why regionally stunned myocardium demonstrates functional reserve with 
inotropic agents. However, it does not explain some of the NMR observations that 
intracellular calcium transients are elevated during early reperfusion. 
Aims of the thesis 
In this thesis, we first address some clinical aspects of coronary flow reserve. In the 
anesthetized swine model, we then describe the relationships between myocardial blood 
flow, metabolism and function during both ischemia and following ischemia-reperfusion. 
(1) In the first section, some of the principles of coronary blood flow reserve as applied 
to patient care will be presented. Such measurements may provide important information 
about abnormalities of the capacity of the coronary vasculature to maximally vasodilate, 
allowing specific diagnoses and therapies. A primary limitation in the clinical setting has 
been inaccurate, non-invasive tools to measure coronary blood flow. Positron emission 
tomography has enormous potential for the quantitative measurements of regional 
myocardial blood flow. We will show how the technique can be applied to selected patients 
with coronary artery disease both prior to and following intravenous infusions of 
dipyridimole. Coronary flow reserve will be measured in both normal and collateral 
dependent myocardial regions in patients, and the results will be compared with those 
obtained in normal volunteers. 
We also investigate the effects of antiischemic agents used by patients on coronary 
flow reserve measurements. In anesthetized swine, absolute and relative coronary flow 
reserve measurements are presented as well as maximal mean coronary flow-pressure 
relationships prior to and following administration of two commonly used classes of drugs. 
(2) Coronary artery disease progresses to the stage where the vascular supply can not 
meet the demands of the myocardium. At this point, autoregulation of blood flow fails and 
ischemia develops. With further increases in demand or decreases in coronary blood flow, 
ventricular function and aerobic metabolism are abruptly altered. In the second section, we 
define the relationship between myocardial blood flow, function and metabolism during 
graded reductions in perfusion pressure, in order to understand the adaptive processes of 
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the myocardium during acute ischemia. We also determine the degree of myocardial flow 
and metabolic reserve that is present at a time when autoregulation of blood flow is lost. 
This includes the assesment of pharmacological vasodilator reserve during increased work 
load and the importance of regional differences in vasomotor tone, during myocardial 
ischemia. 
(3) With the clinical interest in thrombolysis, cardiovascular research has now focused 
on myocardial injury incurred following ischemia-reperfusion. It has now been established 
that the relationship between myocardial function, coronary blood flow and metabolism are 
transiently altered. In this final section, we characterize these relationships in models of 
myocardial stunning induced by less than 15 minutes of ischemia followed by 30-60 minutes 
of reperfusion, both under basal conditions and during inotropic and chronotropic 
stimulation. 
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Abstract 
Using positron emission tomography and the inhalation of C02 (oxygen-15), we have 
measured coronary flow and flow reserve in myocardium perfused by normal and 
collateralized vessels in five patients and compared the results to five volunteers. All 
patients had chronic stable angina with coronary artery disease limited to a completely 
occluded vessel which received non-jeopardized, interarterial collaterals. Wall function was 
normal by ventriculogram and by 2D echocardiogram both at rest and following the 
dipyridamole infusion. During the basal state, flow in the control group was 0.89 .±_0.07 rnl/ gj 
min and was not statistically different from myocardium perfused by normal and completely 
collateralized vessels in the patient group (0.99.±_0.10 and 0.86.± 0.14 respectively). Following 
dipyridamole infusion, flow in the control group increased to 3.69.±_1.00 and in the normally 
perfused regions in patients to 2.97.±_0.94 mljgjmin (NS). In the collateral dependent 
regions, the increase was less than controls (1.66.±_1.02; p < .005). Flow reserve in controls 
was 4.1.±_0.9 compared with 3.1.±_1.1 in normal regions (NS) and 1.9.±_0.9 in collateralized 
regions (p < .005) in patients. Within each patient, the ratio of flow reserve in normal and 
collateralized regions was determined and correlated well with total exercise time (r=0.95; 
p=.01) and peak double product (r=0.83; p=.08) during symptom limited exercise tests. 
In conclusion, coronary flow to collateral dependent noninfarcted myocardial regions 
is normal, but pharmacological reserve is limited. The altered relative flow reserve in these 
regions correlates well with exercise performance and explains in part, why these patients 
continue to have ischemia at high work load. 
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Introduction 
The physiological significance of well developed coronary collaterals, in patients with 
coronary artery disease has been of great concern to clinicians. Unfortunately, inadequate 
means of myocardial blood flow measurements in humans has limited the understanding of 
their importance. When well developed in the distribution of an occluded artery, collaterals 
seem to provide enough perfusion to maintain myocardial viability. In support of this, such 
patients have been shown to have normal thallium perfusion scans (1-3) and regional wall 
motion measurements ( 4-9). 
Their capacity to increase flow to myocardium supplied by diseased coronary 
arteries, either following stress or with vasodilators is also of great interest. In the chronic 
infarct model in dogs, collaterals have been shown to maintain both resting and exercise 
induced perfusion, although these results vary between individual animals (10-13). In 
humans, it is not clear whether collaterals recruit flow during high work load. For instance, 
studies performed in patients with advanced coronary artery disease and well developed 
collaterals have shown that flow reserve to collateral dependent myocardium is not great 
enough to prevent ischemia induced by either exercise (14-18) or pharmacological stress 
(19). 
Positron emission tomography (PET) is evolving into an important technology for 
the quantitation of regional myocardial blood flow and flow reserve. Several groups have 
now shown that the results correlate . well with flow measurements obtained from 
radio-labeled microspheres in dogs, over a wide range of flows (20-23). Using the inhalation 
of oxygen-15 labelled C02 as a tracer, we studied 5 normal volunteers and 5 patients with 
collateral dependent myocardium. Our aim was to first evaluate the efficiency with which 
collaterals perfuse non-infarcted myocardium at rest. Secondly, we wished to determine the 
pharmacologic flow reserve in collateral dependent myocardium, and how it compares with 
normally perfused myocardium. Thirdly, we hypothesized that the degree of altered flow 
reserve through these collaterals would predict the functional capacity of these patients, as 
measured by performance on graded exercise tolerance tests. 
Methods 
Patient selection 
We chose a highly select group of patients with coronary artery disease to best 
determine the importance of collateral coronary flow. In review of angiograms performed 
at Hammersmith Hospital, we identified five men (54-64 years old), with disease limited to 
an occluded major epicardial vessel that completely opacified via interarterial collaterals. 
Coronary angiography was performed within 3 months of the PET study and ventricular 
function in the distribution of the occluded artery was normal by left ventriculography. In 
addition, no wall motion abnormalities were demonstrated with 2D echocardiography either 
at rest or following an infusion of intravenous dipyridamole (0.56 mg/kg over 4-5 minutes). 
Patients denied a prior history of myocardial infarction but all complained of chronic stable 
exertional angina. 
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Each patient underwent a symptom limited exercise tolerance test (Modified Bruce 
protocol) prior to the PET scan. The tests were stopped because of typical angina, and 
ischemia was confirmed by at least 1 mm ST depression at peak exercise. Table 1 lists the 
clinical and exercise data for each patient, showing total exercise time and double product 
(systolic blood pressure X heart rate) at peak exercise. 
Table 1: Clinical data in all 5 patients with normal and collateral dependent myocardium 
PT# HISTORY CORONARY EXERCISE TEST 
ANGIOGRAPHY SBP X HR Time (min) 
1 63 yo male; Fx class II occluded RCA with 24,000 10.7 
angina for 3 years LAD collaterals 
2 64 yo male; Fx class II occluded LAD with 26,790 10.1 
angina for 12 years RCA collaterals 
3 61 yo male; Fx class II occluded LAD with 18,000 6.0 
angina for 3 years RCA collaterals 
4 54 yo male; "walk thru" occluded RCA with 28,800 18.0 
angina for 2 years LAD collaterals 
5 63 yo male; Fx class II occluded LAD with 25,960 12.3 
angina for 12 years RCA and CX collaterals 
Control group 
5 healthy volunteers (25-39 years of age) served as a control group. All were men and 
none had any prior history of angina or heart disease. Myocardial blood flow was 
determined at rest and following the same dipyridamole dose as with the patients. 
24 
PET protocol 
PET scanning was performed using an ECAT 931-08/12 tomograph (CTI Inc., 
Knoxville, Tennessee). The scanner provides for fifteen simultaneous slices covering an axial 
field of view of 10.8 em, which is sufficient to comprise the entire heart and major vessels 
in a single scan. In clinical studies, images are reconstructed with a spatial resolution of 8.4 
X 8.4 X 6.6 mm. 
All scans were performed following an overnight fast and at least 72 hours after 
withdrawl of antianginal therapy. Informed consent was obtained and an intravenous heparin 
lock placed in an arm vein. Subjects were positioned on the bed and a 5 minute rectilinear 
transmission scan acquired using the gallium-68 ring source. This scan was used in such a 
way that the heart was completely viewed by the 15 slices. The skin was marked with a felt 
pen and a laser light source used to ensure constant positioning throughout the study period. 
A 20 minute transmission scan was obtained for attenuation correction of subsequent 
emission scans. Tracer amounts of radioactive gases were administered via a mouthpiece 
and a one-way exhaust valve which ensured adequate delivery of the tracers and proper 
removal of expired gas. Oxygen-15 (tl/2 = 2 min.) labelled carbon monoxide was given at 
a concentration of 3 MBq and at a flow rate of 1 ml/min. for 4 minutes. One minute after 
discontinuing the gas supply, a 6 minute emission scan was obtained and several venous 
blood samples were drawn through the intravenous line for measurement of c1so activity 
in a well counter. Samples were decay corrected and the scan was later used for 
determination of blood volume and the selection of arterial input regions of interest. 
Fifteen minutes later, to allow for decay of the oxygen-15, regional myocardial blood 
flow was determined, using continuous inhalation of oxygen-15 labelled carbon dioxide over 
3.5 minutes at 6 MBq. Under the catalytic influence of carbonic anhydrase, the gas is rapidly 
transferred to the water pool in the lung capillary bed. Inhalation of oxygen-15 C02 
therefore, is a convenient way of administering oxygen-15 water. A total of 25 dynamic 
frames (ranging from 5 to 30 seconds) were collected over 7 minutes covering the inhalation 
and washout periods (23). Fifteen minutes later, intravenous dipyridamole (0.56 mgjkg) was 
infused over 4-5 minutes with continuous 12 lead EKG and and blood pressure 
monitoring. Within 1-2 minutes of completing the infusion, the protocol was repeated. At 
the conclusion of the scan, 75-100 mg of aminophilline was given intravenously to reverse 
any residual drug effects. 
Data analysis 
Over 60 myocardial and 10 arterial input regions of interest (ROis) (3 mm diameter 
circles) were identified and stored for each subject. ROis were selected from the left atrium 
and used as the input function only when recovery exceeded 95% of the values obtained 
from blood samples of oxygen-15 measured in a well counter. On a seperate extravascular 
density image obtained by subtracting the scaled c1so emission scan from the transmission 
scan, myocardial ROis were localized on the center of the myocardium. An offline Sun 
computer network in conjunction with an Analyze soft ware program (Mayo Clinic) allowed 
reorientation of transverse sections into short and long axes. This facilitated the proper 
placement of ROis onto myocardium in the distribution of either normal or collateralized 
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vessels. Time activity curves were then generated by projecting the myocardial and arterial 
input ROis on the dynamic water images. The arterial time activity curves were averaged 
in order to generate a statistically sound input function. In the patient group, the myocardial 
time activity curves were divided and averaged into two regions: one perfused by normal and 
one perfused by collateral vessels. In volunteers, myocardial time activity curves were taken 
from all myocardial regions. Using the arterial input function, these myocardial curves were 
fitted to a two compartment model using standard non-linear interactive least-square fitting 
techniques for regional myocardial blood flow, volume of distribution of water and arterial 
blood volume (23). Figure 1 is a representative myocardial flow image in a normal volunteer 
with the blood volume subtracted. 
Figure 1: Representative transaxial myocardial water image with blood volume subtraction in 
a normal subject after the administration of dipyridamole. The left of the image corresponds to 
the left of the subject. Note the homogeneous distribution of the tracer throughout the left 
ventricle. 
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Statistics 
In the control group, blood flows at rest and following dipyridamole were determined 
for four different myocardial regions (septum, inferior, anterior and lateral walls), as well 
as for the entire myocardium. In the patient group, flows were determined in two separate 
myocardial regions: normally perfused and collateral dependent myocardium. Flow reserve 
in each subject was calculated by the ratio of dipyridamole to rest flow. Results are 
· expressed as means .±. standard deviation. Comparisons are made between normally 
perfused and collateral dependent myocardium in the patients and the values obtained from 
the entire myocardium in the volunteers. Statistical significance is tested by unpaired t-test 
using the bonferroni correction. Myocardial flows are also tested by paired student's t-test 
in the two regions in the patients. Changes in heart rate and blood pressure following 
dipyridamole are also tested within each group by paired student's t-test. 
In each patient, a ratio of collateralized to normal myocardial flow reserve was 
calculated. This was plotted against the patient's exercise time and double product. 
Regression lines were determined by simple curve fits. 
Results 
Hemodynamics 
The effects of the dipyridamole infusion on resting hemodynamics were different 
between groups. In the normal volunteers, heart rate increased from 59.±.8 at rest to 110.±.14 
beats per minute (p < .01) within 4 minutes of the infusion. Systolic blood pressure over the 
same period dropped only from 111.±.12 mm Hg to 110.±.14 (NS). In the patient group, heart 
rate increased to a lesser degree following dipyridamole (64.±.4 to 79.±.16 beats per minute 
(NS)) while systolic blood pressure also changed little from 116.±.13 to 115 .±.19 mm Hg 
(NS). Two patients (#3 and #5) complained of chest pain during the infusion, and STT 
changes were noted on the EKG in patient #5. All subjects received intravenous 
aminophylline following the scanning protocol. 
Myocardial blood flow in volunteers 
In the control group, blood flows at rest and following dipyridamole were 0.89.±_0.07 
and 3.69.±.1.00 rnl/g/rnin respectively. Flow reserve was 4.1.±_0.9. Figure 2 shows the results 
of myocardial blood flow in four different regions, determined separately. This emphasizes 
that in a group with presumed homogenous flow distribution, the model used for the flow 
calculation is not biased upon the location of the region of interest. 
Myocardial blood flow in patients 
Figure 3 is an example of the images obtained from patient #5. Table 2 gives the 
results of myocardial blood flow for all 5 patients, in normally perfused (N) and collateral 
dependent (C) regions. Flow reserve is listed for each region, as well as the relative flow 
reserve values (C/N). 
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Figure 2: Myocardial blood flow (mljgjmin) in four different regions in volunteers, during two 
flow states (means .±. sd). 
Figure 3 : These water images were obtained from a patient with a complete occlusion of the 
left anterior descending coronary artery and collateral circulation from the right coronary artery. 
Note the perfusion defect in the anterior and anteroseptal segments during vasodilation. 
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Table 2 : Myocardial blood flow (MBF-ml/g/min) and flow reserve in normally perfused (N) 
and collateral dependent (C) myocardium 
Patient# MYOCARDIAL BLOOD FLOW CORONARY Fl.OW RESERVE 
N c N c N c CfN 
1 0.84 0.76 3.93 2.03 4.7 2.7 0.57 
2 0.94 0.73 2.12 0.89 2.3 1.2 0.52 
3 1.08 0.91 2.69 0.95 2.5 1.0 0.42 
4 1.05 1.07 4.00 3.29 4.1 3.0 0.73 
5 1.06 0.85 2.11 1.12 2.0 1.3 0.66 
means± SD 0.99 ± 0.86 ± 2.97* ± 1.66 ± 3.1 ± 1.9 ± 
0.10 0.14 0.94 1.02 1.1 0.9 
* p < 0.05 vs rest 
Figure 4 compares myocardial blood flow at rest and with dipyridamole for the volunteers 
and for the normal and collateralized regions in the patients. At rest, there are no statistical 
differences between either collateralized or normally perfused regions in patients, compared 
with controls. Following dipyridamole however, the flow increment in the myocardium 
perfused by collaterals is significantly less than that in the myocardium of normal volunteers 
(p < .005). Although there was a tendency for lower flows in the normally perfused regions 
in patients at the high flow state, these were not statistically different from volunteers. 
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·-p<.OOS vs volunteer dipyridamole 
(1-test with bonferroni correction) 
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normal collateralized 
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Figure 4: Myocardial blood flow in patients with collateral dependent and normally perfused 
myocardium versus normal volunteers. 
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Flow reserve in collateralized myocardium versus functional capacity: 
We wished to determine if relative flow reserve in the collateralized regions could 
predict functional capacity with the graded exercise tests. Thus, the ratio of flow reserve in 
the collateral dependent and normally perfused regions was determined and is shown in 
Table 2 for each patient. These,then, are plotted against the exercise time and double 
product at peak exercise for each patient (figure Sa and Sb). The correlation between the 
relative differences in flow reserve between the two regions and total exercise time was good 
(r=0.95; p<.Ol) and between double product slightly weaker (r=0.83; p=.08). 
a Flow reserve ratio of collateralized and normal myocardium vs exercise time 
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b Flow reserve ratio of collateralized and normal myocardium vs exercise work 
" 
0.80 
;: y = - 2.5258e-2 + 2.4485e-2x RA2 = 0. 703 
" 0.75 
"' ~ 
~ 
0.70 
~ 0.65 
... 0.60 E 
0 
c 
i3 
0.55 
" .!::! 0.50 
.. 
:;:; 0.45 ~ 
0 0.40 
" 16 18 20 22 24 26 28 30 
double product (SBP X HR) X 1000 
Figure 5: The ratio of flow reserve in collateral dependent and normally perfused myocardium 
versus (a) total exercise time and (b) peak double product (systolic blood pressure X HR). 
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Discussion 
The physiological role of coronary collaterals is best studied in a group of patients with 
normal myocardial function and an occluded major epicardial artery perfused by 
non-jeopardized interarterial collaterals (24). In such patients, using positron emission 
tomography, we have quantitated myocardial blood flow at rest and with dipyridamole both 
in normally perfused and collateral dependent myocardium. Based on our results, we 
conclude that well developed collaterals can provide normal flow to noninfarcted myocardial 
regions during rest. The vasodilator reserve in the distribution of these collaterals following 
dipyridamole is limited however, and the degree of this alteration correlates well with 
exercise capacity. This helps explain why this group of patients continue to complain of 
angina at high work loads. 
These results are consistent with the findings of other studies of myocardial collaterals, 
both in man and animal models. Well developed intrarnyocardial collaterals for instance, 
have been shown to provide enough perfusion at rest to preserve regional mechanical 
function. Nearly half of all patients with an occluded artery and angiographicaly 
demonstrable collaterals have normal wall motion compared with about 10% without 
obvious collaterals ( 4-8). The results of thallium uptake in such patients have also been well 
characterized. At rest, 40-50% of patients with collateral dependent myocardium maintain 
normal thallium perfusion, which corresponds well with the percentages reported to have 
normal wall motion (1-3). In chronic dog models, complete collateralization can be 
successfully induced by an ameroid constrictor over several weeks to months. In this model, 
rest flow is normal and myocardial function is preserved, despite complete arterial occlusion 
(10-13). 
Although collaterals may provide enough flow at rest, their ability to increase perfusion 
during stress or with vasodilators is subject to many variables. In the dog model, the ability 
for collaterals to increase flow in response to exercise is not uniform and some dogs 
enhance flow more efficiently than others (10-13). In patients, this variability is confounded 
by insensitive methods of flow measurements. For instance, such patients have normal 
thallium perfusion with maximal exercise, implying that interarterial collaterals provide near 
maximal flow at high work load (1-3). On the other hand, It has been suggested that 
thallium perfusion during exercise is less sensitive than the electrocardiogram for detecting 
ischemia in patients with collaterals (25). Using the exercise EKG to test the efficiency of 
flow reserve via collaterals, patients with significant coronary artery disease and well 
visualized collaterals on angiography demonstrate no less ischemia when compared with an 
equally matched group without collaterals (14-17). Percutaneous transluminal angioplasty 
bas offered some additional information about the physiological role of collaterals in 
attenuating ischemia. Patients with good collaterals distal to a severe stenosis experience less 
clinical and electrocardiographic evidence of ischemia and have higher great cardiac vein 
flow during balloon inflation than patients without collaterals (26). Distal perfusion pressure 
also seems to be higher during balloon inflation in these patients and thus would suggest 
greater myocardial perfusion to the myocardium at risk (27). 
The novelty of these experiments is that we have combined relative vasodilator reserve 
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in regions of collateral flow with functional capacity to show that a good correlation exists. 
Vasodilator response to pharmacological agents in collateralized myocardium has been 
observed in animal models but its quantitation in respect to the normal vasculature is 
unknown. In a chronic dog model with collaterals induced by gradual coronary occlusion 
over an 8 week period, the conductance in the vasculature of collaterals was found to be 
33% of that in the control bed, implying the presence of some reserve (28). In a similar 
model, the addition of nitrates during ischemia has been shown to dilate coronary collateral 
vessels and significantly improve contractile force in the ischemic region (29,30). Studies in 
humans however have shown minimal blood flow reserve in the distribution of intercoronary 
collateral vessels in response to isoproterenol infusion (18). 
In the distribution of the normally perfused myocardium in patients, flow reserve was 
close to 3, which is consistant with that observed by coronary sinus thermodilution with 
equivalent doses of dipyridamole (31 ). It is lower, however than the results of our volunteers 
which was over 4. The latter value is consistent with flow reserve reported elsewhere with 
either positron emission tomography and rubidium-82 (32) or during intracoronary doppler 
recordings (33). One explanation for these differences may be the differences in 
hemodynamics following infusion of dipyridamole. In the control group, heart rate increased 
to a greater degree than in the patients, and thus may have caused a greater increase in 
myocardial oxygen consumption. Another possible reason for the differences is that the 
patients may have had small vessel coronary artery disease in "normally perfused" regions, 
and thus lower flow reserve values. 
Conclusions 
We have studied with positron emission tomography, a highly select group of patients 
to characterize vasodilator reserve in collateral dependent myocardium. Potential problems 
with our data include the small number of patients and the heterogeneity in flow 
measurements between patients. Despite these limitations, we have shown that well 
developed collaterals can supply normal coronary perfusion, to noninfarcted, collateral 
dependent myocardium during resting conditions. Pharmacological reserve however, is 
limited in these regions, and the degree of alterations correlates well with exercise capacity. 
This gives some understanding of why such patients with well developed intramyocardial 
collaterals experience ischemia with increasing work load. 
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Abstract 
In 29 anesthetized swine, we determined the effect of 3 anti-ischemic drugs on 
coronary flow reserve and the maximal mean coronary flow-pressure relationship. The 
responses to 3 doses of either the 131-selective adrenoceptor antagonist metoprolol, the B1-
selective adrenoceptor partial agonist epanolol or the calcium antagonist nifedipine were 
studied and compared with a control group (n=6jgroup). Intracoronary bolus infusions of 
adenosine (20 JJ.g/kg/0.2 ml) were administered without and during 3 levels of coronary 
stenoses in each animal, prior to and following each dose of drug, to obtain maximal 
coronary blood flows. Absolute coronary flow reserve (the ratio of maximal to resting 
coronary blood flow) and relative coronary flow reserve (the ratio of maximal coronary 
blood flow with a stenosis to maximal coronary blood flow without a stenosis) were 
calculated for each group at equivalent levels of stenoses. In addition, the slope and the 
extrapolated pressure-intercept at zero flow of the maximal mean coronary flow-pressure 
relationship were obtained at baseline for each animal, and compared with subsequent 
measurements following each dose of drug. In the nifedipine group, absolute coronary flow 
reserve decreased from a baseline value of 4.5.±).9 to 1.9.±.0.3 (p<0.05) following the last 
dose, reflecting in part the increase in resting coronary blood flow with the drug. Relative 
coronary flow reserves at similar levels of stenoses however, increased from 0.33.±.0.06 to 
0.47.±.0.10 (p<0.05) over the same time period, suggesting an altered maximal vasodilator 
response. The slopes of the maximal mean coronary flow-pressure relationships decreased 
from 2.27 .±.0.49 at baseline to 1.54.±.0.51 ml/(min.mm Hg) following the final dose (p < 0.05). 
No changes in any of the parameters were observed in the other three groups. In conclusion, 
nifedipine alters the maximal mean coronary blood flow response as manifested by a dose-
dependent increase in relative coronary flow reserve values at equivalent levels of stenoses 
and a reduction of the slopes and extrapolated pressure-intercepts at zero flow of the 
maximal mean coronary flow-pressure relationships. No such effects were observed with 
either metoprolol, or epanolol. This nifedipine-adenosine interaction may have important 
implications for the drug's anti-ischemic effectiveness. It also should be a consideration in 
the interpretation of serial coronary flow reserve measurements in patients on nifedipine 
treatment. 
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Introduction 
The concept of absolute coronary flow reserve has become a useful tool for 
understanding human coronary physiology. Defined as the ratio of maximal to resting 
coronary blood flow, it may be helpful in assessing the functional significance of coronary 
artery stenoses1 as well as the need for revascularization in selected patients.2 It has also 
provided insight into altered coronary vasoreactivity of small vessels in a number of 
pathophysiological states, including ventricular hypertrophy3, heart failure4, syndrome x5 and 
early post coronary reperfusion.6 
Because anti-ischemic drugs are commonly used in patients undergoing coronary 
flow reserve studies, it is important to determine whether these agents affect coronary flow 
reserve. Some evidence suggests that these drugs may alter vascular reactivity independent 
of changes in hemodynamics. Calcium antagonists, for instance, blunt the degree of reactive 
hyperemia following brief periods of coronary occlusion in dogs 7-9 as well as following 
injection of contrast in patients.10 Th9' have also been shown to attenuate the maximal 
coronary vasodilator response in dogs. B-adrenoceptor antagonists have also been shown 
to reduce peak hyperemic flow following brief coronary artery occlusions in dogs.11,12 
The interpretation of absolute coronary flow reserve measurements can often be 
difficult in situations where resting coronary blood flow or systemic hemodynamics are 
altered.13-16 Relative coronary flow reserve, the ratio of maximal coronary blood flow during 
a given stenosis to the maximal coronary blood flow without a stenosis has been introduced 
as a more sensitive measure of the maximal coronary blood flow capacity independent of 
such changes.15 Likewise, the determination of the maximal mean coronary flow-pressure 
relationship over a wide range of perfusion f?ressures also can more accurately characterize 
the maximal coronary blood flow capactiy. -l9 
The objective of this study was to study the effects of certain anti-ischemic agents 
on the maximal coronary blood flow capacity using measurements that are more 
independent of changes in resting coronary blood flow and systemic hemodynamics. Because 
absolute coronary flow reserve may be influenced by these factors, we also measured relative 
coronary flow reserve and the maximal mean coronary flow-pressure relationship. The 
effects of two classes of anti-ischemic agents on the maximal coronary blood flow capacity 
were studied. The studies were carried out in open chest anesthetized swine, testing three 
different drugs: the B1-selective adrenoceptor antagonist metoprolol, the B1-selective 
adrenoceptor partial agonist epanolol and the calcium antagonist nifedipine. Epanolol was 
chosen because unlike metoprolol, it exhibits its B1-adrenoceptor antagonistic properties at 
doses which have minimal effects on systemic hemodynamics.20 
Methods 
Preparation 
Following an overnight fast, 29 cross-bred Landrace-Yorkshire pigs (HVC, Redel, 
The Netherlands) of either sex (24-42 kg) were sedated with intramuscular 20 mg/kg 
ketamine (AUV, Cuijk, The Netherlands) and intravenous 5 mg/kg metomidate (Janssen 
Pharmaceutica, Beerse, Belgium). Animals were intubated and connected to a respirator for 
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intermittent positive pressure ventilation with a mixture of oxygen and nitrous oxide (1:2). 
Ventilator settings were adjusted during the experiment to maintain normal arterial pH 
(7.35-7.45), pC02 (35-45 mm Hg) and p02 (> 100 mm Hg). The external jugular vein was 
cannulated with two 7F catheters for administration of haemaccel (Behringwerke A.G., 
Marburg, Germany) to replace blood withdrawn for sampling. The anesthetic regimen 
consisted of an intravenous bolus of 150 mg/kg a-chloralose (E. Merck, Darmstadt, 
Germany), dissolved in boric acid solution, and a continuous intravenous infusion of 5 
mgjkg/h sodium pentobarbitone (Apharma, Amhem, The Netherlands). Via the left carotid 
artery, a 7F Sensodyn micromanometer-tipped catheter (B. Braun Medical B.V., Uden, The 
Netherlands) was advanced into the left ventricle (LV) and used to monitor LV pressure 
and its first derivative (LVdP/dt). The femoral arteries were cannulated with 7F catheters 
for aortic blood pressure measurements and arterial blood gas collections. Rectal 
temperature was monitored throughout the experiment and maintained near 37 • C with 
external heating pads. 
Following intravenous administration of 4 mg pancuronium bromide (Organon 
Teknika B.V., Boxtel, The Netherlands), a midline thoracotomy was performed and the 
heart was suspended in a pericardia! cradle. After ligation of the left mammary vessels, the 
second left rib was removed for ease of further instrumentation. The left anterior descending 
coronary artery (LAD) was dissected free of its adventitia, and an electromagnetic flow 
probe (2.25 or 2.50 mm; Skalar, Delft, The Netherlands) and a variable hydraulic occluder 
(R.E. Jones, Silver Spring, Maryland, USA) were placed proximally. Meticulous attention 
was paid to the positioning and stability of the flow probe and zero flows were checked 
regularly throughout the experimental protocol. Immediately distal to the probe and 
occluder, a small cannula (0.8 mm-outer diameter) was inserted into the LAD for 
administration of adenosine and measurement of coronary perfusion pressure. Reactive 
hyperemia following a coronary artery occlusion lasting 15 seconds was recorded pre- and 
post- cannula placement to ensure that no attenuation of maximal coronary blood flow had 
occurred due to obstruction of the vessel by the catheter. 
Regional segment length shortening was measured with sonomicrometry (Triton, 
Technology Inc., San Diego, CA, USA) in the subendocardial and subepicardial layer of the 
area perfused by the LAD. Pairs of ultrasonic crystals (Sonotek Corporation, Del Mar, Ca, 
USA) were placed approximately 10 mm apart in each region. Systolic shortening in the two 
layers was calculated from the difference between lengths at end-diastole (time of onset of 
positive dP /dt) and end-systole (time of peak negative dP/dt) and expressed as a percent 
of end-diastolic length.21 Baseline end-diastolic length measurements were later normalized 
to 10 mm. 
Throughout the experimental period, recordings (50 mm/s) were made of aortic, left 
ventricular and coronary arterial pressures in addition to LV dP / d~ax> coronary blood flow 
and segment length. Studies were performed in accordance with the position of the 
American Heart Association on research animal use adopted November 11, 1984, and under 
regulations of the Erasmus University. 
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Experimental protocol 
Four experimental groups, each with 6 animals were studied. In three groups, the 
effects of three intravenous doses of either metoprolol (0.1, 0.5, and 1.0 mg/kg in cumulative 
doses), epanolol (10, 50, 200 JLg/kg in cumulative doses) or nifedipine (0.5, 1.0 and 2.0 
JLg/kg/min in continuous infusions) on coronary and systemic hemodynamics were studied. 
Metoprolol and epanolol were given as bolus injections over 2 min in a volume of 10 ml. 
The fourth group of animals received equivalent volumes of saline and served as controls 
to establish reproducibility of the measurements during the execution of the experimental 
protocol. Measurements were obtained during four experimental periods: baseline and 10 
minutes following administration of each new dose of drug or saline. Hemodynamic 
recordings and measurements of mean and phasic maximal coronary blood flow were 
obtained in response to intracoronary bolus injections of adenosine. The maximal coronary 
blood flow response could always be obtained with 20 JLg/kg adenosine in a volume of 0.2 
ml injected over 5 seconds. This response was always greater than the peak hyperemic 
response to a coronary artery occlusion lasting 15 seconds. The maximal mean coronary 
flow-pressure relationship was further defined by repeating the adenosine injections during 
3-4 levels of stenosis applied with the hydraulic occluder. These were in the autoregulatory 
range to prevent changes in subendocardial and subepicardial contractile function. Figure 
1 is a representative example of the tracings prior to and immediately following adenosine 
without and with two levels of stenosis. Maximal mean coronary flow-pressure relationships 
were obtained following each dose of drug, within 45 minutes of its administration. 
Because of changes in heart rate induced by the different drugs, a fifth group (n = 5) 
was added to determine the effect of modest increases in heart rate on the maximal mean 
coronary flow-pressure relationship. Following baseline measurements of systemic 
hemodynamics, myocardial contractile function, and the maximal mean coronary flow-
pressure relationship, the left atrium was paced at 40 beats/min above the control heart rate 
for 5 min and subsequently all measurements were repeated. This increase in heart rate was 
comparable to the changes in heart rate observed in the experimental groups. 
Drugs 
Adenosine (E. Merck, Darmstadt, Germany) was dissolved in saline to a final 
concentration of 100 JLg/kgjml. Epanolol ("Visacor", ICI-Pharmaceuticals, Macclesfield, 
Cheshire, UK) and metoprolol tartrate ("Selokeen", Astra Pharmaceuticals BV, Rijswijk, The 
Netherlands) were also dissolved in saline. Nifedipine ("Adalat", Bayer AG, Wuppertal, 
Germany) was dissolved in a mixture of polyethyleneglycol 400, glycerol and distilled water 
and diluted with saline to a final concentration of 1 JLg/kg/ml. The drug was infused at rates 
of 0.5, 1.0 and 2.0 ml/min and protected from light exposure. 
The doses of all three drugs were selected to represent therapeutic ranges. In two 
pilot experiments, the Bradrenoceptor antagonistic properties of epanolol were studied by 
determining the potency to inhibit the isoproterenol-induced increases in heart rate and LV 
dP/dtmax· The infusion of 10, 50 and 200 JLg/kg of the drug in cumulative doses showed 
isoproterenol dose ratios of 10, 50 and 150, respectively, for both parameters. 
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Figure 1. Representative tracings from one animal showing the response to intracoronary 
adenosine without and during two levels of stenoses. Depicted are aortic pressure (AOP; mm 
Hg), coronary perfusion pressure (CPP; mm Hg), mean coronary perfusion pressure (MCPP; 
mm Hg), left ventricular pressure (LVP; mm Hg), maximal rate of rise of left ventricular 
pressure (LVdP /dt; mm Hg/s), coronary blood flow (CBF; ml/min) and subendocardial ( endo) 
and subepicardial (epi) segment length (SL; mm). 
Data and statistical analyses 
Maximal mean coronary flow-pressure relationships following adenosine were 
generated from the points collected during each sampling period, and correlations and 
regressions were determined by first order curve fitting. The maximal mean coronary flow-
pressure relationship was described by the slope and the extrapolated pressure intercept at 
zero flow. Two levels of stenoses were also selected from each group with equivalent 
stenosis resistances. Resistances were determined from the pressure difference between 
mean arterial and mean coronary perfusion pressures divided by coronary blood flow at rest. 
Absolute coronary flow reserve (ACFR) was calculated by the formula: 
ACFR = maximal coronary blood flow 
resting coronary blood flow 
Relative coronary flow reserve (RCFR) was calculated at equivalent levels of stenoses by 
the formula (15): 
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RCFR = maximal coronary blood flow in the presence of a stenosis 
maximal coronary blood flow without a stenosis 
All data are expressed as means ± S.D .. Inter -and intragroup variability was tested 
for statistical significance by ANOV A (F-test; Fischer's PLSD). The changes in the pacing 
group were tested for significance by the paired t-test. Statistical significance was accepted 
atp<0.05. 
Results 
Systemic hemodynamics (Table I) 
There were no statistical differences in the pre-drug baseline values between groups. 
In the control group, baseline mean arterial pressure was 91.±.20 mm Hg and remained 
stable throughout the experiment. Heart rate increased from 94.±.13 at baseline to 104.±.15 
beats/min during the final experimental period (p < 0.05) and left ventricular end-diastolic 
pressure decreased from 8.±.2 to 5.±.2 mm Hg over the same period of time. Following the 
final dose ofmetoprolol, mean arterial pressure and heart rate had decreased by about 15%, 
and LVdP/dtmax by nearly 50%. These changes were significantly different from those 
occuring in the control group at the same point of time. In the epanolol group, the changes 
in systemic hemodynamics were not different from those in the control group except that 
heart rate did not increase during the experiment. In the nifedipine group, mean arterial 
pressure decreased with each dose and was about 33% lower than baseline following the last 
dose. Heart rate increased with each dose but these changes were not significantly different 
from those occurring in the control group. 
Coroncuy hemodynamics and absolute coronary flow reserve (Table 2) 
There were no statistical differences between groups for any of the pre-drug baseline 
parameters. With increasing doses of metoprolol, coronary perfusion pressure was lowered 
causing a reduction in adenosine-induced maximal coronary blood flow. Baseline coronary 
blood flow was also reduced, which explains why absolute flow reserve at each dose 
remained unchanged. With increasing doses of epanolol, coronary blood flow, both at rest 
and following adenosine was not altered and absolute coronary flow reserve remained 
unchanged. With increasing doses of nifedipine, resting coronary blood flow was increased 
and maximal coronary blood flow decreased. Absolute coronary flow reserve was lower with 
each dose reflecting both the higher resting coronary blood flow and lower maximal 
coronary blood flow at lower perfusion pressures. 
Relative coronary flow reserve (Table 3): 
Because absolute coronary flow reserve may vary with changes in resting coronary 
blood flow and in systemic hemodynamics, we determined relative coronary flow reserve 
following each dose of drug at two equivalent levels of stenoses. The calculated stenosis 
resistances of the moderate (A) and severe (B) stenoses were 0.19.±.0.04 and 0.57.±.0.08 mm 
Hg.min/ml respectively, and were not different between groups during the experimental 
Table 1: Systemic Hemodynamics Following Administration of Anti-ischemic Agents 
Baseline Dose 1 Dose 2 Dose 3 
CONTROL 
MAP 91 ± 20 89 ± 18 94 ± 15 91 ± 16 
HR 94 ± 13 96 ± 12 101 ± 16 104 ± 15* 
LVdP/dtmax 1750 ± 250 1710 ±. 280 1740 ± 320 1680 ± 440 
LVEDP 8 ± 2 7 ± 1 6 ± 2* 5 ± 2* 
METOPROLOL 
MAP 93 ± 13 88 ± 17 86 ± 20 78 ± 16*# 
HR 112 ± 15 104 ± 11 97 ± 6* 96 ± 7*# 
LVdP/dtmax 1940 ± 540 1420 ± 230* 1190 ± 210* 1030 ± 180*# 
LVEDP 8 ± 2 9 ± 2 9 ± 2# 9 ± 2# 
EPANOLOL 
MAP 92 ± 5 88 ± 10 89 ± 13 88 ± 11 
HR 101 ± 23 100 ± 13 100 ± 9 100 ± 6 
LVdP/dtmax 1760 ± 370 1910 ± 460 1770 ± 500 1640 ± 480 
LVEDP 7 ± 1 6 ± 1 6 ± 1 6 ± 1 
NIFEDIPINE 
MAP 99 ± 8 89 ± 10* 72 ± 3*# 66 ± 7*# 
HR 92 ± 18 97 ± 20 105 ± 26* 112 ± 26* 
LVdP/dtmax 1780 ± 290 1650 ± 360 1570 ± 410 1470 ± 480 
LVEDP 9 ± 1 9 ± 1 8 ± 2 9 ± 3 
MAP, mean arterial pressure (mmHg); HR, heart rate (beats/min); LVdP/dtmiiX' maximum rate of rise of left ventricular pressure 
(mmHg/s); LVEDP, left ventricular end-diastolic pressure (mmHg). * p<0.05 versus baseline;# p<0.05 versus changes in the control 
group; see text for doses. Values are given as mean ± SD. 
Table 2: Coronary Hemodynamics and Absolute Coronary Flow Reserve Following Administration of Anti-ischemic Agents 
Baseline Dose 1 Dose 2 Dose 3 
CONTROL 
CBF-rest 28 ± 14 26 ± 12 25 ± 12 24 ± 12 
CBF-adenosine 114 ± 55 115 ± 51 116 ± 42 110 ± 45 
MCPP-rest 91 ± 20 89 ± 18 94 ± 15 91 ± 16 
MCPP-adenosine 83 ± 16 81 ± 14 85 ± 13 81 ± 14 
ACFR 4.2 ± 0.4 4.5 ± 0.4 5.1 ± 1.6 4.9 ± 1.1 
METOPROLOL 
CBF-rest 30 ± 9 26 ± 5 23 ± 5* 21 ± 4* 
CBF-adenosine 109 ± 36 101 ± 41 99 ± 42 82 ± 24* 
MCPP-rest 93 ± 13 88 ± 17 86 ± 20 78 ± 16*# 
MCPP-adenosine 83 ± 11 79 ± 18 78 ± 17 72 ± 13* 
ACFR 3.8 ± 1.5 4.1 ± 1.9 4.4 ± 2.2 4.2 ± 1.8 
EPANOLOL 
CBF-rest 31 ± 12 30 ± 9 29 ± 9 26 ± 10 
CBF-adenosine 116 ± 31 115 ± 25 122 ± 37 113 ± 37 
MCPP-rest 92 ± 5 88 ± 10 89 ± 13 88 ± 11 
MCPP-adenosine 84 ± 5 80 ± 10 78 ± 12* 74 ± 11* 
ACFR 4.0 ± 1.1 4.1 ± 1.0 4.3 ± 0.8 4.5 ± 1.1 
NIFEDIPINE 
CBF-rest 33 ± 13 44 ± 19*# 45 ± 19*# 40 ± 19 
CBF-adenosine 130 ± 24 105 ± 28*# 88 ± 22*# 74 ± 20*# 
M_.CPP-rest 99 ± 8 89 ± 10* 72 ± 3*# 66 ± 7*# 
MCPP-adenosine 87 ± 7 80 ± 8* 69 ± 3*# 61 ± 7*# 
ACFR 4.5 ± 1.9 2.6 ± 0.7# 2.1 ± 0.4*# 1.9 ± 0.3*# 
CBF-rest, mean coronary blood at rest (ml/min); CBF-adenosine, mean coronary blood flow during adenosine (mml/min); MCPP-rest, 
mean coronary perfusion· pressure at rest (mmHg); ACPP-adeiiosine, mean coronary perfusion pressure during adenosine (mmHg); 
ACFR, absolute coronary flow reserve; * p<0.05 versus own baseline;# p<0.05 versus control in same dose group; see text for doses. 
Values are given as mean ± SD 
Table 3: Relative Coronary Flow Rese!Ves During~ Equivalent Moderate and Equivalent Severe Stenoses Following Administration of 
Anti-ischemic Agents 
Baseline Dose 1 Dose 2 Dose 3 
CONTROL 
moderate 0.59 ± 0.14 0.52 ± 0.10 0.57 ± 0.18 0.60 ± 0.21 
severe 0.35 ± 0.09 0.35 ± 0.14 0.32 ± 0.10 0.32 ± 0.10 
METOPROLOL 
moderate 0.54 ± 0.12 0.57 ± 0.10 0.52 ± 0.14 0.56 ± 0.08 
severe 0.39 ± 0.19 0.34 ± 0.12 0.36 ± 0.10 0.35 ± 0.10 
EPANOLOL 
moderate 0.51 ± 0.08 0.56 ± 0.09 0.56 ± 0.16 0.57 ± 0.12 
severe 0.33 ± 0.08 0.32 ± 0.07 0.33 ± 0.11 0.35 ± 0.17 
NIFEDIPINE 
moderate 0.60 ± 0.08 0.73 ± 0.12*# 0.69 ± 0.11 0.73 ± 0.14* 
severe 0.33 ± 0.06 0.40 ± 0.10 0.47 ± 0.11 *# 0.47 ± 0.10*# 
* p<0.05 versus baseline; # p<0.05 versus control in same dose group; see text for doses. Values are given as mean ± SD 
.p. 
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periods. At baseline, relative coronary flow reserve in the nifedipine group was 0.60_±0.08 
and 0.33_±0.06 for the moderate and severe stenoses respectively and were similar between 
the other groups. Relative coronary flow reserves remained constant during all doses in the 
contro~ metoprolol and epanolol groups, however in the nifedipine group, with the 
moderate and severe stenoses, they increased to 0.73±_0.14 (p<O.OS) and 0.47±.0.10 
(p < 0.05) respectively following the final dose. 
Maximal mean coronary flow-pressure relationships (Figure 2, Table 4) 
Using the maximal mean coronary flow-pressure points, we generated lines to further 
characterize changes in maximal vasodilator capacity. Figure 2 shows representative 
examples of the maximal mean coronary flow-pressure relationships from an individual 
animal from each group, during each of the four experimental periods. Regression lines 
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Figure 2. Examples of maximal mean coronary flow-pressure relationships from each of the four 
experimental groups. Regression lines were generated from several coronary flow-pressure points 
following intracoronary administration of adenosine at baseline and following three doses of 
dmg. Nifedipine altered the maximal response to adenosine with a reduction in the slope and 
extrapolated pressure-intercept at zero flow of the maximal mean coronary flow-pressure 
relationship. 
Table 4: Slopes and Extrapolated Pressure-intercepts at Zero Flow of the Maximal Mean Coronary Flow-Pressure Relationships 
Following Administration of Anti-ischemic Agents 
Baseline Dose 1 Dose 2 Dose 3 
CONTROL 
slope 2.14 ± 0.65 2.22 ± 0.69 2.18 ± 0.72 2.15 ± 0.63 
extrapolated P zf 29 ± 4 29 ± 10 34 ± 8 30 ± 4 
METOPROLOL 
slope 2.05 ± 0.81 2.24 ± 0.99 2.05 ± 0.80 1.87 ± 0.61 
extrapolated P zf 29 ± 10 29 ± 10 28 ± 9 28 ± 11 
EPANOLOL 
slope 2.30 ± 0.53 2.27 ± 0.13 2.43 ± 0.17 2.56 ± 0.62 
extrapolated P zf 34 ± 8 28 ± 3 30 ± 4 29 ± 8 
NIFEDIPINE 
slope 2.27 ± 0.49 1.98 ± 0.62 1.86 ± 0.45* 1.54 ± 0.51 * 
extrapolated P zf 30 ± 4 25 ± 4 21 ± 8* 20 ± 7* 
extrapolated P zf• extrapolated pressure-intercept at zero flow. *p < 0.05 versus baseline; see text for doses. Values are given as mean 
± SD 
:!3 
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were determined by first order curve fitting, and the results of the correlations, slopes and 
extrapolated pressure intercepts at zero flow have been listed in Table 4. All the lines 
generated from these points showed significant linear correlations (? > 0.96) and were 
highly reproducible in the control group (mean change in slope values of only 2±7% 
between experimental periods). In the epanolol and metoprolol groups, there were no 
statistical differences in slopes or extrapolated pressure intercepts at zero flow following any 
of the doses, compared with pre-drug baseline values. Nifedipine on the other hand, 
decreased the slope of the maximal mean coronary flow-pressure relationship as well as the 
extrapolated pressure-intercept following each dose. The differences were significant 
following the last two doses. 
Regional myocardial segment length changes: (Table 5, Figure 3) 
None of the groups showed a significant change in subendocardial or subepicardial 
segment lengths with any of the three doses without a stenosis (Table 5). Function was 
recorded during all stenoses to ensure that the maximal mean coronary flow-pressure 
relationship was not altered due to an ischemia-induced change in systolic compressive 
forces. In Figure 3, subendocardial segment length changes are shown following the last dose 
for each of the groups, prior to and during the moderate and severe stenoses. As shown, 
function did not significantly change in any of the groups during these two levels of stenoses 
even with adenosine, indicating that differences in the maximal mean coronary flow-pressure 
relationship between groups were not due to a change in systolic compressive forces. 
Heart rate and the maximal mean coronary flow-pressure relationship (Table 6) 
Because heart rate between the experimental groups was different following drug 
administration, we included 5 additional animals to determine the effect of increasing heart 
rate in a similar range by atrial pacing. At baseline, heart rate was 96±13 beats/min and 
mean arterial pressure was 91±16 mm Hg. During adenosine, endocardial segment length 
shortening was 20±6% without a stenosis and 20±.7% (NS) during the severest stenosis. 
Pacing at a heart rate of 40 beats/min above baseline did not affect systemic hemodynamics. 
With the pacing and during adenosine, subendocardial segment length shortening was 
18±. 7% without the stenosis and 16±.9% (NS) during the severest stenosis. The slope of the 
maximal mean coronary flow-pressure relationship was 3.96±.0.56 at baseline and during 
pacing was 3.79±0.34 ml/(min.mm Hg) (NS). These data show that moderate increases in 
heart rate in the range observed in our experimental groups can not account for the 
differences in the maximal mean coronary flow-pressure relationship between the 
anti-ischemic agents. 
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Figure 3. Subendocardial end-diastolic length (EDL), end-systolic length (ESL), systolic segment 
length shortening (SLS), mean coronary perfusion pressure (CPP) and mean coronary blood 
flow (CBF) are shown following the final dose of drug in each group. The measurements were 
made without ( 0 ) and during the moderate ( ~ ) and severe ( • ) stenoses. r, rest; a, 
adenosine). There were no significant differences in function for any of the groups, at these two 
levels of stenoses. Values are given as mean ± SD. 
Table 5: Regional Myocardial Segment Length Changes Shortening Following Administration of Anti-ischemic Agents 
Baseline Dose 1 Dose 2 Dose 3 
CONTROL 
Subepicardial segment length 
end-diastole (mm) 10.0 9.9 ± 0.2 9.9 0.2 9.8 0.5 
end-systole (mm) 8.5 ± 0.3 8.4 ± 0.4 8.5 0.3 8.4 0.4 
systolic shortening (%) 15 ± 3 15 ± 3 14 2 14 3 
Subendocardial segment length 
end-diastole (mm) 10.0 9.8 ± 0.2 9.6 0.2 9.4 0.4 
end-systole (mm) 8.0 ± 0.6 7.9 ± 0.5 7.9 0.5 7.8 0.6 
systolic shortening (%) 20 ± 6 19 ± 6 18 6 18 4 
METOPROLOL 
Subepicardial segment length 
end-diastole (mm) 10.0 10.2 ± 0.4 10.3 0.5 10.4 0.3 
end-systole (mm) 8.8 ± 0.5 9.0 ± 0.5 9.1 0.5 9.2 0.4 
systolic shortening (%) 12 ± 5 12 ± 4 12 3 12 2 
Subendocardial segment length 
end-diastole (mm) 10.0 10.2 ± 0.2 10.2 0.4 10.2 0.3 
end-systole (mm) 8.2 ± 0.3 8.4 ± 0.4 8.5 0.4 8.6 0.5 
systolic shortening (%) 18 ± 3 18 ± 3 16 4 15 4 
EPANOLOL 
Subepicardial segment length 
end-diastole (mm) 10.0 9.6 ± 0.2 9.7 0.4 9.7 0.3 
end-systole (mm) 8.7 ± 0.2 8.4 ± 0.5 8.3 0.6 8.5 0.6 
systolic shortening (%) 13 ± 2 13 ± 4 14 4 12 5 
Subendocardial segment length 
end-diastole (mm) 10.0 9.7 ± 0.1 9.7 0.2 9.5 0.3 
end-systole (mm) 8.3 ± 0.4 8.1 ± 0.5 8.1 0.5 8.1 0.6 
systolic shortening (%) 17± 4 16 ± 5 16 4 15 5 
NIFEDIPINE 
Subepicardial segment length 
end-diastole (mm) 10.0 9.8 ± 0.3 9.9 0.2 10.0 0.1 
end-systole (mm) 8.1 ± 0.2 8.0 ± 0.2 8.1 0.2 8.4 0.5 
systolic shortening (%) 19 ± 2 18 ± 3 18 3 16 4 
Subendocardial segment length 
end-diastole (rom) 10.0 9.8 ± 0.3 9.9 0.2 10.0 0.1 
end-systole (rom) 7.9 ± 0.4 7.8 ± 0.5 8.1 0.4 8.1 0.8 
systolic shortening (%) - 21 ± 4 21 ± 5 18 5 19 6 
None of the changes reached statistical significance; see text for doses. Values are given as mean ± SD 
Table 6: Mpximal Mean Coronary Flow-Pressure Relationship Pre -and Post-Atrial Pacing (n = 5) 
Control 
Pacing 
HR 
96 ± 13 
136 ± 17* 
Systemic hemodynamics 
MAP 
91 ± 16 
89 ± 18 
LVdP/dtmax 
1548 ± 169 
1536 ± 250 
LVEDP 
9 ± 2 
7 ± 1 
Coronary blood flow 
Rest 
47 ± 8 
48 ± 10 
Adenosine 
201 ± 46 
179 ± 47* 
Maximal mean coronary flow-pressure relationship 
Slope 
3.% ± 0.56 
3.79 ± 0.34 
Extrapolated P zf 
26 ± 3 
28 ± 4 
HR, heart rate (beats/min); MAP, mean arterial blood pressure (mmHg); LVdP /dtmax• maximal rate of rise of left ventricular pressure (mmHg/s); LVEDP, left ventricular end-diastolic 
pressure (mmHg); Coronary blood flow (ml/min); Slope (mlf(min.mmHg)); Extrapolated Pzf> extrapolated pressure-intercept at zero flow (mmHg); * p<0.05 versus baseline. Values 
are given as mean ± SD 
Vt 
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Discussion 
This study was designed to characterize the effects of three anti-ischemic agents on 
absolute and relative coronary flow reserve and the maximal mean coronary flow-pressure 
relationship. We have shown that metoprolol and epanolol had no effect on relative 
coronary flow reserve or the slope and extrapolated pressure-intercept at zero flow of the 
maximal mean coronary flow-pressure relationship. Nifedipine on the other hand, not only 
reduced maximal coronary blood flow by its effects on perfusion pressure but in addition, 
altered the maximal coronary blood flow response to adenosine over the range of perfusion 
pressures tested. This is best illustrated in Figure 3 which demonstrates that increasing doses 
of the drug reduced the slope and extrapolated pressure-intercepts of the maximal mean 
coronary flow-pressure relationship. 
The interpretation of pharmacological interventions on absolute coronary flow 
reserve has inherent limitations.l9 We attempted to minimize the effects of changes in 
systemic hemodynamics on maximal mean coronary blood flow by determining the maximal 
mean coronary flow-pressure relationship over a range of pressures. A number of factors can 
still alter the maximal vasodilator capacity in response to vasodilators, independent of their 
effect on vasomotor tone.14 Preload changes, for instance, alter the maximal coronary 
vascular conductance and pressure-zero flow values in a capacitance free model in 
anesthetized dogsP This was not responsible for the observed findings in the nifedipine 
group however, because no changes in left ventricular end-diastolic pressure were noted. In 
the control group, left ventricular end-diastolic pressure was reduced from 8 mm Hg to 5 
mm Hg over the course of the experiments but the maximal vasodilator r~sponse to 
adenosine was unchanged. This suggests that small changes in preload have little effect on 
the maximal vasodilator capacity. These data support recent studies in humans where 
maximal coronary blood flow measurements were unchanged when pulmonary capillary 
wedge pressure was increased from 9 to 16 mm Hg with rapid saline loading.26 Changes in 
heart rate may also affect maximal coronary blood flow.l4 In conscious dogs, a significant 
attenuation in maximal hyperemic flow to adenosine has been shown when heart rate is 
increased from 150 to 200 beats/min.16 In the nifedipine group, heart rate increased 
modestly from 92 to 112 beats/min and could conceivably have been responsible for the 
altered maximal mean coronary flow-pressure relationship. However, we have included an 
additional group of animals to show the effect of the maximal mean coronary flow-pressure 
relationship following similar changes in heart rate. As shown in Table 6, it is unlikely that 
the changes in heart rate in the nifedipine group were in a range that would independently 
alter maximal coronary blood flow. These data suggest that small changes in heart rate in 
a lower physiological range have a negligible effect on the maximal mean coronary 
flow-pressure relationship. Observations in patients, for example, have shown that maximal 
coronary blood flow is unchanged when heart rate is increased from 76 to 120 beats/min 
with atrial pacing.26 
Absolute coronary flow reserve measurements were included in the present study, 
but are not necessarily specific to changes in the coronary vasculature. They may be altered 
because of changes in resting coronary blood flow or systemic hemodynamics. In the 
metoprolol group, absolute flow reserve remained constant due to proportionate reductions 
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in both resting and adenosine-induced maximal coronary blood flows. In the nifedipine 
group, absolute coronary flow reserve was lowered because of both the increase in resting 
and reduction in maximal coronary blood flows. The latter not only reflected the reduced 
perfusion pressure during increasing doses of nifedipine but also the altered response to 
adenosine. Relative coronary flow reserve has been shown to be a more reliable predictor 
of vasodilator capacity during a fixed stenosis, independent of changes in systemic 
conditions.15 During equivalent levels of stenoses, we showed an increase in relative flow 
reserve with increasing doses of nifedipine, which is consistent with the findings of the lower 
slopes and leftward shift of the extrapolated pressure-intercepts at zero flow of the maximal 
mean coronary flow-pressure relationship. 
The effects of calcium antagonists on the maximal coronary vasodilator capacity have 
been reported in several models and the results are consistent with our findings. In open 
chest dogs, nifedipine was shown to blunt both coronary reactive hyperemia following a 30 
second occlusion and the response to intracoronary infusions of adenosine? In conscious 
dogs, coronary reactive hyperemia to coronary artery occlusions lasting 10 seconds, was 
attenuated 2 hours after the administration of nifedipine when coronary blood flow and 
systemic hemodynamics had returned to pretreatment values.8 Similarly, in 12 patients 
undergoing coronary angiography, contrast-induced reactive hyperemia was shown to be 
reduced following an infusion of intravenous diltiazem, suggesting that the effect is not 
limited to nifedipine.10 Because coronary perfusion pressures were not measured in any of 
these studies, it is difficult to determine whether the reduced flow responses were specific 
to changes in the coronary vasculature or a result of changes in systemic hemodynamics. 
The effects of B-adrenoceptor antagonists on resting and maximal coronary blood 
flow have also been well studied. In anesthetized dogs, these drugs blunt the degree of peak 
reactive hyperemia following brief periods of occlusion.11,12 In conscious animals as well as 
humans, they increase resting end-diastolic coronary resistance but do not alter maximal 
coronary blood flow.ZZ-25 The latter results are more consistent with our findings where 
neither metoprolol nor epanolol affected the maximal mean coronary flow-pressure 
relationship. The altered reactive hyperemia observed following administration of B-
adrenoceptor antagonists is probably more influenced by a lower oxygen demand during the 
occlusion period and therefore may not be representative of intrinsic changes in maximal 
vasodilator capacity. 
We have shown that nifedipine alters the maximal mean coronary flow-pressure 
relationship to adenosine. The application of these data are important in the interpretation 
of clinical flow reserve measurements as an index of stenosis severity in patients using the 
drug. In addition, this specific nifedipine-adenosine interaction may have important 
therapeutic implications. It has been suggested that adenosine receptors in different tissues 
also bind nifedipine and its dihydropyridine analogs_7 By inhibiting adenosine receptors in 
the myocardium during ischemia, it is possible that a regional redistribution of flow away 
from the subendocardium is prevented by nifedipine.8 This may explain why nifedipine 
improves subendocardial perfusion during moderate levels of stenosis.9 It is not clear 
whether the interaction of nifedipine and adenosine also applies to other calcium antagonists 
and also to other smooth muscle vasodilators. For example, intracoronary Doppler 
measurements of maximal flow measurements in in response to papaverine have not been 
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altered following infusions of diltiazem. 28 
Limitations of the study 
In the present study, we calculated the extrapolated pressure-intercept at zero flow 
of the maximal mean coronary flow-pressure relationship. This parameter helps to define 
the maximal mean coronary flow-pressure relationship, but cannot be used as an actual 
pressure-intercept at zero flow and should therefore not be interpreted as such. In view of 
the capacitance effects that occur throughout the cardiac cycle and which are enhanced 
during increasing severity of stenosis due to the increased diastolic and systolic coronary 
perfusion pressure variations (Figure 1 ), we chose to present only mean coronary blood flow 
As a consequence we cannot differentiate between diastolic and systolic effects of the anti-
ischemic drugs. 
Conclusions 
The results of this study in anesthetized swine show that the calcium antagonist 
nifedipine alters the maximal mean coronary flow-pressure relationship following 
intracoronary adenosine, an effect that was not observed with either the Brselective 
adrenoceptor antagonist metoprolol or the Brselective adrenoceptor partial agonist 
epanolol. The effects of nifedipine may have important implications for its anti-ischemic 
actions. It also should be a consideration when serial coronary flow reserve measurements 
are used to assess stenosis severity in patients using the drug. 
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Import~nce of vasomotor tone to myocardial function 
and regional metabolism during constant flow ischaemia 
. . 1n sw1ne 
Edward 0 McFalls, George A Pantely, Cheryl G Anselone, David J Bristow 
Abstract 
Study objective- The aim was to test the hypoth· 
esis that the release of vascular tone with adenosine 
during constant flow ischaemia alters both transmu-
ral function and regional metabolism in a detrimental 
way. 
Design- In one group of anaesthetised swine, the 
effects of graded reductions of flow on segmental left 
ventricular function, myocardial oxygen consump-
tion (MVo2), and lactate production in the distribu-
tion of the left anterior descending coronary artery 
(LAD) were detennined. In a second group, a model 
of constant flow ischaemia was induced to test how 
altering vascular tone with adenosine changed the 
relationship of flow, function, and metabolism. 
Experimental material - The experiments were 
perfonned in 20 open chest, anaesthetised swine. 
Protocol A consisted of 11 animals and protocol B of 
nine animals. 
Measurements and main results - In protocol A, 
during graded ischaemia, reductions in flow, % 
systolic wall thickening (WTh), nonnalised MVo2 
and % lactate extraction (o/oLE) correlated well with 
reductions in coronary perfusion pressure when 
fitted with 3rd order polynominal curves (r = 0.78, 
0.87, 0.85 and 0.81 respectively; p<0.00001). In 
protocol B, during constant flow ischaemia, at 
control, % WTh was 33 (SD 11)%, mean coronary 
artery pressure was 72(10) mm Hg,. mean LAD 
transmural flow was 0.99(0.43) ml·min-1·g-l, and % 
LE was + 14(9)%. With inflation of a hydraulic 
occluder on the LAD, perfusion pressure was lo-
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wered to 38(5) mm Hf and transmural flow dropped 
to 0.76(0.31) ml·min- ·g-1 (intact vasomotion). Dur-
ing an infusion of intra coronary adenosine with flow 
held constant (absent vasomotion), o/oWTh was 
further reduced from 27(9) to 13(10) (p<0.001), and 
%LE from -18(42) to -70(61) (p<0.05). MVo2 with 
and without vasomotion did not differ signifi-
cantly at 3.14(0.75) and 3.18(0.86) ml·min-'·g-1 
respectively. 
Conclusion- In swine coronary circulation, r.edui:-
tions in regional function, MVo2 and lactate produc-
tion correlate well with reductions in flow and 
perfusion pressure during ischaemia with vasomotor 
tone intact. The effect of adenosine on vascular tone 
during constant flow ischaemia caused dramatic 
reductions in function and lactate extraction without 
altering MVo2• This emphasises the important role 
of vascular tone in protecting both transmural func-
tion and regional metabolism during moderate 
ischaemia. 
During myocardial ischaemia, the degree of 
preservation of perfusion to subendocardial layers is an 
important determinant of the degree of functional and 
metabolic alterations. 1-4 This in turn is dependent on 
multiple factors, one of which is coronary perfusion 
pressure. >-I? Another factor which affects sub-
endocardial perfusion is vasomotor tone, which may 
differ within regions of the myocardium at various 
levels of ischaemia. An infusion of adenosine during 
moderate ischaemia in dogs; for instance, has been 
shown to reduce vascular tone primarily in the 
subepicardium, with a redistribution of flow away 
from the subendocardium. 18 12- 14 In both 
anaesthetised and awake dogs, adrenergic innervation 
to the subepicardial regions of the myocardium has also 
been shown to play an important role in maintainin~ 
subendocardial perfusion during flow reductions. 1 
The loss of this a mediated vascular tone causes a 
maldistribution of flow along with a reduction in wall 
thickening. 20 21 
Although altering vasomotion during ischaemia has 
been shown to alter function, the effects on regional 
metabolism in a model of constant flow ischaemia have 
not been shown. Therefore, in anaesthetised swine, we 
first determined the relationship of perfusion pressure 
to wall thickening, lactate production, and myocardial 
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oxygen consumption with intact vasomotion over a 
wide range of ischaemic flow reductions. We then 
studied the effects of modifying vasomotor tone with 
adenosine, at two levels of ischaemia during which flow 
was held constant. The data support the hypothesis 
that during ischaemia, vascular tone in the 
subepicardium plays aD. important role in preserving 
both transmural wall thickening and correlates of 
metabolism, including myocardial oxygen 
consumption and l;lctate production. 
Methods 
ANIMAL PREPARATION 
We performed two sets of , experiments. The 
preparation was similar in t>o'th, and has been 
described previously. 22 23 Domestic swine of either 
sex weighing between 31 and 47 kg were studied. 
Premedication consisted of an initial inrramuscular 
dose of xylazine (2 mg·kg-1) and ketamine (12 
mg·kg-1). Anaesthesia was then provided by a bolus of 
intravenous morphine sulphate (Z mg·kg-1) and 
ketamine (10 mg·kg-1). A constant intravenous 
infusion of morphine sulphate (1 mg·kg-1·h-1) and 
ketamine (10 mf:·kr'·h-1) was maintained throughout 
the experiment. 2 d-Tubocurarine, 2 rnl in-
travenously, was given during the surgical preparation 
to minimise muscular activity during the use of 
electrocautery. Animals were intubated, placed on a 
piston respirator, and ventilated with oxygen enrich~ 
air. The respirator was adjusted to keep arterial pH 
between 7.35 and 7.45, Pc~ at 4.7-6.0 kPa, and Po2 
above 13.3 kPa. Rectal temperature was monitored 
and kept between 36.7 and 38.3°C. Through a 
cutdown, the femoral vein and artery were cannulated. 
A midline sternotomy was performed and the heart 
suspended in a pericardia! cradle. A catheter was 
placed in the left atrium and one in the apex of the left 
ventricle for recording pressure and its first derivative. 
The left anterior descending coronary artery was 
dissected free from surrounding tissue and a Statham 
flow probe (2.0-2.5 mm diameter) followed by an 
inflatable hydraulic occluder were placed proximally. 
Distally, a small silicone catheter (inside diameter 0.3 
mm, outside diameter 0.6 mm) was inserted and used 
to monitor distal coronary pressure. Using a similar 
technique, a catheter was inserted into the distal great 
cardiac vein for sampling regional venous lactate and 
oxygen saturation from the ischaemic left anterior 
descending artery bed. On the left ventricular free wall 
served by the left anterior descending artery, epicardial 
and endocardial ultrasonic crystals (5 MHz) were 
placed perpendicular to each other and their proper 
position confirmed at the conclusion of each 
experiment. End diastolic wall thickness was measured 
at the on,set of positive dP/dt, and end systolic wall 
thickness was measured 20 ms before peak negative 
dP/dt. The extent of wall thickening was calculated as 
the difference hi· mm between end systolic and end 
diastolic dimensions and expressed as a percentage 
change from end diastolic wall thickness. 
Phasic and mean coronary flow and pressure, 
electrocardiogram, systolic left ventricular wall 
thickness, and left ventricular pressure and its first 
derivative were recorded during each study on an eight 
channel Mark 200 Brush recorder. Pressure was 
measured using Statham P-23 Gb pressure transducers 
Calibrated against a mercury manometer. Flow probe 
zero readings by transient left anterior descending 
artery occlusion were obtained at the conclusion of 
each ischaemic period. Oxygen (02) content was 
determined on a Lex-OrCon and the %02 extraction 
was computed by dividing the arterial-coronary venous 
0 2 content difference (vol %) by the arterial 0 2 content 
and multiplying by 100. Myocardial oxygen 
consumption (MVo2) was determined by multiplying 
0 2 content differences by the flow probe reading in the 
first protocol (A) and microsphere flows in the second 
protocol (B). 
Lactate concentrations were determined from 
plasma by an electrode technique18 and lactate 
extraction calculated by dividing the difference of 
arterial and cardiac vein lactate concentration by the 
arterial concentration and multiplying by 100. 
Studies were performed in accordance with the 
Tabkl Fvncricnal and tMtaboli<. flariabks al conlTOI and during graded reducrions in flow (pro10eol A). Dara are means (SD) 
Control During fZqw reducrion 
(n=ll) 
Pressure 77(13) so 45 40 35 30 25 20 
(mmHg) (n=7) (n=6) (n=3) (n=4) (n=5) (n=4) (n=3) 
Coronary flow (ml·min-1) 31(16) 25(14) 27(13) 15(5) 18(9) 12(8) 10(3) 5(3) 
Normalised flow 100 86(7) 79(13) 82(11) 59(9) 41(34) 42(16) 19(14) 
Wall thickening (%) 30(11) 25(11) 23(9) 31(16) 21(5) 6(8) 7(10) 1(5) 
Normalised % wall thickening 100 83(11) 80(13) 61(22) 55(17) 16(27) 19(46) 12(26) 
% <hygen ertraction 83(7) 89(6) 87(8) 92(4) 91(3) 93(4) 93(4) 93(4) 
MVo, (ml·mio-1) 3.2(1.5) 2.8(1.6) 2.7(0.7) 1.9(0.6) 1.8(0.7) 1.1(0.7) 1.1(0.5) 0.9(0.5) 
NomWised MVo2 100 89(7) 85(13) 86(7) 63(11) 44(35) 51(18) 31(16) 
Lactate ertraction (%) +11(16) -«36) +2(26) -123(125) -210(177) -160(107) -296(150) -362(25) 
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Figure I Coronary perfusion pressure versus (A) normalised 
flow, (B) normalised wall thickening, (C) normalised M Vo2, and (D)% lactate extraction at control and during variable ischaemia 
in I I swine(protocolA). 
63 
position of the American Hean Association on research 
animal use adopted November 11, 1984, and under the 
regulations of the Animal Care Committee of the 
Oregon Health Sciences Center. 
EXPERIMENTAL DESIGN 
Protocol A -The objective of this protocol was to 
obtain steady state functional and metabolic data at 
control and over a range of ischaemic flow reductions 
with intact vasomotion. The value SO mm Hg was 
chosen as the upper limit of the ischaemic range 
because this re~resents the point where autoregulation 
begins to fail. 2 At the beginning of each experiment, 
control measurements were made of pressure, flow, 
and wall thickness and simultaneous arterial and 
regional cardiac vein samples were drawn for 
determining oxygen content and lactate concentration. 
By use of a screw clamp attached to the occluder, 
coronary pressure was then lowered and measurements 
and blood samples obtained between 2 and S min of a 
steady state. The pressures were selected at S mm Hg 
intervals between 20 and SO mm Hg with the order 
randomly assigned. Pressure was allowed to rerum to 
normal after each set of measurements and the animal 
allowed to recover for at least IS min. It was required 
that function rerum to 90% of the original control value 
in order to include the results of subsequent 
measurements. This, we believe, eliminated any 
residual effects of prior ischaemic pressures on 
subsequent measurements . 
Protocol B -The objective in this protocol was to 
test how altered vascular tone during constant 
ischaemic flow affects transmural function and 
regional metabolism. We wished to induce two levels 
of ischaemia, with identical total flow but altered 
vascular tone, by using an infusion of intracoronary 
adenosine. The animals were prepared as described 
above with an additional left anterior descending artery 
catheter inserted proximal to the flow probe for 
infusion of adenosine.26 As in protocol A, initial 
measurements and blood samples were obtained for 
each animal and in addition regional myocardial blood 
flow was measured at control and at each subsequent 
ischaemic pressure. Radioactive microspheres (New 
England Nuclear, (9-11 micron) labelled with either 
141Ce, 51Cr, 103Ru or 95Nb were injected into the left 
atrium over 30 s while a reference sample was 
withdrawn from the aorta at a constant rate of 10 
ml·min-1 for 2 min. Microspheres were suspended in 
0. 9% saline and agitated for IS min prior to injection. 
Approximately 2-3 million spheres were injected for 
each measurement. 
Coronary flow was then lowered with the occluder to 
a level that reduced systolic wall thickening by 1 S-20%. 
The same measurements and samples as listed for the 
control period were obtained within 2-S min of 
achieving steady state and microspheres were injected. 
Adenosine (20 fLg·kg-1·min-1) was then infused into 
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the proximal left anterior descending artery catheter 
resulting in a rise in coronary flow. The occluder was 
adjusted so that coronary flow measured by flow probe 
was equal to the initial ischaemic flow. In a steady 
state, measurements and samples were again obtained 
and another set of microsphres was injected. 
After removal of the heart, the distribution of each 
coronary artery was identified by injecting 20 ml of 
different coloured dyes at equal pressures into each 
coronary artery. The heart was then placed in 10% 
buffered formalin. After 3-7 d, the tissue perfused by 
the left anterior descending artery was separated from 
the remaining left ventricle, and both were divided into 
inner, mid, and outer regions. The entire heart was cut 
up into approximately one gram tissue samples and 
each sample counted for 5 min using a programmable 
Nuclear Data ND600/600 multichannel analyser 
connected to a Packard Instrument Changer. 
Transmural and regional flows were calculated. 8 Since 
the objective was to perfuse the myocardium at two 
different pressures at a constant ischaemic transmural 
flow, we established prospectively that microsphere 
transmural flows at the two ischaemic periods were 
within IS% of each other. 
STATISTICS 
In the initial graded ischaemia studies (protocol A), 
flow, systolic wall thickening, and regional MVo2 were 
normalised to the control values at each ischaemic 
pressure. Scatter plots for coronary pressure were 
made with normalised flow, wall thickening, and 
MVo2 and% lactate extraction, and fitted with third 
order polynominal curves. For the constant flow 
experiments (protocol B), comparisons of the rwo 
ischaemic groups of data were made with paired 1 tests. 
All data are expressed as means (SD). 
Results 
HAEMODYNAMIC VARIABLES 
Eleven animals were studied in protocol A. During the 
control state, the left ventricular systolic and diastolic 
pressures were 99(13) mm Hg and 8(2) mm Hg 
respectively, and the heart rate was 94(13) beats· 
min-1• During the experiment, a maximum change of 
9% (mean) was observed in the heart rate or systolic 
blood pressure at any of the low pressures compared 
with control. 
Twelve animals were used in protocol B but the data 
from three are not included because transmural flow 
was not constant as specified by the design. At control, 
heart rate was 94(14) beats·min-1 and systolic and 
diastolic pressures were 96(11) and 10(2) mm Hg 
respectively. There were no statistical differences in 
these variables berween the control and rwo ischaemic 
periods. 
GRADED FLOW REDUCTIONS WITH INTACT 
VASOMOTION (PROTOCOL A) 
In the 11 animals, measurements were obtained at 
control and at a total of 32 pressures over the ischaemic 
range. Due to sustained effects on function from prior 
periods of ischaemia, the number of measurements in 
any given animal was limited. As discussed, we believe 
the arbitrary 90% recovery of function between 
• Subendo !low 
r?:1 Mid !low 
!ill Subepi !low 
Vasomolion 
intact 
Vasomotion 
absent 
(constant flow ischaemia) 
Figure 2 Regional coronary flow at conrrol and during constant 
flow ischaemia, with and without adenosine (protocolS). 
*p<O.OS; :f:p<O.OOI v control. 
Table II Constant flow ischaemia (protocol B). Data are means (SD). Statistical comparisons are between rwo ischaemic periods 
Constant flow ischaemia 
Control Vasomotion intact VasomOiion absent 
LAD flow (ml·min-1·g-1) 0.99(0.43) 0.76(0.31) NS 0.76(0.28) 
Inner/outer flow ratio 0.96(0.08) 0.91(0.26) p<0.01 0.59(0.16) 
MVo2 (m1·mm-1·100 g-1) 4.23(1.21) 3.14(0.75) NS 3.18(0.86) 
Wall thickening (%) 33(11) 27(9) p<0.05 13(10) 
Lactate extraction (%) +14(9) -18(42) p-<0.05 -70(61) 
LAD pressure (mm Hg) 72(10) 38(5) p<0.01 33(4) 
LAD=left anterior descending coronary artery; MVo2=myocardial oxygen consumption 
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Figure 3 (A) transmural flow, (B) %wall thickening, (C) % 
lactate extraction, and (D) myocardial oxygen consumption at 
control and during constant flow ischaemia, with and without 
adenosine (protocol B). 
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measurements allowed an accurate assessment of the 
effects of each ischaemic pressure and eliminated 
residual changes from prior measurements. 
Coronary flow was obtained by flow probe in these 
experiments and myocardial oxygen consumption 
(MVo2) expressed in ml·min-1• Because of interanimal 
variability in% wall thickening, flow, and MVo2 , these 
values were normalised to control values for each low 
pressure. All the data for the graded reductions in 
pressure protocol are listed in table I. 
Figure 1 shows perfusion pressure at control for the 
11 animals, and for each ischaemic period plotted 
against: (a) normalised flow, (b) normalised % wall 
thickening, (c) normalised MVo2 , and (d) % lactate 
extraction. As shown, reductions in flow, wall 
thickening, MVo2 , and lactate extraction correlated 
well with reductions in coronary pressure when fitted 
with third order polynominal curves (r = 0.78, 0.87, 
0.85, 0.81 respectively; p<O.OOOOl). These curves 
emphasise that during ischaemia with intact vasomotor 
tone, transmural function and regional metabolism are 
directly dependent on flow and perfusion pressure 
once autoregulation fails. 
CONSTANT FLOW ISCHAEMIA WITH ALTERED 
VASOMOTION (PROTOCOL B) 
The results of this protocol are shown in table II. At 
control, transmural flow was 0.99(0.43) ml·min·1·g·1 
and with vasomotion intact was then reduced to 
0.76(0.31) ml·min"1·g·1• This was associated with a 
modest reduction in wall thickening and lactate 
extraction, which was consistent with the findings 
from protocol A for a 20-25% reduction in flow (table 
I). Vasomotor tone was then released with the infusion 
of adenosine, and flow was held constant. Figure 2 
shows the transmural blood flow in the subendo-, mid, 
and subepicardial layers at control and during the two 
ischaemic periods. The only region which increased 
flow in response to adenosine was the subepicardium. 
This release of vasomotor tone resulted in a significant 
reduction in inner/outer ratios and was associated with 
a 5 mm Hg drop in perfusion pressure (table II). The 
changes in function, lactate production, and MVo2 at 
control and during ischaemia with and without 
vasomotor tone are further illustrated in fig 3. Panel 
(A) shows transmural flow, which was unchanged 
between the two ischaemic periods. Percent wall 
thickening and % lactate extraction were 33(11) and 
+ 14(9) respectively at control. With the loss of 
subepicardial vasomotor tone during ischaemia,% wall 
thickening was reduced from 27(9) to 13(10) (table II). 
This change is represented in panel (B). Percent lactate 
extraction during the same period was also reduced 
from -18(42) to -70(61) (p<O.OS) and is shown in (q. 
Myocardial oxygen consumption at control was 
4.23(1.21) ml·min"1·100 g·1• It is interesting that 
despite the reductions in wall thickening and lactate 
extraction with the loss of vasomotor tone, oxygen 
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consumption remained unchanged with and without 
vasomotion (fig 3D). 
Discussion 
The most important frnding in this study is that during 
moderate ischaemia, subepicardial vascular tone plays 
an important role in preserving regional myocardial 
metabolism, as well as transmural function. With total 
coronary flow held constant during the two ischaemic 
periods in protocol B, the effect of adenosine on 
subepicardial resistance reduced wall thickening and 
increased lactate production dramatically. In addition, 
the reduction in wall thickening with the infusion of 
adenosine was not associated with a parallel reduction 
in myocardial oxygen consumption, as might have 
been predicted from protocol A (fig 1C). This suggests 
that subepicardial vascular tone during ischaemia has 
an additional protective effect of minimising the cost to 
the myocardium by limiting the amount of oxygen 
consumed. 
Our results of the graded flow reduction experi-
ments in protocol A are consistent with the frndings of 
other workers. In open chest anaesthetised dogs, 
reductions in total coronary flow beyond 15-25% 
correlated well with reductions in regional function in a 
near linear fashion. 27- 29 More recently, it has been 
shown that reductions in regional wall shortening 
during variable ischaemic flows are better correlated 
with subendocardial flow than with either total or 
subepicardial flow. Weintraub et a/ 6 observed in 
anaesthetised dogs that below a perfusion pressure of 
50 mm Hg, reductions in transmural flow were linearly 
related to diastolic pressure. Normalised % systolic 
shortening, however, was best correlated with suben-
docardial blood flow when fit by a sigmoidal equation. 
In unanaesthetised dogs, similar relationships between 
graded subendocardial flow and transmural function 
have been observed. Gallagher et al2 found a mildly 
curvilinear but highly significant correlation between 
normalised wall thickening and subendocardial flow 
during six groups of variable ischaemic flows, with 
only a weak fit between total or subepicardial flow. In a 
similar model, Vatne~ has described a significant 
exponential relationship between reductions in seg-
mental length and subendocardial flow with graded 
flow reductions. 
These studies have extended the work of others in 
regard to oxygen consumption and lactate production 
during graded reductions in flow. We have shown that 
the degree of anaerobic glycolysis as measured by 
lactate extraction is inversely related to the degree of 
reduction in pressure over the ischaemic range. Figure 
1B shows the magnitude of change in lactate extraction 
over a wide range of pressures during ischaemia which 
parallels the reductions in function. Stowe et a/30 
studied the effects of various degrees of flow reduction 
in open chest swine and found only a weak correlation 
between reductions in flow and lactate extraction. In 
their study, only one ischaemic measurement was 
made per animal 15-60 min after the onset of reduced 
flow. The large degree of interanimal variability in 
lactate extraction limits its use as an indicator of 
ischaemia31 32 and together with the extended time of 
ischaemia may have influenced their results. The fact 
that we obtained multiple measurements per animal 
within 2-5 min of ischaemia may explain the differ-
ences in correlation between studies. 
Subendocardial perfusion during ischaemia has 
been shown to be dependent upon coronary perfusion 
pressure. s.-16 It is also dependent on factors in the 
subepicardium which maintain vascular tone. During 
moderate degrees of ischaemia in anaesthetised animal 
preparations for instance, adenosine has a greater 
vasodilator effect in subepicardial regions, and may 
induce a maldistribution of flow away from the 
subendocardium. 12 18 The recent observations of a 
adrenergic coronary vasoconstriction during ischaemia 
has also emphasised the importance of subepicardial 
tone to transmural flow distribution. 19 In anaesthe-
tised dogs, Nathan et al showed that subendocardial 
perfusion during constant ischaemic flow was lower in 
the presence of a blockade, thus showing the protec-
tive effects of a mediated constrictor tone in the 
subepicardium.21 The same effect has been shown 
during exercise in dogs, where intact a receptors 
maintained uniform transmural blood flow dis-
tribution. 20 
The relationship of MVo2 to regional function 
during and following ischaemia is also of great interest. 
In the graded ischaemia protocol, reductions in MVo2 
paralleled the changes in mechanical function over the 
ischaemic range of pressures and flows (fig 1C). 
During the constant ischaemic flow protocol, however, 
wall thickening was reduced but MVo2 remained 
unchanged (fig 3D). This implies that the myocardium 
consumes oxygen inefficiently for any level of work 
load when vasomotor tone is altered during ischaemia. 
There are several potential explanations for this. It is 
possible that with the release of vasomotor tone in the 
subepicardium during ischaemia, areas of myocardium 
are perfused which are unable to contribute to overall 
transmural thickening. A similar phenomenon may be 
present in regions of stunned myocardium where 
oxygen consumption is heterogeneous, despite an 
overall decrease in function. 33 34 An equally plausible 
reason for observing no change in MVo2 during the 
two ischaemic flows is that wall thickening is only a 
minor determinant of overall oxygen consumption. 
Therefore, during constant flow ischaemia, reductions 
in wall thickening during adenosine infusion have little 
effect on myocardial oxygen consumption. It is also 
possible that changes in MVo2 are more dependent on 
changes in flow than oxygen extraction, and therefore 
little variation would be expected during constant 
ischaemic flow. 
In summary, we have shown that during graded 
Constant flow ischaemia and vasomotor tone 
reductions in flow, with vasomotion intact, reductions 
in regional wall thickening, myocardial oxygen con-
sumption, and lactate extraction correlate well with 
reductions in coronary perfusion pressure. In a model 
of constant ischaemic flow, adenosine releases vasomo-
tor tone, primarily in the subepicardial regions, and 
reduces transmural wall thickening while increasing 
lactate production without a change in MVo2• There-
fore, subepicardial tone during moderate ischaemia 
plays an important role in preserving both function and 
metabolism. 
LIMITATIONS OF THE STUDY 
A major criticism of this study is the use of anaesthesia, 
which may independently alter coronary vascular tone. 
Our coronary dissections were minimal and we can 
only assume that our findings would apply to awake 
animals. In support of this is the fact that multiple 
srudies have used adenosine to alter coronary reactivity 
and have shown similar effects in both anaesthetised 
and unanaesthetised animals. The use of adenosine to 
stimulate maximum vasodilatation has been universal 
but deserves some comment. At variable heart rates, its 
effect on the degree of transmural vasodilatation may 
not be uniform. 6 Because no statistical difference in 
heart rate was observed between the ischaemic groups, 
this was not a problem. Of importance is the site of 
action of the agent relative to the region of the 
myocardium. Crystal el a/35 srudied the effects of 
coronary adenosine infusion in anaesthetised dogs and 
showed at a constant non-ischaemic pressure, equiva-
lent increments in flow transmurally. They also 
showed no effects on myocardial oxygen consumption, 
small vessel blood volume, or packed cell volume. The 
potential negative inotropic effects of adenosine also 
deserve comment. In isolated atrial muscle prepara-
tions, adenosine in physiological concentrations has 
been shown to inhibit catecholamine mediated in-
creases in myocardial contractility. 36 This is unlikely to 
have contributed to the drop in function in our 
experiments since adenosine in doses sufficient to 
cause maximal coronary vasodilatation has not been 
shown to have negative inotropic effects. 13 
Finally, the use of regional atriovenous gradients for 
the detertnination of myocardial consumption during 
ischaemia may be criticised as being ·heterogeneous, 
particularly in non-steady-state conditons. 37 We be-
lieve that our measurements were obtained after a long 
enough period to allow for equilibration of regional 
flows. In terms of its sensitivity for regional changes in 
flow, table I shows that oxygen and lactate extraction 
were quite sensitive to alterations in perfusion pressure 
over a range of even 5 mm Hg. 
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1987.-During myocardial ischemia, we tested whetper coro-
nary blood flow would increase in response to tachycardia, 
thereby employing known coronary flow reserve. We instru-
mented the left anterior descending (LAD) coronary circulatiol) 
in anesthetized pigs and performed three sets of experiments 
while coronary pressure was controlled and several heart rate 
increases were p-roduced, 1) Pacing-induced tachycardia at nor-
mal LAD pre'!sure was characterized by increased LAD flow 
and myocardial oxygel) consumption, without production of 
lactate. 2) Tachycardia at a mean LAD pressure of 38 mmHg 
was associated with a lower, fixed coronary flow and oxygen 
consumption. At average heart rates of 90 and 150 beats/min, 
LAD flow was 19.6 a[ld 19.4 ml/min and corresponding myo-
cardial blood flows were 0.59 al)d 0.54 ml·g-'·min-1• Lactate 
was produced at al) rates and local myocardial function declined 
progressively. 3) Coronary flow at low LAD pressure doubled 
during tachycardia when intracoronary adenosine was added. 
The increase to t)le subepicardium was >100%, whereas sub-
endocardial flow changed little. There is persistent coronary 
flow reserve during moderately severe myocardial ischemia, 
even when metabolic demand is increased by tachycardia. This 
reserve, however, is predomjnantly subepicardial. 
coronary circulation; myocardial oxygen cop.sumption; lact-ate 
metabolism; adenosine 
DESPITE MYOCARPIAL ISCHEMIA resultin~ from mo!Ier-
ately low coronary arterial pressure,. the coronary vas-
cular bed does not vasodilate fully. Several studies have 
shown that considerable coronary flow reserve is induc-
ible by adenosine at ischemic levels of pressure (1, 6, 10, 
24). Su-ch increases in myocardial blood flow do not seem 
to improve local myocardial function and metabolism 
significantly in the ischewic..zone, suggesting that the 
region has been set at a new relationship among flow, 
function, and metabolism. It is not clear why this reserve 
of vasodilation exists in the presence of ischemia, or 
what the responses to an increase in local myocardial 
metabolic demand might be In this situation. Prior in-
vestigations of the effect of increased demand on coro-
nary dynamics, myocardial performance, and metabolism 
at low pressure levels have been few and have led to 
divergent conclusions (16, 29). 
Our study was designed to investigate the effects of 
increased heart rates at a controlled, low coronary artery 
pressure on coronary flow dynamics, local left ventricular 
mechaiJical function, and metabolism. We postulated 
that the demands imposed by the increased metabolic 
requirements of heart rate would result in coronary vas-
odilation, using known flow reserve. This would be ex-
pressed as an increase in total coronary blood flow, or, 
at the least, in tjle level of coroQary flow during late 
diastole. 
Our experiments demonstrated that this was not the 
case, however. CoronaFY blood flow and myocardial ox-
ygeq consumption (MVo2) proved to be remarkably con-
staqt at low coronary pressure, despite considerable in-
creases in heart rate and in the face of coronary flow 
reserve, demonstrated by intracoronary adenosine. This 
pharmacologically induced increase .in flow was distrib-
uted mainly to the subepicardium of the left ventricle, 
and the subendocardium received l!lUCh less of an incre-
ment. 
METHODS 
Preparation 
Seventeen do!I)estic pigs were studied; weights ranged 
from 33 to 50 kg. The preparation was similar to that 
previously reported (24-26) and is summarized below. 
Premedication was given with xylazine (2 mg/kg) and 
ketamine (10 mg/kg). intramuscularly. Anesthesia was 
provided with morphine sulfate (2 mg/kg) and ketamine 
(6 mg/kg) intravenously, followed by a constant infusion 
of morphine at 1 mg-kg-1 -h-1 and ketamine 10 mg-kg-1 • 
h-1; chondrocurine was given as required when anesthe-
sia level was assured. 
Ventilation with oxygen-enriched air was produced 
with a piston ventilator so as to produce an arterial pH 
between 7.35 and 7 .45, partial arterial pressure of C02 
(Paco,l between 35 and 45 and partial arterial pressure 
of 0 2 (Pa0 ,) above 100 mmHg. Rectal temperature was 
monitored and maintained above 98·F. After a midline 
sternotomy was performed, catheters were inserted into 
the left ventricular apex and left atrium, as well as the· 
aorta and inferior vena cava from the femoral region. 
The proximal left anterior descending coronary artery 
(LAD) had the following placed in or around it. A small 
Silastic catheter (0.3 mm !0, 0.6 mm OD) was inserted 
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in the mid-LAD for recording pressure; its response 
characteristics have been described (24). An electromag-
netic flow probe (2.0 or 2.5 mm) was placed on the LAD 
proximally, immediately followed by an inflatable fluid-
filled occluder around the vessel. Another Silastic cath-
eter was inserted into the anterior cardiac vein as it 
coursed parallel to the LAD, at the same level as the 
LAD occluder. It was used to sample coronary venous 
blood. For protocol3, a second LAD catheter was inserted 
proximally for infusion of adenosine. 
Meticulous attention was paid to the positioning and 
stability of the electromagnetic flow probe. The zero base 
line for the system was set during complete occlusion of 
the LAD, produced by inflation of the occluder. Once 
placed on the LAD, the transducer was not moved or 
adjusted during an experiment. No.recordings were used 
if problems developed with the probe, i.e., all data are 
from experiments with stable, continuous flowmeter op-
eration without adjustment of its position. Zero flow was 
checked briefly after each experimental period. Measure-
ments were made of mean flow and that at end diastole, 
defined as 30 ms before the onset of the QRS complex. 
Myocardial blood flow was measured with radioactive 
microspheres (11 ± 0.3 JLID diam, New England Nuclear) 
labeled with 141Ce, 51Cr, 103Ru, and 95Nb (18). A reference 
sample was withdrawn from the aorta at a rate of 10 ml/ 
min for 2 mins. Left atrial injection of spheres spanned 
30 s and was begun shortly after the start of the reference 
sample collection. Preparation and counting of spheres 
was performed as we previously reported (24). 
A pair of ultrasonic crystals (5 MHz) was placed in 
the anterior wall of the left ventricle in the region served 
by the LAD (27). One crystal was sewn to the epicardium 
and the second was inserted obliquely to its subendocar-
dial position. The crystals were used to measure diastolic 
wall thickness and systolic thickening, with timing of 
mechanical systole as described by Gallagher (12). After 
the hearts had been removed, different colored dyes were 
injected simultaneously at. the same rate in the LAD and 
right coronary arteries to define the myocardial region 
served by the LAD and to assure that the dimension 
crystals were well in the center of it. 
Pressures were recorded with Statham P23 Gb trans-
ducers. Pressures, electromagnetic flow, ultrasonic crys-
tals, and electrocardiographic signals were recorded on 
an eight-channel Mark 200 Brush pen recorder. Oxygen 
content of arterial and coronary venous samples was 
determined in duplicate with the Lex-02-Con. 
Plasma lactate concentration was determined in trip-
licate using the method of Clark (8, 9). Blood samples 
were drawn into iced syringes containing heparin fluo-
ride. They were promptly centrifuged, and the plasma 
was then decanted and frozen for later analysis. Lactate 
consumption or production was expressed in micromoles 
per minute, ignoring red blood cell (RBC) content of 
lactate. 
Small electrodes were clipped to the lateral·wall of the 
right atrial appendage and used for atrial pacing with a 
clinical pacemaker, generally set at 5 rnA. 
Protocols 
A total of 17 swine was studied. There were Reven 
animals in protocol I, used to study the effects of an 
increase in heart rate at normal coronary pressure. Ten 
animals were included in protocol 2, which studied the 
effects of increased heart rate at low coronary pressure. 
Five of these animals participated in both protocols I and 
2. In these, stable hemodynamics were present after the 
pacing protocol at normal LAD pressure, and the pacing 
study at low pressure was performed. Five other animals 
were studied in protocol 3; none of these participated in 
other protocols. 
Protocol 1: pacing at normal coronary pressure. This 
set of experiments was performed to confirm that our 
preparation would respond to atrial pacing at normal 
LAD pressure with an increase in mean and end-diastolic 
coronary flow, and in MVo2• Approximately 30 min after 
the completion of the surgical procedure, control mea-
surements were made. Atrial pacing was then begun, by 
choosing a heart rate slightly above the spontaneous 
rate, which consistently produced capture (the control-
paced rate). This averaged 12 beats/min faster then the 
spontaneous rate. Increases in heart rate were then stud-
ied at 10-beat/min increments above that, up to 60 beats/ 
min above the paced control, but with return to the 
control-paced rate between each one. Before the next 
increase in rate was studied, stable control findings were 
obtained. The sequence of the increases in heart rate was 
varied, although the most extreme increase in rate ( +60 
beats/min) was reserved for last. 
Blood' samples for oxygen and lactate analyses were 
drawn in the control and paced control periods, and with 
increments of 20, 40, and 60 beats/min. Sampling was 
performed after 3 min of stability at a given rate. · 
Protocol 2: pacing at low LAD pressure. These experi-
ments were the primary focus of our study. We.wished 
to determine whether an increase in coronary and myo-
cardial blood flow and MVo2 could be induced with atrial 
pacing at moderately low LAD pressure. We studied 
several moderate increases in rate, so as· not to miss an 
increment in flow that might be lost at faster rates, with 
progressive loss of diastolic time. 
After control measurements at the spontaneous heart 
rate, a paced heart rate was produced that provided 
consistent capture of the heart; this control paced rate 
averaged 90 beats/min. After measurements were made 
at that rate, the coronary hydraulic occluder was inflated 
to reduce LAD pressure and flow. The extent of reduction 
desired was that which would decrease systolic left ven-
tricular wall thickening by -20-35%. This LAD mean 
pressure level was then employed for all subsequent. 
experimental periods in that animal. Once that level was 
determined, and held for 3 min, blood samples were 
obtained and measurements recorded. The heart rate 
was then continued at the control-paced setting, and the 
coronary occlusion released. After a period of stability, 
the occlusion was set at the same level of mean pressure 
as in the preceeding period, and a different heart rate 
produced at increments of 10 beats/min up to a total of 
60 beats/min above the control-paced rate. Between each 
of these experimental periods, the occlusion was released, 
and the control-paced rate reproduced. The rest interval 
between each experimental period varied from 5 to 25 
min. 
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Blood samples for oxygen and lactate studies were 
obtained in all experimental periods (control, control 
paced, control paced at low pressure, and low pressure 
plus 10, 20, 30, 40, 50, and 60 beats/min above the 
control-paced rate) after 3 min of stability. As in protocol 
1, the sequence of heart rates was varied so as to avoid a 
systematic change, but the 60 beat/min heart rate in-
crease was done last. 
Ten animals had four microsphere determinations of 
myocardial blood flow, all of which were performed dur-
ing low pressure. In five animals these determinations 
were made during the control-paced rate and at incre-
ments of 10, 20, and 30 beats/min. In the other five 
animals, measurements were made at the control-paced 
rate as well as with 20-, 40-, and 60-beatjmin increments. 
Protocol3: pacing at low LAD pressure with and with-
out intracoronary adenosine. In five other animals, mea-
surements were first made at the control and control-
paced heart rates. As in protocol2, the LAD pressure was 
then lowered and measurements made at the control-
paced rate. The rate was then increased by 20, 40, and 
60 beats/min above the control-paced rate, whereas mean 
LAD pressure was kept constant. After 3 min at a given 
rate, sampling was done. Then intracoronary adenosine 
was begun at a dose of 20 l'g · kg-1 • min-t. Measurements 
were repeated after stable readings were present. A period 
of normal LAD pressure and control-paced rate was 
provided between the different increased rates, but not 
between measurements with and without adenosine, 
which was added at a given rate. Microsphere flow mea-
surements were made at low LAD pressure with and 
without adenosine during heart rate increments of 20 
and 60 beats/min. 
Calculations 
MVo2 was calculated for the region served by the LAD 
beyond the flow transducer as the product of mean LAD 
flow (flowmeter) and the arteriocoronary venous oxygen 
difference. 
Lactate consumption or production was calculated on 
the basis of plasma values by the formula: lactate, !'mol/ 
min = (1 - hematocrit)(coronary flow)(AV lactate dif-
ference). 
Systolic wall thickening was the difference between 
systolic and diastolic thickness, expressed as a percent 
of diastolic thickness (12). 
Statistical Analysis 
Results are given as means and standard deviations. 
Most of the variables were tested by one-way analysis of 
·variance with repeated measures. Range testing was done 
with Tukey's test. For some of the microsphere flow 
determinations, two-way analysis of variance was done 
to compare effects of heart rate change within the LAD 
and non-LAD distributions. For the evaluation of some 
relationships, regression analysis was performed. 
RESULTS 
Representative tracings are presented in Fig. 1. 
Protocol I: Normal LAD Pressure 
We wished to be certain that our preparation behaved 
as expected in response to increased heart rate at normal 
pressure. The spontaneous heart rate averaged 81 beats/ 
min, the control paced rate was 93, and the average paced 
maximum in this group was 153. End-diastolic LAD flow 
rose with each increment in rate and increased substan-
tially overall, more than doubling between rates of 81 
and 153 beats/min (35.3-73.4 ml/min, P < 0.0005, Figs. 
1 and 2). There was a strong positive correlation between 
heart rate and the average values for end-diastolic flow 
a~ each rate (r = 0.96). Mean LAD flow increased Jess, 
wtth an overall change of 38%. 
Increases in heart rate were associated with increased 
diastolic thickness, reflecting a smaller diastolic volume 
(4, 27). This relationship was systematic, with correla-
tion coefficients for the relationship between heart rate 
and diastolic thickness in individual experiments which 
averaged 0. 79 and were between 0.84 and 0.93 in six of 
the seven studies. There was a modest decrease in systolic 
thickening with increased heart rate, from 38% in the 
control state to 28% at a heart rate of 153 (P < 0.0005, 
Fig. 3). 
MVo. rose with increases in heart rate; the maximum 
change was 38% (P < 0.0005). The rise in oxygen con-
sumption varied in a linear fashion with the increase in 
heart rate (r = 0.81). 
The amount of lactate consumed did not change with 
pacing; net lactate production did not occur. Thus evi-
dence of anaerobic metabolism was not found in this 
preparation at the heart rates produced at uncontrolled 
(normal) LAD pressure. 
Protocol 2: Low LAD Pressure 
Results are presented in Tables 1 and 2 and Figs. 1-3. 
Heart rate and LAD pressure. The spontaneous heart 
rate averaged 74 beats/min, and the cqntrol-paced rate 
was 90; the maximum paced rate averaged 150 beats/ 
min. The standard deviation of -9 beats/min at each 
paced rate reflects the different rates in different ani-
mals, not variation in the paced rate in each animal. 
Mean LAD pressure was lowered after measurements 
were made at the control-paced rate. The mean pressure 
chosen in each animal produced a -25% decrement in 
systolic wall thickening at the control-paced rate. The 
pressures to achieve this ranged from 28 to 50 mmHg in 
different animals. Once chosen, a given mean pressure 
was used consistently throughout the remainder of the 
rates in that animal. The standard deviation for LAD 
pressure of -7 mmHg during the low pressure periods 
reflects different levels in different animals, rather than 
variation within an animal. The degree to which low 
mean LAD pressure could be reproduced during the 
experiments was shown by the mean difference of sub-
sequent periods from the original control-paced-low pres-
sure period, of 1.1 ± 2.2 (SD) mmHg. 
End-diastolic and mean LAD flow. When LAD pressure 
was lowered at the control-paced rate, mean LAD flow 
fell 26% and LAD end-diastolic ·flow fell 54% (P < 
0.0005). Thereafter, at rates up to 60 beats/min ahove 
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FIG. 1. A: record from protocol! with induced tachycardia at 
normal left anterior descending artery (LAD) pressure. An over-
all 15% increase in end-diastolic LAD flow is associated with 
the increase in rate. Control systolic left ventricular (LV) wall 
thickening of 38% decreases to 34% with a control-paced rate of 
no beats/min. It then declines slightly to 28% with a further 
increment of 60 beats/min. Timing for calculation of thickening 
is shown by short vertical lines. B: same animal, during protocol 
2. When LAD pressure is lowered, thickening declines to 31%, 
associated with a 50% fall in mean LAD flow. When tachycardia 
is produced, function decreases to 25% (20-beats/min increment) 
and then to 7% (60-beats/min increment). Addition of adenosine 
(adeno) at each paced rate substantially increased mean LAD 
flow, demonstrating previously unused coronary reserve. ECG, 
electrocardiogram. 
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FIG. 2. Values are means ± SD for end-diastolic left anterior de-
scending artery (LAD) flow. Open circles, measurements during pacing-
induced tachycardia at normal LAD pressure; closed circles, protocol 2 
low LAD pressure group; C, control at normal pressure; CP, paced-
control heart rate at normal pressure; CP low, low LAD pressure at 
control-paced rate. +10, +20, etc., increments in heart rate at low LAD 
pressure. End-diastolic flow rises sharply in normal pressure group. 
First two closed circles represent control and control-paced data at 
normal LAD pressure in protocol2. Thereafter, LAD pressure was kept 
constantly low; flow fell and did not rise with tachycardia. 
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FIG. 3. Values are means± SD for systolic function in myocardial 
zone perfused by· LAD. Format and abbreviations are same as in Fig. 
2. 
the paced control rate, neither mean nor end-diastolic 
flows significantly increased. For example, mean LAD 
flow was 19.6 ml/min at the control-paced rate during 
low pressure and was 19.4 ml/min at 60 beats/min faster. 
Myocardial blood flow by microsphere determinations. 
Two sets of data were obtained, each from five animals. 
One set was at the low-pressure control rate and 10, 20, 
and 30 beats/min above it; the other was at increments 
of 20, 40, and 60 beats/min. All points were obtained 
during low LAD pressure. Results are summarized in 
Table 2. 
In the LAD region flow did not increase significantly 
in either series with increases in heart rate at low LAD 
pressure. In fact, at the faster rates, there was a down-
ward trend in subendocardial flow, and a decrease in the 
subendocardial-to-subepicardial ratio, Efs demonstrated 
by regression analysis (r = -0.63). 
In the non-LAD region, which was exposed to normal 
coronary pressure, increases in transmural flow occurred 
in the 20, 40, 60 series (P < 0.01). Increases 'in all three 
layers were suggested by regression analysis. The average 
endocardial-to-epicardial flow ratios remained between 
1.10 and 1.31 in the two series of rates. 
Every measurement in every animal showed a lower 
value for flow in the LAD region than the non-LAD 
region and this change was significant by two-way anal-
ysis of variance (P < 0.05 in the + 20, 40, 60 series and 
P < 0.01 in the + 10, 20, 30 series). 
Left ventricular wall function. In the control-paced low 
pressure period, LV systolic wall thickening had declined 
by design. Further increases in heart rate produced pro-
gressively more severe reductions in function (Fig. 3). At 
a rate of 60 beats/min above the paced-control rate, the 
value for systolic thickening had declined from an aver-
age of 36.7 to 5.1%, and the wall was dyskinetic in some 
animals. 
There was no consistent relationship between heart 
rate and end-diastolic thickness, as seen in protocol 1. 
The average correlation coefficient between these vari-
ables was 0.26 from the 10 experiments. 
The relationship between end-diastolic wall thickness 
and systolic thickening was also quite different than in 
protocol!, wherein a consistent negative relationship was 
found between the average values for these two variables. 
At low pressure, systolic thickening was more or less 
completely dissociated from end-diastolic thickness, i.e., 
resting thickness changed little while thickening declined 
markedly. 
Oxygen and lactate data. Comparing MVo 2 during the 
paced low-pressure control period with the six subse-
quent increases in heart rate, no increase was found. At 
an average rate of 90 beats/min, 2.1 ml/min was mea-
sured, vs 2.05 at rate 150. There was a strong, positive 
correlation between oxygen consumption per beat and 
systolic wall thickening (r = 0.97). Oxygen extraction 
from arterial blood increased from 76.4% in the original 
control period to 89.4 with low pressure. This value 
gradually increased modestly to 92.7% extraction at the 
fastest heart rate. 
Lactate consumption was present in the control and 
control-paced period, promptly changed to production at 
low pressure and stayed negative. Looked at as simply 
positive or negative· quantities, there is shift of extraction 
from positive to negative at low LAD pressure as shown 
by Cochran's Q test (P < 0.001). Lactate consumption 
shifted to production with low pressure and progressively 
rose (P < 0.0005, Table 1). 
Protocol3: Low LAD Pressure and Adenosine 
Although adenosine-mediated changes in coronary 
blood flow have been well documented at spontaneous 
heart rates, it was not known if vasodilation reserve was 
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TABLE l. Pacing-induced tachycardia during ischemic LAD pressure 
Control Control Low Pressure 
l:J. Heart Rate, beats/min 
p Pace Pace +20 +40 +60 
Heart rate, beats/min 74.1±13.4 89.9±9.4 90.1±9.2 110.0±9.4 130.3±9.1 150.2±9.5 <0.0005 
Mean LAD pressure, 75.0±12.7 77.2±14.6 37.3±7.6 38.5±7.2 39.0±7.7 38.3±6.8 <0.0005 
mmHg 
End-diastolic LAD 63.7±10.4 70.1±14.1 22.2±4.6 22.3±4.5 23.6±4.5 25.8±4.5 <0.0005 
pressure, mmHg 
Mean LAD flow, mlfmin 23.9±6.8 26.4±7.2 19.6±5.5 20.5±6.6 20.1±7.1 19.4±5.8 <0.0005 
End-diastolic LAD flow, 30.2±11.9 41.2±13.3 18.9±7.0 19.8±6.5 21.9±7.8 21.9±7.2 <0.0005 
ml/min 
Systolic wall thickening, 36.7±10.4 31.6±9.7 23.9±6.5 18.2±8.3 6.9±10.3 5.1±7.6 <0.0005 
% 
End-diastolic wall 8.65±1.1 9.02±1.1 8.86±1.1 9.00±1.1 8.85±1.2 9.08±1.2 NS 
thickness, mm 
M'Vo2,ml/min 2.11±0.74 2.34±0.72 2.10±0.69 2.13±0.86 2.19±1.00 2.05±0.87 NS 
Lactate consumption, 4.4±5.4 5.1±6.1 -3.4±12.4 -4.8±11.3 -19.4±20.8 -10.6±12.6 <0.0005 
J.Lmol/min 
LV systolic pressure, 92.4±18.1 95.6±16.9 92.7±17.8 86.8±14.8 88.1±14.6 81.0±10.7 <0.0005 
mmHg 
LV diastolic pressure, 8.7±3.0 6.9±1.9 7.0±1.4 6.1±2.0 6.4±2.2 6.9±2.4 NS 
mmHg 
Values are means± SO. LAD, left anterior descending artery; .6. heart rate, increases of 20, 40, and 60 beats/min in control pace heart rate~ 
MVo2, myocardial 0 2 consumption; LV, left ventricular; NS, not significant. 
TABLE 2. Microsphere determinations of myocardial blood flow during pacing at ischemic LAD pressure 
LAD Distribution Non-LAD Distribution 
Low pressure +10 +20 +30 ANOVA Correlation Low pressure +10 +20 +30 ANOVA Correlation control (probability) control (probability) 
Subendocardial flow, 0.41 0.40 0.49 0.45 NS 0.12 0.66 0.67 0.86 0.86 NS 0.11 
ml· min-1 • g-1 ±0.17 ±0.11 ±0.21 ±0.14 (NS) ±0.15 ±0.25 ±0.28 ±0.26 (NS) 
Midwall flow, 0.54 0.54 0.62 0.62 NS O.Q7 0.65 0.66 0.82 0.80 NS 0.02 
ml·min-1·g-1 ±0.19 ±0.15 ±0.16 ±0.17 (NS) ±0.18 ±0.24 ±0.24 ±0.32 (NS) 
Subepicardial flow, 0.54 0.50 0.66 0.67 NS 0.01 0.60 0.58 0.74 0.75 NS 0.03 
ml· min-1 • g-t ±0.16 ±0.21 ±0.24 ±0.24 (NS) ±0.12 :t0.21 ±0.23 ±0.23 (NS) 
Ratio 0.76 0.86 0.76 0.68 NS 0.22 1.10 1.16 1.16 1.15 NS 0.47 
±0.28 ±0.17 ±0.24 ±0.10 (NS) ±0.13 ±0.11 ±0.10 ±0.09 (<0.05) 
Total flow, 0.51 0.49 0.60 0.60 NS O.Q7 0.63 0.64 0.79 0.80 NS O.ol 
ml· min-1 • g- 1 ±0.16 ±0.17 ±0.19 ±0.19 (NS) ±0.13 ±0.23 ±0.24 ±0.27 (NS) 
LAD Distribution Non-LAD Distribution 
Low pressure +20 +40 +60 ANOVA Correlation Low pressure +20 +40 +60 ANOYA Correlation control (probability) control (probability) 
Subendocardial flow, 0.58 0.53 0.45 0.41 NS -0.45 0.84 1.02 1.00 0.97 NS 0.45 
ml-min- 1 ·g- 1 ±0.17 ±0.15 ±0.21 ±0.20 (<0.05) ±0.11 ±0.23 ±0.!9 ±0.20 (<0.05) 
Midwall flow, 0.61 0.60 0.53 0.53 NS -0.29 0.85 0.98 1.02 0.97 NS 0.58 
ml· min-1 • g- 1 ±0.10 ±0.12 ±0.26 ±0.25 (NS) ±0.20 ±0.25 ±0.19 ±0.19 (<0.01) 
Subepicardial flow, 0.59 0.68 0.59 0.62 NS 0.10 0.65 0.81 0.81 0.78 <0.001 0.58 
ml· min-1 • g-1 ±0.13 ±0.10 ±0.13 ±0.10 (NS) ±0.11 ±0.17 ±0.14 ±0.14 (<0.01) 
Ratio 0.99 0.77 0.73 0.64 NS -0.63 1.31 1.25 1.24 1.26 NS 0.10 
±0.27 ±0.21 ±0.29 ±0.23 (<0.01) ±0.09 ±0.11 ±0.18 ±0.30 (NS) 
Total flow, 0.59 0.63 0.54 0.54 NS -0.24 0.75 0.92 0.92 0.88 <0.01 0.57 
ml· min-1 • g-1 ±0.12 ±0.09 ±0.18 ±0.15 (NS) ±0.13 ±0.20 ±0.16 ±0.15 (<0.01) 
Values are means± SD; n- 5. All determinations were made dunng low LAD pressure. +10, +20, etc., mcrements m heart rate above the 
paced control; ratio, subendocardial-to-subepicardial flow ratio. ANOVA, analysis of variance. See Table 1 for abbreviations. Correlation 
coefficients (r) were calculated from the regression of all flow data points on heart rate. 
still present at high heart rates, as well. Thus protocol3 
was performed at three rate increases with and without 
' intracoronary adenosine. Table 3 summarizes the results. 
' Heart rate and LAD pressure. The changes in heart 
rate were similar to the other two protocols. The average 
spontaneous rate of 93 beats/min was captured with the 
paced rate of 100; the average maximum produced in this 
protocol was 164 beats/min. The mean LAD pressure 
that produced an 18% decrement in systolic wall thick-
ening was 44 mmHg at the control-paced rate. 
End-diastolic and mean LAD flow. Changes at the 
control-paced rate at low pressure were as seen in protocol 
2. When intracoronary adenosine was added at each of 
the four rates (control paced, +20, +40, +60) marked 
increases in end-diastnlic flow occurred (P < 0.0005). 
Mean flow values demonstrated similar changes. At the 
control-paced rate at low pressure, adenosine increased 
the mean flow from 30.2 to 78.2 and at 60 beats/min 
faster rate, 27.6 changed to 67 ml/min. Thus, despite the 
encroachment on cliastolic time hy tachycardia, marked 
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TABLE 3. Results from pacing-induced tachycardia during low LAD pressure, 
before and during intracoronary adenosine 
Low Low ll Heart Rate, beats/min 
Control Control Pressure Pressure ANOVA Pace Pace Pace+ +20 +20 +40 +40 +60 +60 Adena (Adena) (Adena) (Adena) 
Heart rate, beats/min 93.2 100.2 102.0 102.6 120.0 120.0 142.0 142.0 164.4 164.4 <0.0005 
±18.8 ±12.5 ±9.0 ±9.8 ±12.2 ±12.2 ±8.4 ±6.4 ±8.9 ±8.9 
Mean LAD pressure, 82.0 83.8 44.0 43.6 44.4 43.6 44.0 42.6 42.4 43.4 <0.0005 
mmHg ±10.8 ±11.9 ±5.9 ±4.8 ±4.9 ±4.7 ±4.7 ±5.5 ±4.4 ±5.0 
End-diastolic LAD 71.8 73.5 25.8 26.3 28.3 28.0 34.5 31.0 35.8 36.8 <0.0005 
pressure, rnmHg ±9.3 ±6.6 ±2.1 ±2.2 ±4.8 ±3.9 ±6.2 ±4.4 ±5.3 ±5.0 
Mean LAD flow, ml/min 37.8 37.4 30.2 78.2 28.0 54.6 27.6 62.0 27.6 67.0 <0.0005 
±9.5 ±8.7 ±8.4 ±30.0 ±7.6 ±23.0 ±7.4 ±23.4 ±5.5 ±29.7 
End~diastolic LAD flow, 53.6 63.0 31.2 85.4 26.6 57.4 29.4 69.6 29.4 70.8 <0.0005 
ml/min ±12.3 ±15.3 ±8.0 ±32.9 ±8.7 ±29.3 ±9.9 ±32.0 ±7.0 ±37.4 
Systolic wall thickening, % 34.2 31.2 25.8 26.8 14.4 18.4 13.4 14.6 6.4 9.0 <0.0005 
±17.5 ±15.7 ±13.5 ±12.8 ±16.0 ±9.8 ±3.8 ±5.7 ±6.8 ±3.9 
MV'o2,ml/min 3.95 3.93 3.47 3.80 3.40 3.58 3.42 3.78 3.32 4.60 <0.05 
±1.00 ±0.87 ±0.87 ±1.01 ±1.16 ±1.22 ±1.03 ±1.19 ±0.51 ±1.16 
02 extraction, % 75.6 77.2 84.4 39.2 87.4 48.0 86.8 44.0 86.6 53.2 <0.0005 
±12.3 ±9.8 ±6.9 ±13.1 ±7.8 ±9.4 ±4.1 ±8.3 ±5.7 ±17.0 
LAD subendocardial flow, 0.57 0.64 0.48 0.50 <0.05 
ml·min-1 ·g-1 ±0.12 ±0.09 ±0.16 ±0.10 
LAD midwall flow, 0.63 0.88 0.59 0.77 <0.05 
ml·min-1·g-1 ±0.13 ±0.07 ±0.17 ±0.17 
LAD subepicardial flow, 0.61 1.28 0.74 1.66 <0.001 
ml· min-1• g- 1 ±0.14 ±0.23 ±0.31 ±0.44 
Ratio 0.95 0.51 0.58 0.31 <0.0005 
±0.22 ±0.14 ±0.13 ±0.06 
Total flow, rnl·min-1 ·g-1 0.58 0.97 0.61 1.07 <0.0005 
±0.14 ±0.17 ±0.25 ±0.21 
Values are means ± SD. At each rate during low LAD pressure, intracoronary adenosine (adena) was added. See Table 1 for abbreviations. 
ANOV A, analysis of variance. 
flow reserve was easily demonstrable. 
Myocardial blood flow. The results are shown in Table 
3 and Fig. 4. Total transmural LAD flow rose each of the 
times adenosine was added ( +20, and +60 beats/min, P 
< 0.01 by range testing). The increments were 67 and 
75%, somewhat less than seen by flowmeter. By range 
testing, the greatest adenosine-induced changes were in 
the subepicardial layer, wherein flow more than doubled 
with the addition of adenosine at the two paced rates. 
The actual subendocardial flow changed little with aden-
osine. The inner-to-outer ratio fell markedly because of 
the subepicardial increase. Flow to the subepicardium of 
the LAD region with adenosine exceeded flow to the 
subepicardium of the non-LAD region, which was not 
exposed to adenosine or low pressure. 
Left ventricular wall function. There was a progressive 
fall in systolic wall thickening produced by the tachycar-
dia. Addition of intracoronary adenosine and the attend-
ant increases in coronary blood flow did not alter the 
depressed function during the 5-10 min over which mea-
surements were made. None of the changes with addition 
of adenosine was significant compared with its own con-
trol. 
Oxygen and lactate data. A striking change was the 
decrease in oxygen extraction from arterial blood during 
adenosine infusion. Thus, despite persistent reductions 
in local systolic wall thickening, extraction fell from the 
low pressure control value of 84-39% and from. 87 to 53% 
at the paced rate of 60 beats/min increase. MVo, tended 
to be higher when adenosine was added; in each case the 
adenosine value was higher than the value before it. The 
increases at the four low pressure heart rates were 10, 5, 
11, and 39%. Only the last change, at an increment at 60 
beats/min was significant (P < 0.05). 
Significant improvement in anaerobic metabolism was 
not seen in the lactate results. The statistically meaning-
ful changes were between the normal pressure data (first 
two of the experimental periods) and the low pressure 
data, (the remaining part of the protocol). There was a 
trend toward worsening of lactate metabolism with in-
creased heart rate, but the variations were great and 
lactate extraction was noted during one ischemic period. 
DISCUSSION 
The primary purpose of this study was to determine, 
during myocardial ischemia, whether increases in coro-
nary blood flow could be stimulated by increased heart 
rate, thus using flow reserve known to be present in the 
coronary circulation. We recognized that such changes 
in mean or late diastolic flow would be the result of 
complex interactions among coronary pressure, diastolic 
and systolic time, coronary vasomotor tone, and changes 
in demand related to changes in mechanical function. 
We first demonstrated increased LAD flow and MV02 
with pacing at normal pressure, which were expe~ted 
findings (2, 3, 5, 28, 33). We then tested the response of 
the system to tachycardia at a LAD pressure that had 
been reduced to the point at which a modest decrement 
in systolic wall function occurred. The average decrease 
in coronary flow and systolic function corresponded to 
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FIG. 4. Results of microsphere determinations of myocardial blood 
flow during two levels of pacing· induced tachycardia, at low left anterior 
descending artery (LAD) pressure, before and during intracoronary 
adenosine infusion. Data points from each animal are shown. Marked 
increases in subepicardial flow are produced by adenosine, with little 
change in subendocardial flow, resulting in a decline in the subendo-
cardial-to-subepicardial ratio. 
the same degree as observed by others (12, 30). Tachy-
cardia produced further, progressive worsening of left 
ventricular function in the zone perfused by the LAD, 
but flow did not increase significantly whether measured 
at end diastole or as mean flow (flowmeter and micro-
spheres). Accordingly, MVo;was also a fixed quantity, 
given the already high degree of oxygen extraction with 
low pressure perfusion. 
Two adjustments were associated with the constant 
MV02• First, left ventricular systolic wall thickening 
decreased progressively in the ischemic segment, reflect-
ing less oxygen usage per beat. Second, left ventricular 
systolic pressure decreased with pacing at low pressure, 
perhaps from failure of the ischemic segment to contrib-
ute adequately to global left ventricular function. The 
lactate extraction ratio and values for consumption to 
extraction clearly showed a switch to an anaerobic state 
with low LAD pressure, with and without the additional 
increments in heart rate by pacing. The problem 
worsened as rate was accelerated, as noted by others (31). 
The adenosine experiments then showed the persist-
ence of considerable flow reserve, not used despite the 
increased demand due to tachycardia; dramatic reduc-
tions of oxygen extraction to levels of less than half of 
the preadenosine values occurred with adenosine admin-
istration. Thus, when spontaneous regulatory mecha-
nisms were allowed to prevail, net flow was not maximal 
during tachycardia as myocardial demand was forced 
upward. 
We found that the inducible flow reserve was limited 
to the midwall and subepicardium at high heart rates, 
consistent with other studies of coronary stenosis with 
adenosine that have shown preferential flow increases to 
the outer layers (14). At a rate increase of 20 beats/min 
with low LAD pressure, the flow increase with adenosine 
in the subendocarcium averaged 12%. No change was 
seen at +60 beats/min. In the subepicardium the corre-
sponding increases were 110 and 124%, and the midwall 
increases were 40 and 31%. Thus there is a gradient of 
flow reserve across the left ventricular wall during in-
creased metabolic demand at low pressure, as suggested 
by Grattan et al. and by Warltier et al. (15, 32). The 
subendocardium has greater need, yet less reserve. The 
subendocardial reserve previously demonstrated at the 
spontaneous heart rate is apparently exhausted as rate 
is increased, even to the level of our control-paced pe-
riods. 
Previous efforts to evaluate the response of coronary 
flow to tachycardia during ischemia have provided vari-
able results. Studies in humans with angina pectoris 
demonstrated that coronary sinus flow increased with 
accelerating heart rate, up to the point of coronary in-
sufficiency (34). At first, this might suggest vasodilation 
in low pressure regions of the circuit. However, down-
stream coronary pressures are not available in such stud-
ies and coronary sinus flow may represent a mixture of 
ischemic and nonischemic segments. In some animal 
experiments, it has been concluded that tachycardia in 
the presence of coronary stenosis results in a redistri-
bution of flow from subendocardial to subepicardial lay-
ers, and some have observed an absolute decrease in flow 
to the inner region (22, 23). A decrease in total, trans-
mural flow has also been observed (29). 
Re~ently, Grover and Weiss reported a 53% increase 
in MV 0 2 in a region served by a stenotic coronary artery 
with pacing (16). This is quite different from our results. 
Differences between their report, others, and ours could 
be explained by several factors. In many of the prior 
studies, distal coronary pressure was not measured and 
not controlled as an independent variable. Thus coronary 
resistance is difficult to estimate. In our experiments, 
the low mean LAD pressure was controlled, as was heart 
rate, with flow as the test variable. In addition, most 
prior studies have been in dogs, which have substantial 
epicardial collaterals capable of delivering blood to an 
ischemic zone. The pig, in contrast, has virtually no 
exchange between the major coronary branches (13). 
Thus flow could increase, at a given low pressure, via 
collaterals in the dog but not in the pig. Alternatively, 
the pig and dog coronary circulations could be intrinsi-
cally different in their response to ischemia. 
It is of further interest that the increased myocardial 
blood flow produced by adenosine did not significantly 
improve the depressed mechanical function of the ische-
mic LV wall segment, although there was a modest trend 
. upward each of the four times adenosine was added. This 
is consistent with our earlier observations (24). One 
might argue that the persistence of depressed function is 
due to inadequate flow increase to the subendocardium, 
i.e., the increased flow is not sufficient to make a differ-
ence. There are other tenable explanations, however, as 
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the increment in flow to much of the LV wall was not 
trivial, and oxygen extraction from LAD blood fell re-
markably with adenosine-induced vasodilation. The pos-
sibility remains that depression of contraction is due to 
metabolic inhibitors of function, such as tissue lactate 
levels resulting from anaerobic metabolism, as proposed 
by Neely, requiring more time to be washed out (21}. 
The progressive fall in systolic wali thickening with 
increasing heart rate during low LAD pressure demon-
strates that the response of the heart to ischemia is 
graded. With a constant LAD flow, tachycardia disturbs 
the relationship between supply and demand in a pro-
gressive manner. Each heart-rate step upward was ac-
companied by a further decrement in function. There 
was not a threshold value for flow or demand at which 
function was suddenly markedly depressed. This is rea-
sonable, since supply·was constant, demand increasing, 
and supply of oxygen per beat to support function must 
fall. Still not explained are how these adjustments are 
mediated, why the full reserve of vasodilation is not 
employed, nor why there is such a disparity between 
subendocardial and subepicardial flow reserve. 
There is considerable recent evidence of the impor-
tance of a-adrenergic tone in the coronary bed during 
exercise, hypoperfusion, and tachycardia (2, 7, 17, 19, 
20}. Some studies found that blockade of such effect 
results in increased coronary flow and higher MVo, (17, 
19}. Nathan and Feigl (20} concluded, however, that 
adrenergically mediated tone is necessary to insure ade-
quate subendocardial perfusion, and to avoid a steal of 
blood to the outer layers. Our study was not designed to 
address these issues, but we can say that with tachycar-
dia, low LAD pressure, and then addition of maximal 
pharmacological vasodilation, subendocardial flow did 
not fall. The decrease in inner-to-outer flow ratio that 
was found was due to the large increase in subepicardial 
flow. 
Conclusions 
Our experiments have shown that, at the low coronary 
pressures and range of heart rates studied, myocardial 
blood flow and oxygen consumption are remarkably con-
stant. As a consequence of the increased metabolic de-
mand produced by tachycardia, there is a progressive fall 
in local ventricular systolic wall function with stepwise 
increases in rate. This occurs despite substantial coro-
nary flow reserve throughout the spectrum of heart rates 
tested. The observations were made in a vascular bed 
that does not have significant collateral interchange with 
other coronary vessels. The additional flow induced by 
adenosine was largely distributed to the subepicardium, 
however, and metabolic need was presumably greater in 
the subendocardium. The subendocardial flow reserve 
previously demonstrated at spontaneous heart rate by 
several laboratories appears to he quickly exhausted 
when demand is increased. 
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Relation of lactate production to postischaemic 
reduction in function and myocardial oxygen 
consumption after partial coronary occlusion in 
sw1ne 
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University, Portland, Oregon, USA 
SUMMARY Postischaemic myocardial dysfunction (stunning) induced by partial occlusion of the left 
anterior descending coronary artery and its relation to lactate production during reperfusion were 
studied in nine swine. A 40% reduction in regional left ventricular wall thickening, as measured by 
ultrasonic crystals, was prospectively defined as stunning. A perfusion pressure of 20 mmHg was 
maintained with a hydraulic occluder for each ischaemic period and was monitored by a distal arterial 
catheter. To achieve a 40% reduction in function, four animals required three ischaemic periods 
(mean ischaemic flow reduction 73%), four two (86% flow reduction), and one one (93% flow 
reduction). At 25 min of reperfusion transmural flow was slightly reduced from 0.67 ml· g-1·min-1 at 
control to 0.58 ml·g-1·min-1 (p<0.05), whereas regional flow endocardial to epicardial flow ratio 
was unchanged. At 60 min reperfusion, percentage systolic wall thickening was reduced to 25% from 
a control of 39% (p<O.Ol) and parallel reductions in regional myocardial oxygen consumption from 
4.3 ml·min-1 to 2.7 ml·min- 1 occurred (p<O.Ol). Lactate extraction was depressed at 15 min 
reperfusion (-4.0% compared with control +18.0% (p<0.05)) but returned to control values by 30 
min. It is concluded that postischaemic myocardial dysfunction (stunning) can be induced by partial 
coronary occlusions and that the extent of dysfunction depends on the degree of flow reduction. The 
reductions in myocardial oxygen consumption parallel those of wall thickening during reperfusion 
after stunning. Finally, lactate production occurs during early reperfusion but does not persist with !he 
postischaemic reductions in function and myocardial oxygen consumption. 
The recovery of myocardial function after a brief 
episode of ischaemia, in the absence of infarction, can 
be delayed. 1 This transient reversible dysfunction 
(stunned myocardium) has been shown to occur 
despite the return of normal endocardial blood flow 
after ischaemia. 2- 7 Current hypotheses to explain this 
phenomenon include depletion of energy substrate,2 8 
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generation of oxygen free radicals during 
reperfusion,4 9 an attenuated myocardial response to 
the sympathetic nervous system, 10 and accumulation 
of cellular calcium or glycolytic byproducts. 11- 15 
Lactate production during ischaemia may be a major 
cause of myocardial dysfunction, 11 and its presence in 
tissue during reperfusion16 may play a role in 
postischaemic dysfunction. 
The animal models used to study postischaernic 
dysfunction thus far have used complete occlusion of 
an artery during ischaemia. However, spasm and 
thrombosis leading to brief partial coronary occlusion 
are common clinical findings and the subsequent 
myocardial response is equally important. 
lberefore, we wished to determine (a) if severe 
reductions in flow resulted in postischaemic 
dysfunction and, if so, (b) the relation between 
84 
Lactate and postischaemic ventricular dysfunction 
changes in lactate production during reperfusion and 
myocardial dysfunction. 
Material and methods 
Ten swine (weight 35-54 kg) of either sex were 
premedicated with X(lazine (2 mg·kg-1 im) and 
ketamine (12 mg·kg- im) followed by a bolus of 
morphine sulphate (2 mg·kg-1 iv) and ketamine (10 
mg·kg- 1 iv). This was followed by a continuous 
intravenous infusion of morphine sulphate (I 
mg·kg-1·h-1) and ketamine (10 mg·kg-1·h- 1) that was 
used throughout the duration of the experiment. The 
animals were intubated and ventilated with oxygen 
enriched air using a piston respiratory pump. Tidal 
volume and respiratory rate were regulated in each 
animal to maintain physiological arterial pH 
(7.37-7.45), Pao2 (>100 mmHg (13.3 kPa)), and 
Paco2 (35-45 mmHg (4.7-6.0 kPa). Once adequate 
anaesthesia was administered, tubocurarine (2 ml iv) 
was given to facilitate use of electrocautery. The 
femoral artery and vein were exposed through a 
cutdown and catheters were placed in each. The heart 
was exposed via a midline sternotomy and suspended 
in a pericardia! cradle. A catheter was placed in the left 
atrium for injecting microspheres and one in the apex 
of the left ventricle for recording pressure and its first 
derivative. The left anterior descending artery (LAD) 
was exposed and instrumented using an 
electromagnetic flow probe and hydraulic occluder 
proximally, and a small silastie catheter (internal 
diameter 0.3 mm, external diameter 0.6 mm) was 
positioned in the mid-portion of the vessel to record 
pressure. Our previous experience with this catheter 
size has shown no effect in altering coronary 
distribution, flow reserve, or resting lactate 
production. 17 18 Another small silas tic catheter was 
inserted into the great cardiac vein draining the 
ischaemic zone for determining regional venous 
lactate and oxygen saturation. Ventricular function 
was measured by epicardial and endoc~9ial ultrasonic 
crystals and was expressed as percentage systolic 
fractional thickening. 17 The correct position of the 
crystals was confirmed at the conclusion of each study. 
Measurements of oxygen content were made on a LEX 
0 2 CON analyser and of plasma lactate by an electrode 
technique. 19 
Regional myocardial blood flow was measured by 
injecting 9-11 p.m microspheres labelled with a 
~amma emitting radionuclide e41Ce, 51 Cr, 103Ru, or 
5Nb) through the left atrial catheter. Reference 
samples of arterial blood were drawn over 2 min 
during each injection, and regional blood flow per 
gram of tissue calculated as reported previously. 17 At 
the conclusion of the experiment, Evans blue and acid 
red dyes were injected into the right and LAD arteries 
respectively. Flow was then determined in the 
endocardial, mid and epicardial regions of the LAD 
and nori-LAD arteries. After surgical preparation was 
complete heparin (10 000 units iv) was given to 
prevent clotting of coronary catheters. 
PROTOCOL 
Five minutes of complete arterial occlusion have been 
shown to induce a 40% reduction in wall thickening 
with up to 30 min of reperfusion. 5 Therefore, we 
prospectively chose a 40% reduction in postischaemic 
function as our definition of stunning with up to three 
ischaemic periods to achieve this. The hydraulic 
occluder was inflated to reduce distal coronary 
pressure to 20 mmHg for 5 min. If postischaemic 
function was not reduced by 40% after 30 min of 
reperfusion the ischaemic period was repeated. A 
pressure of 20 mmHg was chosen since this is about 
I 0-13 mmllg above the pressure at which flow stops in 
swine, 18 allowing some flow to occur. Our previous 
work has also shown this pressure drop to be severe 
enough to induce some level of dysfunction. 20 During 
final reperfusion, simultaneous arterial and coronary 
venous samples were obtained at 3, 15, 30, 45, and 60 
min for measuring lactate concentration and oxygen 
content. Calculations included: MV02 = (total LAD 
flow by flow probe) x (arterial minus venous oxygen 
content); % lactate extraction = [(arterial lactate 
minus venous lactate)/arteriallactate] x 100; % wall 
thickening = [(end systolic thickness minus end 
diastolic thickness)/end diastolic thickness] X 100. 
Regional blood flow by microspheres was determined 
before ischaemia (control) and 25 min after the final 
ischaemic period. 
STATISTICS 
All data are expressed as mcan(SEM). Multiple 
comparisons were made by one way analysis of 
variance (ANOV A) with repeated measures and range 
testing by Tukey's procedure. Single comparisons 
were analysed by Student's 1 test. 
Results 
Ten animals were studied initially. Ventricular 
fibrillation occurred in three animals; of these, two 
were converted to sinus rhythm within 1 min with 
paddles placed on the chest wall. The third animal 
could not be converted promptly and is not included in 
the results. 
IIAEMODYNAMIC DATA 
Table I shows mean heart rate, systolic blood 
pressure, and double product (systolic blood pressure 
multiplied by heart rate) at control and 60 min 
reperfusion after the final ischaemic period. A 
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TABLE! 1 Haemodynamic data. Values are mean(SEM) 
Repufu.sion tim~ (min) 
Control 3 6 9 /2 15 30 45 60 
Heart rate 79(4) 
102(3) 
8082(380) 
86(4)* 86(4)* 87(4)* 87(4)* 86(4)* 87(4)* 89(4)* 89(4)* 
Systolic blood pressure 
Double productt 
100(7) 97(8) 93(~) 96(3) 94(3) 92(3) 93(3) 89(3) 
8~04(~88) 8292(655) 8031(410) 8238(350) 8037(323) 7913(209) 8208(434) 7937(335) 
tHeart rate times systolic blood pressure. 
"'p<0.05 compared with control. 
~ NS 
01 
c I.[J 
I 
·c 
Cll 
~ 
.!,! 
£ 30 -] 
ti 
,g 20 '-
.!: 
(I 
:§ 
Ill 
>. 10 1-Vl 
~ 
0 Control 
** 
** 
A B 
FIG I Percentage systolic fractional thickening at control 
and 30 min after two consecutive periods of low pressure (A 
and B). Values are mean(SEM); n=8. ••p<O.OJ vs control. 
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FIG 2 Percentage systolic fractional thickening at control 
and after stunning (recovery time). Values are mean(SEM ); 
n=7. *p<0.05, ***p<O.OOJ vs control. 
significant rise in heart rate and lowering of systolic 
blood pressure were noted over the course of the 
experiments despite attention to the level of 
anaesthesia~ and fluid administration. The double 
product, however, remained unchanged over the same 
period, and therefore myocardial oxygen consumption 
remained relatively constant. 
POSTISCHAEMIC DYSFUNCTION 
All nine animals showed at least a 40% reduction in 
wall thickening with up to three ischaemic periods. 
0 
l·OO Em c~trol 
0 Stunning 
FIG 3 Regional blood flow at control and 25 minutes after 
stunning in (a) LAD and (b) non-LAD areas. 
Endo=endocardial; mid=mid endocardial; 
£pi= epicardial. 
86 
The degree of dysfunction induced was dependent on 
the amount of flow reduction during the ischaemic 
period. Four animals required three ischaemic periods 
to achieve a 40% functional decrement and their flow 
was reduced to a mean of 73% at 20 mrnHg. The four 
swine requiring two periods had an 86% mean 
reduction in flow at the same pressure and the one 
animal receiving one ischaemic period a 93% flow 
reduction during ischaemia. 
Figure 1 shows the reduction in percentage wall 
thickening in those eight animals that received at least 
two ischaemic periods. As shown, each ischaemic 
period induced a subsequent Joss of function during 
reperfusion which was cumulative. However, the 
degree of functional reduction was greatest after the 
initial ischaemic period. 
TABLE 2 Myocardia/flow (ml·g-1 ·min-1) at control and 25 
min into reperfusion. Values are mean(SE¥); n=9 
Lactate and postischaemic yentricular dysfunction 
Figure 2 shows the reductions in wall thickening 
during 60 min of reperfusion after the final ischaemic 
period compared with the control period. As shown, it 
is during the initial 15 min reperfusion period that the 
greatest reductions in function occurred. Dysfunction 
was sustained for at least 60 min into reperfusion. 
REGIONAL BLOOD FLOW 
Figure 3 and table 2 show the regional changes in flow 
in the LAD and non-LAD bed before and after 
stunning. Total transmural flow in the LAD region was 
reduced by only 8% (p<0.05) at 25 min into 
reperfusion compared with conrrol. In the non-LAD 
bed there was a slight but insignificant reduction in 
transmural flow over the same period. The ratio of 
endocardial to epicardial flow, however, remained 
unchanged in both the LAD and non-LAD areas 25 
min into reperfusion compared with the control period 
(table 2). This normalisation of flow distribution 
occurred at a time when function remained depressed. 
M _.:_yoc_a_rdia_._I.:.fl_o_w ______ c_o_nt_ro_I __ 2_5_m_i_n_re.:.p_e.:.rfi_us_io_n :.:.:::::: OXYGEN CONSUMPTION AND LACTATE 
LA~~smural 0.67(0.08) 0.58(0.05)" Complete data were not available in two of the animals 
Endocardial:epicardial ratio 1.07(0.08) 1.03(0.06) during reperfusion and the following results pertain to 
Non LAD: the remaining seven. Figure 4 shows the relation of 
Transmural 0· 70(0.07l 0.67<0·05J myocardial oxygen consumption and percentage 
Endocardial:epicardial ratio 1.16(0.03) 1.23(0.04) lactate extraction at control and 60 min into 
*p<O.OS vs control. reperfusion. Commensurate with the reductions in 
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FIG 4 (a) Myocardial oxygen consumption (MV02) and (b) percentage lactate extraction at control and after stunning 
(recovery time). Values are mean(SEM); n=7. 0p<0.05; *"p<O.OJ; •••p<O.OOJ vs control. 
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wall thickening is a parallel reduction in myocardial 
oxygen consumption over the same period that 
remains statistically lower than control at 60 min. 
Percentage lactate extraction, on the othe( hand, is 
significantly different from · control with a net 
production of lactate at least 15 min into reperfusion. 
By 30 min, however, percentage lactate extraction has 
returned toward control values with overall net 
extraction at a time when function and oxygen 
consumption still remain depressed. 
Discussion 
The phenomenon of stunned myocardium refers to 
reversible dysfunctiorr following total coronary artery 
occlusion unassociated with , myocardial 
necrosis. I-IO 21 A unique aspect of our model was the 
use of a constant arterial pressure during ischaemia, 
which induced variable flow reductions in each 
animal. We have shown that incomplete coronary 
artery occlusion does induce postischacmic 
dysfunction to an extent that appears to be dependent 
on the degree of baseline flow reduction. The most 
severe reduction in wall thickening occurred in the 
animal with a greater than 90% flow reduction during 
ischaemia. This 5 min ischaemic period achieved a 
40% reduction in function during a 30 min reperfusion 
period, which is equivalent to the functional 
reductions observed with 5 min of complete arterial 
occlusion. 5 Those animals that had smaller baseline 
flow reductions at the ischaemic pressure of 20 mm 
mmHg had less postischaemic dysfunction. 
Therefore, the extent of postischaemic dysfunction is 
dependent on both the time of ischaemia5 21 and the 
degree of baseline flow reduction. 
We have also confirmed that the reductions in 
function after multiple incomplete coronary 
occlusions are cumulative, with the greatest 
decrement following the initial ischaemic episode. 
This has been shown in open chest dogs after up to 16 
five minute complete arterial occlusions. 6 22 This is 
contrary to Lange's finding of no cumulative 
deterioration of regional function seen with up to three 
consecutive arterial occlusions.5 Weiner and 
colleagues also showed no cumulative functional 
impairment after three successive 20 min occlusions in 
dogs. 23 The major discrepancy appears to be in the 
reflew period allowed between occlusions. Those 
studies showing a cumulative effect have shorter 
reflew periods, whereas others without such an effect 
use prolonged reperfusion periods (of more than 35 
min). 
Persistent coronary flow redistribution after 
ischaemia does not apper to be the primary mechanism 
in maintaining the stunned myocardium. We have 
shown that postischaemic dysfunction following 
partial arterial occlusions is not associated with 
regional flow disturbances as evidenced by the return 
of endocardial and epicardial flow towards control 
values (table 2). Hcyndrickx and colleagues induced 
transient myocardial dysfunction that lasted for at least 
24 hours after a 15 min arterial occlusion with 
persistent endocardial flow reductions at least three 
hours into reperfusion. 21 Subsequent studies, 
however, have shown a return of regional flow after a 
brief arterial occlusion at a time when myocardial 
dysfunction is sustained. 2- 10 This dissociation of flow 
and functional recovery has led to other theories of 
stunning such as depletion of high energy 
phosphates, 2 8 accumulation of cellular calcium or 
glycolytic.~yproducts, 11 - 15 and generation of free 
radicals during reperfusion. 4 9 The transmural flow 
reduction was slight but significant at · 25 min into 
repcrfusion and is consistent with other studies. 6 7 
This reduction could be explained by the observed 
postischaemic reductions in myocardial oxygen 
consumption and subsequent demand. 
If limited flow during reperfusion was the cause of 
persistent reductions in function and myocardial 
oxygen consumption anaerobic glycolysis and lactate 
production would continue. We therefore compared 
the changes in percentage lactate extraction during 
reflew with changes in function and myocardial 
oxygen consumption. Although considerable 
variability in resting control values for percentage 
lactate extraction docs exist, the myocardium under 
normal conditions should extract lactate. 24 We have 
shown that 20 min into reperfusion, lactate extraction 
returns to control values at a time when wall thickening 
and myocardial oxygen consumption remains 
depressed. Smith studied lactate extraction in open 
chest dogs after a I 0 min arterial occlusion and found 
an insignificant reduction after 20 min of reperfusion. 7 
In a similar model in pigs, after coronary occlusion, 
lactate extraction had not normalised by 5 min of 
reperfusion. 25 It is clear from our work that persistent 
anaerobic glycolysis was not present with persistent 
reduction in function with the stunned myocardium. 
It is interesting that at least 15 min into reperfusion 
lactate extraction in the stunned myocardium remains 
significantly depressed. Taegtmeyer and colleagues 
have shown that after 5 min of ischaemia in isolated rat 
hearts, tissue lactate concentrations remain raised until 
40 min into reperfusion. 16 this would imply that our 
findings represent more than just delayed lactate 
washout. The early postischaemic reflew period may 
demonstrate accentuated anaerobic glycolysis at a 
time when flow has returned to normal. Some support 
of this has been shown with positron emission 
tomography in patients with postischacmic exercise 
tests. By use of radiolabelled fluoro-2-deoxyglucose 
and rubidium-82, studies have shown increased 
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uptake of exogenous glucose in the distribution of 
postischaemic myocardial segments 15 min after 
exercise. 24 This would suggest that the stunned 
myocardium preferentially metabolises glucose early 
in reperfusion, despite adequate oxygen delivery. 
POTENTIAL LIMITATIONS OF STUDY 
Lactate production has been a reliable index for the 
presence of anaerobic glycolysis, 26 and percentage 
lactate extraction has been shown to correlate well 
with tissue gradients of Iactatc.27 However, with 
severe ischaemia lactate production often declines 
owing to inhibition of glycolytic enzymes, failure of 
cellular release of lactate, and substrate depletion. 
This accounts for some of the problems with lactate 
concentrations as a reflection of degree of ischaemia 
during severe reductions in flow. 28 On the other hand, 
the reperfused myocardium is different from severely 
ischaemic myocardium where regeneration of 
anaerobic substrate occurs. Allison and colleagues 
have shown that by 20 minutes after a 20 min occlusion 
glycogen and glycolytic enzymes have returned to 
normal. 3 
Inherent in the definition of stunned myocardium is 
the absence of necrosis as the cause of dysfunction 
following occlusion. One study has shown that more 
than 14 consecutive 5 min arterial occlusions can lead 
to some necrosis. 29 Others have used several 5 min 
occlusions 10 minutes apart and have shown minimal 
irreversible change. 5 6 22 Moreover, none of the 
studies of postischaemic dysfunction cited have found 
necrosis as the potential cause of the 
phenomenon. 2- 10 21 22 In our laboratory,30 as in 
others, 31 substantial necrosis in tissue has not been 
found after up to 15 min of arterial occlusion. We 
therefore feel justified in assuming that our brief 
incomplete arterial occlusions were not associated 
with significant necrosis. · 
CONCLUSION 
We have shown that postischaemic · my_~ardial 
dysfunction (stunning) occurs when a coronary artery 
is subtotally occluded with the degree dependent on 
the extent of baseline flow reduction. Although 
cumulative, the initial postischaemic reductions are 
significantly greater than subsequent ones. The 
reduction in systolic wall thickening seen during 
reperfusion parallels the reduction in regional 
myocardial oxygen consumption, and both are 
sustained long after regional coronary flow has 
returned towards baseline. Finally, anaerobic 
glycolysis, as measured by percentage lactate 
extraction, appears to be enhanced during early 
reperfusion but returns to normal by 30 min before the 
return of function. It is therefore unlikely that the 
accumulation of lactate during reperfusion or the 
Lactate and postischaemic ventricular dysfunction 
continuation of anaerobic glycolysis are associated 
with the persistence of postischaemic dysfunction. 
This study was supported by a Public Health Service 
NIH Training Grant (No 702605156). 
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Abstract 
Study objective- The aim was to compare the responses of intracoronary infusions of 
ATP, an endothelial-dependent vasodilator with adenosine following brief ischemia (10 
minutes) and reperfusion in a model of myocardial stunning. 
Design- In group 1 (n=6), coronary blood blood flow and endocardial (endo) and 
epicardial ( epi) % segment length shortening (SS) were measured in the distribution of the 
left anterior descending artery before and during maximal intracoronary infusions of either 
adenosine or ATP (20 ugjkg/min). Measurements were obtained pre- and post-myocardial 
stunning both at control HR and during atrial pacing (150 beats per minute). In group 2 
(n=6), myocardial blood flows by microspheres and arterial-venous lactate and oxygen 
differences were determined following the same ischemia-reperfusion protocol to 
characterize transmural changes in blood flow and metabolism in this model of stunning. 
Experimental material- The experiments were performed in 12 anesthetized swine. 
Measurements and main results- In group 1, baseline endo and epi SS were 16±.3% 
and 14±.6% and following reperfusion were reduced to 10±.4% and 8±.6% respectively 
(p < .05). Prior to stunning, minimal coronary resistances during adenosine and ATP were 
0.81±..40 and 0.76±_.25 mm Hg-min/ml respectively and following reperfusion were 0.86±_.31 
(NS) and 0.85±_.23 (NS) mm Hg-min/ml respectively. Infusion of either vasodilator 
enhanced function by 30% following reperfusion whereas no such effect was observed prior 
to ischemia. In group 2, no maldistribution of blood flow was observed following the same 
ischemia-reperfusion protocol to account for this vasodilator enhancement in function. % 
lactate extraction values were 29±.11% and 25±.14% at pre-ischemic control and paced 
heart rates respectively and following reperfusion were lowered to 0±.12% without pacing 
(p < .05) and -1±.34% during pacing (p < .05). 
Conclusion- Brief ischemia and reperfusion in swine induces myocardial stunning 
without altering the vasodilator responses of either ATP, an endothelial-dependent 
vasodilator or adenosine. Recruitment in post-ischemic shortening was observed during 
infusions of both vasodilators at a time when maldistribution of flow by microspheres was 
not observed. Possible mechanisms include either enhanced washout of lactate from the 
reperfused myocardium or greater utilization of substrates during higher blood flows. 
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Introduction 
It has now become widely accepted that regional myocardial function can be 
reversibly depressed following brief periods of ischemia and reperfusion (1). Although 
sustained abnormalities in transmural blood flow as measured by radioactive microspheres 
are not the cause of this entity called "myocardial stunning", evidence is accumulating that 
coronary perfusion during the recovery phase is important. Several groups for instance, have 
demonstrated that infusion of vasodilators such as adenosine can improve post-ischemic 
function during late reperfusion (2-7). The mechanism of this vasodilator-enhancement in 
function may be a result of either improved oxygen delivery to heterogeneously reperfused 
regions or a washout of certain metabolic byproducts from the ischemic period (8,9). The 
coronary vasculature in the distribution of regionally stunned myocardium may also be 
altered both structurally and functionally. One hour of occlusion and reperfusion in dogs for 
instance, induces morphological changes in the endothelial cells including focal injury and 
partial detachment from the underlying cell matrix (10). The same degree of ischemia and 
reperfusion has been shown to alter the vasodilator response of several 
endothelial-dependent vasodilators including acetylcholine, bradykinin, arachidonic acid and 
ATP (11-14). 
These findings, often referred to as vascular "stunning", have been induced after 
prolonged ischemic times, which may also cause more permanent alterations. Such 
irreversible changes as necrosis and "no-reflow" have been documented after 20 minutes of 
coronary flow reduction (15). In this study, we wished to determine whether myocardial and 
vascular stunning could be dissociated following a shorter period of ischemia. Vascular 
function prior to and following ischemia-reperfusion was tested by comparing the vasodilator 
responses of intracoronary ATP, an endothelial-dependent vasodilator, with adenosine 
(13,16). Because the effect of increased work load or shear stress could enhance any 
differences in endothelial-dependent mechanisms, the agents were infused both at baseline 
heart rates and during atrial pacing. In a second group of animals, the same 
ischemia-reperfusion protocol was repeated to determine the effects on transmural coronary 
blood flow and regional arterial-venous oxygen and lactate differences. 
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Methods 
GENERAL PREPARATION 
Following an overnight fast, 12 cross-bred Landrace-Yorkshire pigs of either sex 
(25-39 kg) were sedated with intramuscular ketamine (20 mg/kg) and intravenous (iv) 
metomidate (5 mgjkg). Animals were intubated and connected to a respirator for 
intermittent positive pressure ventilation with a mixture of oxygen and nitrous oxide (1:2). 
Ventilator settings were adjusted during the experiments to maintain normal arterial pH 
(7.35-7.45), pC02 (35-45 mm Hg) and p02 ( > 150 mm Hg). The external jugular vein was 
cannulated with two 7F catheters for administration of anesthetics and saline. The anesthetic 
regimen consisted of a bolus of iv alpha chloralose (150 mg/kg) dissolved in boric acid 
solution and a continuous infusion of low dose sodium pentobarbitone (5 mg/kg/h). The 
femoral arteries were cannulated with 7F catheters and used for either aortic blood pressure 
measurements, arterial blood gas collections or reference sampling for microsphere 
determination. Rectal temperature was monitored throughout the experiment and 
maintained near 37 degrees C with external heating pads. Pancuronium bromide ( 4 mg) was 
given iv, and following a midline thoracotomy, the heart was suspended in a pericardia! 
cradle. The left mammary vessels were ligated and the second left rib was removed for ease 
of further instrumentation. The left anterior descending coronary artery (LAD) was 
dissected free of its adventitia, and an electromagnetic flow probe (2.25 or 2.50 mm; Skalar, 
Delft, The Netherlands) and hydraulic occluder were placed proximally. Meticulous 
attention was paid to the positioning and stability of the flow probe and zero flows were 
checked regularly throughout the experimental protocol. Pacing leads were attached to the 
left atrial appendage and connected to a pacing stimulator. 
SPECIFIC INSTRUMENTATION 
Group 1 (n=6). The purpose of this group was to test the vasodilator responses to 
intracoronary adenosine and ATP (Boehringer; Mannheim, W. Germany), prior to and 
following myocardial stunning at two different heart rates (baseline and during atrial pacing 
of 150 beats/min). Immediately distal to the probe and occluder, a small cannula (0.8 
mm-outer diameter) was inserted into the LAD for administration of the vasodilators. A 
microtipped catheter (7F Millar) was advanced into the left ventricle (LV) via the left 
carotid artery and used to monitor LV pressure and its first derivative (LVdP/dt). To 
measure regional segment length shortening in the distribution of the LAD, pairs of 
ultrasonic crystals (Triton, Technology Inc., San Diego, CA, USA) were placed in the 
endocardial and epicardial layers, approximately 10-15 mm apart in each region. Systolic 
shortening in the two layers was calculated from the difference between lengths at 
end-diastole (time of onset of positive dP /dt) and end-systole (time of peak negative dP /dt) 
and expressed as a percent of end-diastolic length (17). 
Group 2 (n=6). The purpose of this group was to determine transmural coronary 
blood flow at baseline heart rate and during atrial pacing (150 beats/min), before and after 
the same ischemic-reperfusion protocol as in group 1. In addition, arterial and LAD 
coronary venous samples were obtained for oxygen and lactate concentrations during each 
of the interventions. Instrumentation in this group was limited, with only a small cannula 
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inserted into the LAD coronary vein for sampling and a catheter inserted into the left 
atrium for administration of radio-labeled microspheres. 
Studies were performed in accordance with the position of the American Heart 
Association on research animal use adopted November 11, 1984 and under the regulations 
of the Animal Care Committees of the VA Medical Center, Minneapolis MN, USA and 
Erasumus University, Rotterdam, The Netherlands. 
EXPERIMENTAL PROTOCOL 
Group 1. Following a 30 minute stabilization period, baseline measurements were 
taken of mean aortic and left ventricular pressures, coronary blood flow, LV dP/dt and 
endocardial and epicardial segment length changes. Maximal vasodilator responses for both 
adenosine and ATP were determined prior to each experiment and those doses used for the 
remainder of the protocol (20-40 ugjkg/min). The maximal dose of intracoronary adenosine 
was infused continuously and recordings obtained after 5 minutes of steady state. The 
infusion was discontinued and following a 5 minute washout period, the maximal dose of 
ATP was begun and measurements obtained after 5 minutes. The protocol was then 
repeated during atrial pacing at 150 beats per minute. 10 minutes of ischemia was then 
induced by adjusting the hydraulic occluder so that coronary blood flow was reduced by 
greater than 80% of the baseline value. We have previously found that this degree of partial 
coronary blood flow reduction induces myocardial stunning with less ventricular fibrillation 
compared with that of complete coronary occlusions (18}. The heart was reperfused for 30 
minutes, and recordings were repeated prior to and following intracoronary infusions of 
adenosine and A TP, without and during repeat pacing. 
Group 2. In this protocol, transmural blood flow was determined at baseline heart 
rate and during atrial pacing, both before and after the same ischemia-reperfusion protocol 
as in group 1. Microspheres were injected prior to and during each pacing intervention as 
well as during the partial coronary occlusion. In addition, simultaneous arterial and LAD 
coronary venous samples were obtained for oxygen saturation and lactate concentrations 
during the same sampling periods. 
REGIONAL MYOCARDIAL BLOOD FLOW 
For each flow measurement in group 2, 1-2 million microspheres (15 microns) of 
either 141-Ce, 113-Sn, 103-Ru, 95-Nb, or 46-Sc (NEN-TRAC, New England Nuclear, Boston, 
Mass.) were injected into the left atrium. Reference arterial blood samples were withdrawn 
from the femoral artery catheter at a fixed rate of 10 ml/min, from 15 seconds prior to until 
1 minute after microsphere injection. At the conclusion of the experiment, the animal was 
sacrificed and the heart excised. The distribution of the post-ischemic myocardium was 
identified by injecting patent violet dye into the LAD coronary artery at the level of the 
occluder. Hearts were fixed in 10% formalin for 48 hours, and separated into LAD and 
nonLAD regions. Each was then divided into 3 equal layers (inner, mid, and outer) and 
placed in 1-2 gram samples. Myocardial and reference blood samples were counted in a 
multichannel analyzer (Gamma Counter-5000; Packard Instrument Inc. USA} and regional 
blood flows determined (19}. 
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ARTERIOVENOUS OXYGEN AND LACTATE 
In group 2 animals, oxygen saturation was determined from arterial and LAD cardiac 
venous samples by an OSM2 system (Radiometer; Copenhagen, Denmark). Blood for lactate 
determinations were collected in iced syringes containing heparin, and promptly centrifuged 
for later analysis by the enzymatic technique (20). Oxygen content was determined from the 
formula (1.34 x Hgb x % oxygen saturation). Oxygen consumption in the distribution of the 
reperfused myocardium was then calculated by the product of microsphere flow and the 
arterial-coronary venous oxygen difference. Percent lactate extraction was calculated by the 
arterial-coronary venous lactate difference divided by arterial lactate X 100. 
STATISTICS 
Results are expressed as arithmetic means .±. standard deviations. Pre- and 
post-ischemia-reperfusion differences were tested for significance at the p < .05 level by 
analysis of variance with repeated measurements (Fisher's PLSD and F-test). In addition, 
microsphere flows during each intervention in group 2 were compared in the LAD and 
nonLAD regions by unpaired t-testing. 
Results 
SYSTEMIC HEMODYNAMICS (GROUP 1) 
Table 1 summarizes the systemic hemodynamics during all interventions in group 1. 
Except for the increase in heart rate, there were no changes in any of the parameters 
following reperfusion compared with pre-ischemic values. 
CORONARY HEMODYNAMICS AND REGIONAL FUNCTION (GROUP 1) 
Coronary blood flows and endocardial and epicardial segment length changes are 
summarized in Table 2. Figure 1 shows a representative tracing in one animal. Following 
reperfusion (baseline-2), coronary resistances (mean arterial pressure/mean coronary blood 
flow) were higher compared with pre-ischemic values at both heart rates. Minimal 
resistances achieved with either adenosine or ATP however were unchanged compared with 
pre-ischemic values. 
Following reperfusion, endocardial and epicardial segment length shortening was 
lower than pre-ischemic values at each heart rate. Figure 2 shows the effect of infusions of 
adenosine and ATP on (a) endocardial and (b) epicardial function prior to and following 
myocardial stunning at control heart rate. As shown, both vasodilators enhanced % segment 
length shortening in the two layers following reperfusion but had no effect prior to 
ischemia-reperfusion. The effect was the same at both heart rates. Because end-diastolic 
lengths and systolic pressures were similar during these interventions, it is unlikely that the 
functional changes were a result of changes in the loading conditions. 
MYOCARDIAL BLOOD FLOW, OXYGEN AND LACTATE (GROUP 2) 
Heart rate was 75.±.20 beats per minute prior to ischemia and increased to 81.±.29 
(p < .05) following reperfusion. Mean arterial pressure decreased slightly but insignificantly 
from 87 .±.16 to 79 .±.16 mmHg during the same interval. During initial atrial pacing, mean 
Table 1 : Systemic Hemodynamics Pre-ischemia and 30 Minutes Post-reperfusion (Group 1) 
Pre-ischemia 30 Minute Reperfusion 
--
Control HR Baseline-1 Adenosine ATP Baseline-2 Adenosine 
MAP 78 ± 17 75 ± 17 74 ± 21 78 ± 12 78 ± 13 
HR 102 ± 6 101 ± 8 100 ± 12 116 ± 8* 116 ± 9* 
LVEDP 7 ± 1 7 ± 2 7 ± 3 7 ± 2 7 ± 2 
LVdP/dtmax 1579 ± 394 1481 ± 337 1434 ± 366 1392 ± 416 1430 ± 390 
Pacing HR 
MAP 76 ± 16 76 ± 18 75 ± 18 76 ± 13 81 ± 12 
HR 150 150 150 150 150 
LVEDP 8 ± 2 8 ± 2 8 ± 2 6 ± 2 5 ± 3 
LVdP/dtmax 1516 ± 351 1377 ± 402 1479 ± 284 1548 ± 218 1610 ± 429 
ATP 
71 ± 
117 ± 
6 ± 
1480 ± 
76 ± 
150 
5 ± 
1645 ± 
'Cl 
00 
13 
13* 
1 
446 
12 
1 
192 
MAP, mean arterial pressure (mmHg); HR, heart rate (beats/min); LVEDP, left ventricular end-diastolic pressure (mmHg); LVdP/dtmax (mmHg/s); 
mean ± SD; • P<0.05 vs Baseline-1. 
Table 2: Coronary Hemodynamics and Regional Function Pre-ischemia and 30 Minutes Post-reperfusion (Group 1) 
Pre-ischemia 30 Minute Reperfusion 
Control HR Baseline-1 Adenosine ATP Baseline-2 Adenosine ATP 
LAD Coronary Artery 
59* Blood Flow 30 ± 13 114 ± 111 ± 54* 21 ± 8 98 ± 32+ 90 ± 33+ 
Resistance 3.06 ± 1.14 0.81 ± 0.40* 0.76 ± 0.25* 4.11 ± 1.12* 0.86 ± 0.31+ 0.85 ± 0.23+ 
Segment Lengths 
Endo ES 9.1 ± 1.5 9.1 ± 1.4 9.1 ± 1.6 9.5 ± 1.4* 9.3 ± 1.3+ 9.4 ± 1.5+ 
Endo ED 10.8 ± 2.0 10.8 ± 2.0 11.0 ± 2.1 10.6 ± 1.9 10.7 ± 1.8 10.8 ± 2.0 
Endo Shortening (%) 16 ± 3 16 ± 3 17 ± 3 10 ± 4* 13 ± 4+ 13 ± 4+ 
Bpi ES 9.5 ± 1.0 9.5 ± 1.0 9.3 ± 1.1 10.1 ± 1.1* 9.9 ± u+ 9.7 ± u+ 
Bpi ED 11.1 ± 1.6 11.0 ± 1.6 10.9 ± 1.8 11.0 ± 1.4 11.0 ± 1.5 10.9 ± 1.6 
Bpi Shortening (%) 14 ± 6 14 ± 6 14 ± 5 8 ± 6* 9 ± 7+ 10 ± 7+ 
Pacing HR 
LAD Coronary Artery 
56* 47* Blood Flow 30 ± 11 106 ± 97 ± 23 ± 5 102 ± 22+ 87 ± 32+ 
Resistance 2.88 ± 1.28 0.86 ± 0.38* 0.90 ± 0.39* 3.55 ± 0.29* 0.81 ± 0.15+ 0.95 ± 0.29+ 
Segment Lengths 
Endo ES 9.8 ± 1.2 9.6 ± 1.1 9.5 ± 1.2 9.2 ± 1.3* 9.3 ± 1.4+ 9.4 ± 1.4+ 
Endo ED 10.8 ± 1.5 10.8 ± 1.5 10.7 ± 1.5 10.6 ± 1.5 10.6 ± 1.4 10.4 ± 1.6 
Endo Shortening (%) 13 ± 2 12 ± 4 11 ± 3 9 ± 4.5* 11 ± 4+ 11 ± 4+ 
Bpi ES 10.4 ± 0.8 10.2 ± 0.8 10.1 ± 0.8 9.7 ± 0.6* 9.5 ± 0.9+ 9.6 ± 0.7+ 
Bpi ED 11.2 ± 0.8 11.1 ± 0.8 11.1 ± 0.8 11.0 ± 0.9 10.7 ± u+ 10.7 ± 1.0+ 
Bpi Shortening (%) 10 ± 5 10 ± 3 8 ± 4 6 ± 6* 7 ± 6+ 8 ± 6+ 
LAD coronary blood flow (ml/min); LAD coronary resistance (mmHg/min/ml); Endo, Endocardial; Bpi, Epicardial; ED, end-diastoli< 
ES, end-systolic; mean ± SD; • P < 0.05 vs baseline-1; + P < 0.05 vs baseline-2. 
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Figure 1: Representative tracing from an animal in group I prior to ischemia and following 
reperfusion. AOP-aortic pressure (mmHg), LVP-left ventricular pressure (mmHg), 
LVdp/dtmax-first derivative of left ventricular pressure (mmHgjsec), CBF-coronary blood flow 
(ml/min), endocardial (Endo) and epicardial (Epi) segment length (SL) changes (mm). 
Myocardial blood flows in the LAD and nonlAD regions are shown in Table 3. 
During ischemia, blood flow in the LAD region was reduced to 20% of baseline (p < .05), 
while in the nonlAD region, the reduction was not statistically significant. Following 10 
minutes of ischemia and 30 minutes of reperfusion, transmural flows returned to 
pre-ischemic baseline values in all layers. During pacing, transmural flow in the reperfused 
regions did not increase to the same degree as in the normal region and was statistically 
lower in the subendocardial layer. 
Myocardial oxygen consumption in the LAD region is also shown in Table 3. 
Although values tended to increase with pacing and decrease following reperfusion, the 
differences were not statistically significant. Lactate extraction during each intervention was 
measured from the reperfused bed and is demonstrated in figure 3. Following 30 minutes 
of reperfusion, lactate production was greater at both heart rates compared with 
pre-ischemic baseline. It is interesting to note that lactate extraction following reperfusion 
remained unchanged at the two heart rates despite relative subendocardial hypoperfusion 
in the LAD region. This suggests that the lower flows were not associated with ischemia. 
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Figure 2:( a) endocardial systolic segment length changes (%)pre-ischemia and post-reperfusion 
at control heart rate in group I. (b) epicardial systolic segment length changes (%) during the 
same interventions. (n = 6;means.±..sd) #-p <.05 vs baseline pre-ischemia; *-p <.05 vs baseline 
post-ischemia arterial pressure was 79.±..10 mm Hg and was 76.±..11 mm Hg following 
ischemia-reperfusion (NS). 
Table 3: Myocardial Blood Flow and Oxygen Consumption Pre-ischemia and 30 Minutes Post-reperfusion (Group 2) 
Transmural 
LAD 
nonLAD 
Endocardium 
LAD 
nonLAD 
Midmyocardium 
LAD 
nonLAD 
Epicardium 
LAD 
nonLAD 
0 2-ex 
MV02 
Baseline 
0.92 ± 0.32 
1.00 ± 0.29 
0.88 ± 0.26 
1.06 ± 0.31 
0.93 ± 0.30 
1.10 ± 0.37 
0.96 ± 0.43 
0.96 ± 0.31 
7.94 ± 2.55 
6.46 ± 1.80 
Pacing Ischemia 30 Min reperfusion 
Myocardial Blood Flow 
1.17 ± 0.69 0.18 ± 0.22* 0.89 ± 0.39 
1.23 ± 0.49 0.82 ± 0.34 0.99 ± 0.37 
1.18 ± 0.62 0.23 ± 0.30* 0.89 ± 0.32 
1.23 ± 0.49 0.87 ± 0.37 1.04 ± 0.43 
1.25 ± 0.75 0.18 ± 0.23* 0.97 ± 0.41 
1.28 ± 0.48 0.88 ± 0.43 1.00 ± 0.35 
1.12 ± 0.73 0.16 ± 0.18* 0.86 ± 0.48 
1.16 ± 0.54 0.85 ± 0.39 0.95 ± 0.40 
LAD Myocardial Oxygen Consumption 
7.56 ± 2.52 
8.11 ± 2.46 
6.64 ± 2.66 
5.04 ± 3.02 
30 Min reperfusion 
+ pacing 
0.89 ± 0.32 
1.10 ± 0.25 
0.84 ± 0.24+ 
1.13 ± 0.19 
0.96 ± 0.32 
1.13 ± 0.23 
0.87 ± 0.41 
1.05 ± 0.34 
7.77 ± 2.85 
5.93 ± 1.58 
*P<0.01; +P<0.05 vs nonLAD region (unpaired t-test); myocardial blood flow-ml/g/min; 0 2-ex (myocardial oxygen extraction)-ml 
0 2/100 ml blood; MV02 (myocardial oxygen consumption)-ml 0 2/100 g/min 
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Discussion 
In this model of myocardial stunning, we have shown that the vasodilator responses 
of intracoronary infusions of ATP and adenosine are not altered following brief ischemia 
and reperfusion. Unlike adenosine, ATP requires an intact endothelium for vasoactivity and 
thus has been used as a marker of altered endothelial cell function (13,16). Other 
endothelial dependent vasodilators such as acetylcholine, prostacycline and bradykinin have 
also been studied in various models of ischemia-reperfusion. In anesthetized dogs for 
instance, their vasodilator capacity is attenuated following 45-60 minutes of complete 
coronary occlusion (11-14). This ''vascular stunning" has primarily been demonstrated after 
prolonged periods of ischemia, which may also induce more permanent changes such as 
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Figure 3: Lactate extraction (%) at control heart rate and during atrial pacing (150 beats per 
min), prior to and following ischemia-reperfusion in group 2. (n = 6;means +sd). 
*-p <.05 vs baseline pre-ischemia 
necrosis and "no-reflow" (15). Our results are consistent with a more recent study which 
shows no differences in vascular reactivity between ADP and adenosine following brief 
ischemia (21). We have extended these findings to ATP and adenosine and in addition, have 
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measured the effect on function during vasodilation. The present study dissociates 
mechanical stunning during reperfusion from functional changes in the vasculature at a time 
when permanent changes are unlikely. 
Following reperfusion, minimal coronary resistances during intracoronary infusions 
of either ATP or adenosine were not different from the pre-ischemic baseline values. This 
is consistent with the findings in both conscious and open-chest dogs, where the vasodilator 
response to adenosine following 10 minutes of ischemia and reperfusion were not altered 
(22,23). In anesthetized dogs, Bolli et al (6) have recently reported that coronary resistance 
was higher in regionally stunned myocardium, 4 hours after a 15 minute occlusion. They also 
reported that minimal coronary resistances during intravenous infusions of adenosine or 
papaverine were higher in the reperfused regions compared with normally perfused 
myocardium and proposed that microvascular stunning existed. It is possible that our model 
of 10 minutes of partial coronary occlusion is not severe enough .to achieve the differences 
that they found after 15 minutes of complete occlusion. Johnson et al (24) however, have 
studied maximal flow-pressure lines during intracoronary adenosine infusions in anesthetized 
swine and showed no change in slopes following 20 minutes of complete occlusion and 15-45 
minutes of reperfusion. This would suggest that functional alterations in the vasculature are 
minimal when ischemia is less than 20 minutes in duration. 
Microvascular stunning is particularly interesting in light of the observations that both 
vasodilators in group 1 enhanced segment length shortening in the reperfused myocardium. 
This flow dependent improvement in function was not observed prior to 
ischemia-reperfusion and thus is different from the original observations made by Gregg 
(25). In group 2 animals, transmural flow distribution returned to normal following the same 
ischemia-reperfusion protocol as in group 1. Although pacing following reperfusion was 
associated with greater differences in flow between the two regions, lactate production did 
not increase and thus it seems unlikely that these changes in flow resulted in ischemia. 
Others have also reported improved function with vasodilation in models of myocardial 
stunning. Following twelve 5 minute ischemic periods in dogs, Stahl et al (2) infused three 
different vasodilators, dipyridamole, papaverine and nitroglycerine and showed a selective 
improvement in segment length following reperfusion. They postulated that the improved 
function resulted from an increase in flow to incompletely reperfused regions. With longer 
periods of ischemia and reperfusion, others have shown that adenosine not only improves 
function but also limits reperfusion injury. The proposed mechanism is a result of 
adenosine's ability to reduce microvascular plugging of leukocytes and thus prevent 
endothelial cell damage and "no-reflow" (3-5). 
Mechanisms other than microvascular "no-reflow" have been investigated to elucidate 
this flow dependent recruitment in function following stunning. Although adenosine and 
ATP can provide substrate for ATP production during reperfusion, this does not seem to 
be the explanation for the improved function. In isolated rat hearts exposed to 3 hours of 
hypothermic arrest, functional recovery improved when reperfused with adenosine but ATP 
levels did not increase (7). It is possible that increased flow during reperfusion improves 
function by the wash-out of metabolic byproducts from the ischemia. In isolated working rat 
hearts, intermittent reperfusion during 40 minutes of global ischemia improved functional 
recovery compared with hearts exposed to no reperfusion (8). The authors hypothesized that 
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intracellular calcium homeostasis was maintained in this model by preventing the buildup 
of intracellular sodium. This might also explain why mitochondrial function is improved 
when dogs have been reperfused with adenosine following brief ischemia (9). 
Our data show that lactate was continuously produced even 30 minutes after 
reperfusion. Because the distribution of coronary blood flow as measured by microspheres 
had returned to pre-ischemic values at that time, it is unlikely that the myocardium was still 
ischemic. It is possible that the higher flows with A TP and adenosine improved contractile 
function by the wash-out of lactate in the reperfused regions. Neely et al (26) have shown 
that lactate production during anaerobic glycolysis may be responsible for ventricular 
dysfunction. In isolated rabbit myocardium, tissue lactate levels have been shown to be 
elevated following brief ischemia and reperfusion and are lower when adenosine is included 
in the reperfusate (27). An alternative explanation to these observations is that vasodilation 
during reperfusion improves contractile function by increasing oxygen delivery and 
enhancing substrate utilization (7). 
In summary, we have shown that alterations in regional function induced by 10 
minutes of partial coronary occlusion and 30 minutes of reperfusion in swine are not 
associated with altered responses to the endothelial-dependent vasodilator ATP or 
adenosine. Post-ischemic function is improved with both vasodilators however, and may 
result from either enhanced washout of metabolic byproducts such as lactate or improved 
utilization of substrates. 
LIMITATIONS OF THE STUDY 
A major criticism of this work is the lack of specifity of the vasodilator responses of 
either adenosine or ATP in regards to the endothelium. Although ATP relaxes 
preconstricted arteries via the release of EDRF in vitro, its mechanism of vasodilation in 
the in tact animal may be more nonspecific. Likewise, adenosine has been considered to be 
an endothelial-independent vasodilator but recent work suggests that its receptors may also 
be linked to guanylate cyclase (28). We feel however, that the inability to attenuate the 
vasodilator response of either agent in this model of myocardial stunning suggests that the 
endothelium remains functionally in tact. 
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Abstract 
Pressure-maximal coronary flow relationship in regionally stunned porcine 
myocardium. Variable results have been reported on maximal coronary flow in stunned 
myocardium. In view of the dependency of maximal coronary flow on perfusion pressure, 
we wished to study the maximal coronary conductance, defined by the slope of the 
pressure-maximal coronary flow relationship, in regionally stunned myocardium. 
Myocardial stunning was induced in 12 anesthetized swine by 15 min of coronary 
perfusion at 20 mm Hg perfusion pressure, resulting in low flow (10-20% of baseline) 
myocardial ischemia, followed by 30 min of reperfusion. Pressure-maximal coronary flow 
relationships were obtained with intracoronary adenosine (20 J.Lg/kg/0.2 ml) at 6 
different coronary perfusion pressures within the autoregulatory range. Subendocardial 
systolic segment length shortening was 19 ± 5% at baseline and 7 ± 6% at 30 min of 
reperfusion (P<0.01), respectively. Post-systolic shortening was -4 ± 5% at baseline and 
4 ± 6% at 30 min of reperfusion (P < 0.01 ). The slope of the pressure-maximal coronary 
flow line increased from 3.34 ± 1.03 to 3.89 ± 1.33 ml/min/mm Hg (P<0.01), while 
calculated maximal coronary flow at 40 mm Hg perfusion pressure was 46 ± 21 ml/min 
at baseline and 40 ± 15 ml/min following stunning (NS). Because myocardial stunning 
per se may have an effect on the maximal coronary conductance we additionally studied 
the effects of altering contractile function of stunned myocardium via selective 
chronotropic (atrial pacing, n = 6) or combined chronotropic and inotropic (intravenous 
dobutamine, n = 6) interventions. Atrial pacing at 40 beats/min above the intrinsic heart 
rate further reduced the fractional systolic segment shortening by 2 ± 2% (absolute 
change,P<0.05), while post-systolic shortening was not affected. In contrast 4 J.Lg/kgjmin 
dobutarnine enhanced systolic shortening by 7 ± 4% (P<0.05), while post-systolic 
shortening was reduced by 7 ± 5% (P<0.05). Despite the diverse effects on contractile 
function, neither intervention significantly altered the pressure-maximal coronary flow 
relationship. In conclusion, severe myocardial stunning was associated with an increase 
in maximal coronary conductance in the autoregulatory range. With interventions which 
altered contractile function, we were unable to show that this increase in maximal 
conductance was related to the change in contractile function. 
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Introduction 
Coronary flow reserve has consistently been reported to be reduced in 
myocardium subjected to periods of ischemia and reperfusion, that are long enough to 
induce myocardial necrosis (5, 13, 15, 19, 27). Mechanisms that have been implicated are 
mechanical obstruction possibly due to capillary damage (2), neutrophil plugging (7), 
myocardial tissue edema or ischemic contracture (11, 22) and increases in vasomotor 
tone (8). In contrast, reports on coronary flow reserve following brief periods of ischemia 
and reperfusion, which induce reversible loss of myocardial contractile function in the 
absence of myocardial necrosis, i.e. "myocardial stunning", show variable results. In a 
number of studies in conscious (16) and anesthetized dogs (12, 25) it has been shown 
that the coronary blood flow responses to maximal doses of vasodilators are unchanged 
in reperfused stunned myocardium following single or multiple brief periods (5-10 min) 
of myocardial ischemia. Similar observations were made in viable myocardium during 
reperfusion following longer periods (45-90 min) of ischemia (21, 27). In contrast with 
these findings, it has been reported in dogs that maximal coronary blood flow is reduced 
during reperfusion following 15 min of ischemia ( 4, 20). 
Discrepancies may in part be related to the steepness of the pressure-flow 
relationship during maximal vasodilation, whereby even small changes in coronary 
perfusion pressure could lead to significant changes in coronary blood flow (14, 18). A 
more appropriate way to characterize the coronary circulation is to determine the slope 
of the coronary pressure-flow relationship during maximal vasodilation, i.e. determine the 
maximal coronary conductance. In the present study we therefore wished to investigate 
the effects of 15 min of severe myocardial ischemia, followed by 30 min of reperfusion, 
on the pressure-maximal coronary flow relationship in anesthetized swine. 
Another factor to be considered, when studying the effects of a brief period of 
ischemia followed by reperfusion on the maximal coronary conductance, is the alteration 
in contractile function that is inherent to myocardial stunning. A change in the pattern 
of myocardial contraction may affect maximal coronary blood flow (17) and the pressure-
maximal coronary flow relationship (14, 26). Alterations in the maximal coronary 
conductance that are due to ischemia and reperfusion-induced changes in the coronary 
vascular responsiveness to vasodilators could be modulated by the change in contractile 
function. To assess the influence of contractile function on the maximal coronary 
conductance in stunned myocardium, we additionally studied and compared the effects 
of selective chronotropic (atrial pacing) and combined inotropic and chronotropic 
(intravenous dobutamine) interventions on the pressure-maximal coronary flow 
relationship in regionally stunned porcine myocardium. 
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Methods 
General 
All experiments were performed in accordance with the Guiding Principles in the 
Care and Use of Animals as approved by the Council of the American Physiological 
Society (DREW Publication No. (NIH) 80-23, 1980) and under the regulations of the 
Animal Care Committee of the Erasmus University Rotterdam, Rotterdam, The 
Netherlands. 
After an overnight fast, cross-bred Landrace x Yorkshire pigs (HVC, Redel, The 
Netherlands) of either sex (25-45 kg, n = 12) were sedated with intramuscular 20 mg/kg 
ketamine (AUV, Cuijk, The Netherlands), anesthetized with intravenous 5 mg/kg 
metomidate (Janssen Pharmaceutica, Beerse, Belgium), intubated and connected to a 
ventilator for intermittent positive pressure ventilation with a mixture of 0 2 and N2 (1:2, 
v jv). Respiratory rate and tidal volume were set to keep arterial blood gases within the 
normal range: 7.35 <pH< 7.45; 35 mm Hg < PC02 < 45 mm Hg and 100 mm Hg < 
P02 < 160 mm Hg. Catheters (7F) were placed in the superior caval vein for 
administration of (i) 100 mg/kg a-chloralose (Merck, Darmstadt, Germany) followed by 
an infusion of 10 mg/kg/h a-chloralose and an infusion of 3-4 mg/kg/h sodium 
pentobarbitone (Sanofi, Paris, France), (ii) 4 mg of the muscle relaxant pancuronium 
bromide (Organon Teknika B.V., Boxtel, The Netherlands) prior to thoracotomy and (iii) 
haemaccel (Behringwerke A.G., Marburg, Germany). Catheters were also positioned in 
the descending aorta for withdrawal of blood samples and measurement of central aortic 
blood pressure. A 7F Sensodyn micromanometer-tipped catheter (B.Braun Medical B.V., 
Uden, The Netherlands) inserted via the left carotid artery, was used to measure left 
ventricular pressure and its first derivative (LVdP/dt). After thoracotomy an 
electromagnetic flow probe (2.5 or 3.0 mm diameter; Skalar, Delft, The Netherlands) and 
a hydraulic occluder (R.E. Jones, Silver Spring, Maryland, USA) were positioned around 
the most proximal part of the left anterior descending coronary artery (LAD). The 
balloon was connected to a 1 ml syringe (Hamilton Bonaduz, Bonaduz, Switzerland) 
driven by a micrometer (Hamilton Co., Reno, Nevada, USA). Meticulous attention was 
paid to the positioning and stability of the flow probe and zero flows were checked 
regularly throughout the experiments. Immediately distal to the flow probe and occluder, 
a small cannula (0.8 mm outer diameter) was inserted into the LAD for administration 
of adenosine and for measurement of coronary perfusion pressure. Reactive hyperemia 
following a 15 s occlusion was performed prior to and after insertion of the cannula into 
the LAD to ensure that no attenuation of maximal coronary blood flow occurred due to 
the presence of the cannula. Regional myocardial segment length shortening was 
measured by sonomicrometry (Triton Technology Inc., San Diego, Ca, USA) using two 
pairs of ultrasonic crystals (Sonotek Corporation, Del Mar, Ca, USA) placed in the 
subendocardial and subepicardial layers of the LAD perfused area approximately 10 mm 
apart (24). Pacings leads were attached to the left atrial appendage and connected to a 
pacing stimulator. 
Experimental Protocol 
Following completion of the surgical procedures, a 30 minute stabilization period 
was allowed before baseline recordings were made of central aortic blood pressure, left 
ventricular blood pressure (L VP) and its first derivative LV dP / dt, coronary perfusion 
pressure, LAD blood flow and subendocardial and subepicardial segment length (Figs. 
1a and 1b). Subsequently, LAD blood flow and perfusion pressure were assessed 
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following maximal vasodilation with 20 J.Lg/kg intracoronary adenosine (0.2 ml), which 
was slowly injected over 5 seconds. This dose of adenosine was compared to 30-40 J.Lg/kg 
adenosine in each experiment and was found to give maximal vasodilation in each 
animal. Furthermore it always exceeded the peak reactive hyperemia following a 15 s 
occlusion. Subsequently, the balloon of the hydraulic occluder was inflated to create up 
to six different levels of coronary perfusion pressure. The perfusion pressures varied 
widely but were always within the autoregulatory range, to avoid changes in contractile 
function. Coronary blood flow and coronary perfusion pressure during maximal 
vasodilation with adenosine were recorded at each level of perfusion pressure. 
Following these baseline recordings, myocardial ischemia was induced by inflation 
of the hydraulic occluder so that coronary perfusion pressure was 20 nun Hg, resulting 
in a 80-90% reduction of coronary blood flow. We chose this regimen because it induces 
myocardial stunning, with less ventricular fibrillation compared to complete occlusions. 
After 15 min, the hydraulic occluder was released and the heart was reperfused for 30 
minutes, at which time all recordings were repeated. 
Following all measurements at 30 min of reperfusion the 12 pigs were randomly 
divided into two groups. In six animals the left atrium was paced at 40 beats/min above 
the intrinsic heart rate level at 30 minutes of reperfusion, while the other six animals 
received an intravenous infusion of 4 J.Lg/kg/min dobutamine. The 40 beats/min increase 
was chosen because this corresponded with the increment in heart rate induced by 4 
J.Lg/kg/min dobutamine in 3 pilot experiments. Ten minutes after the onset of atrial 
pacing or start of the dobutamine infusion, recordings were repeated. We chose to study 
the effects of dobutamine and atrial pacing in parallel experiments, rather than 
sequentially in each experiment, to exclude any possible reperfusion duration-dependent 
effects on myocardial contractile function and hence the pressure-maximal coronary flow 
relationship. 
Data analysis and presentation 
From each of the three experimental periods (baseline, myocardial stunning, atrial 
pacing or dobutamine) we obtained coronary blood flow under basal conditions 
(autoregulation) and during maximal vasodilation with adenosine. Coronary flow reserve 
ratio was calculated as the ratio of maximal coronary blood flow divided by coronary 
blood flow during autoregulation (9). Pressure-maximal coronary flow lines were 
generated from the 6 points collected during each sampling period, and correlations ~r2) 
and regressions were determined by first order curve fitting. In all 12 animals the r of 
the pressure-maximal coronary flow line exceeded 0.98 at all time points. 
From the tracings the segment lengths of the subendocardial and subepicardial 
layers were assessed at end-diastole, end-systole and post-systole. End-diastolic length 
(EDL) was measured at the onset of positive LV dP / dt, while end-systolic length (ESL) 
was measured at peak negative LV dP / dt (1, 10). Post-systolic length (PSL) was measured 
at the point where negative LV dP / dt had returned to zero. This point corresponded with 
maximal post-systolic shortening following stunning in 11 of the 12 animals. Fractional 
systolic shortening (SS) was calculated as 
SS = EDL-ESL 
--;==-;---- X 100 (%) 
EDL 
and fractional post-systolic shortening (PSS) was calculated as 
PSS = PSL - ESL 
--=~-X 100 (%) 
EDL 
117 
All results have been presented as arithmetic means ± SD. Data at baseline and 
following myocardial stunning have been presented as absolute values; data during either 
atrial pacing or dobutamine have been presented as absolute changes from myocardial 
stunning values. Statistical analysis was performed using the paired t-test with Bonferroni 
correction. The effects of dobutamine were compared to atrial pacing with the unpaired 
t-test. 
Drugs 
Adenosine (E. Merck, Darmstadt, Germany) was dissolved in saline at a 
concentration of 100 J.Lg/kg/ml for intracoronary administration of a bolus infusion of 0.2 
ml (20 J.Lg/kg). Dobutarnine (Eli Lilly Nederland, Amsterdam, The Netherlands) was 
dissolved in saline at a concentration of 4 J.Lg/kg/ml and infused intravenously at a rate 
of 1 ml/min. 
Results 
During ischemia one animal encountered ventricular fibrillation, while two 
animals fibrillated during reperfusion. Sinus rhythm could be restored in each animal 
with a single De-countershock and these animals have therefore been included in the 
analysis. 
Systemic hemodynamics 
Fifteen min of myocardial ischemia and 30 min of reperfusion resulted in a 
decrease in mean arterial blood pressure of 13±7% (P<0.01), and an increase in heart 
rate of 15±15% (P<0.05). LVdP/dtmax was reduced by 23±13% (P<0.01), while left 
ventricular end-diastolic pressure was not affected (Table 1 ). 
Mean arterial blood pressure did not change during either atrial pacing at 40 
beats/min above the intrinsic heart rate or the intravenous infusion of 4 J.Lg/kg/min 
dobutamine (Table 1). Dobutarnine increased heart rate by 32± 15 beats/min, which was 
not significantly different from the heart rate response in the atrial pacing group. 
LVdP/dtmax increased by 72±25% during dobutamine, while this parameter was not 
affected by atrial pacing. Finally, left ventricular end-diastolic pressure was lowered by 
dobutamine but not by atrial pacing. 
Myocardial contractile function 
At 15 min of ischemia, subendocardial and subepicardial fractional systolic 
segment shortening were -1.9 ± 2.3% and -2.1 ± 2.0%, respectively. Post-systolic 
segment shortening was 9.4 ± 5.1% and 9.5 ± 3.1% in the subendo- and subepicardial 
layers, respectively. At 30 min of reperfusion myocardial stunning was present in both 
myocardial layers, as systolic shortening of the post-ischemic segment was approximately 
one-third of baseline value, while post-systolic shortening was still present (Table 2). 
Atrial pacing did not affect end-systolic segment length but end-diastolic length 
Table 1: Systemic hemodynamics in 12 swine before and after myocardial stunning (15 min ischemia and 30 min repeifusion) and following subsequent 
stimulation with either atrial pacing (n = 6) or intravenous dobutamine (n = 6). 
Absolute change from myocardial stunning 
Baseline Myocardial stunning 
Atrial pacing Dobutamine 
Mean arterial blood pressure (mmHg) 93 ± 16 80 ± 12** -1 ± 2 -5 ± 7 
Heart rate (beats/min) 101 ± 20 115 ± 21* 40+ 32 ± 15+ 
LVdP/dtmax (mmHg/s) 1740 ± 250 1330 ± 260** 70 ± 100 1020 ± 4oo+o 
LV end diastolic pressure (mmHg) 9.3 ± 2.0 9.7 ± 2.1 -1.3 ±. 1.5 -2.1 ± 0.4+ 
The left atrium was paced at 40 beats/min above the heart rate recorded following myocardial stunning; dobutamine was infused intravenously at a 
rate of 4 1-Lg/kg/min. LV = left ventricular. Data at baseline and myocardial stunning have been expressed as absolute values. The data for atrial pacing 
and dobutamine have been expressed as absolute changes from the myocardial stunning values. All data have been presented as mean ± SD. *P<0.05 
myocardial stunning vs baseline; * * P < 0.01 myocardial stunning vs baseline; + P < 0.05 vs myocardial stunning; 0P < 0.05 dobutamine versus atrial pacing. 
Table 2: Normalized myocardial segment length and fractional shortening in 12 swine before and after myocardial stunning (15 min ischemia and 30 
min reperfusion) and following subsequent stimulation with either atrial pacing (n = 6) or intravenous dobutamine (n = 6). 
Absolute change from myocardial stunning 
Baseline ~yocardial stunning 
Atrial pacing Dobutamine 
Sub endocardium 
Segment length (mm) 
end-diastole 10.0 10.3 ± 0.7 -0.2 ± 0.3 -0.6 ± 0.2+ 
end-systole 8.1 ± 0.5 9.6 ± 1.1 ** 0.1 ± 0.4 -1.2 ± 0.4+0 
post-systole 8.5 ± 0.6 9.2 ± 0.8** 0.2 ± 0.2 -0.4 ± 0.2+ 0 
Fractional segment shortening (%) 
3.7+0 systole 19.4 ± 5.0 7.3 ± 6.2** -2.2 ± 1.7+ 6.6 ± 
post-systole -4.0 ± 4.5 3.9 ± 5.6** -1.0 ± 2.8 -7.0 ± 4.7+ 
Subepicardium 
Segment length (mm) 
0.3+ end-diastole 10.0 10.6 ± 0.5** -0.2 ± 0.2 -0.4 ± 
end-systole 8.6 ± 0.4 10.1 ± 0.8** 0.1 ± 0.2 -0.9 ± 0.6+0 
post-systole 8.7 ± 0.4 9.5 ± 0.8** 0.1 ± 0.4 -0.5 ± 0.2+ 0 
Fractional segment shortening (%) 
4.3+0 systole 14.2 ± 3.9 4.6 ± 4.9** -2.6 ± 1.6+ 4.7 ± 
post-systole -0.7 ± 3.3 5.5 ± 5.0** -0.3 ± 3.9 -3.8 ± 5.6 
The left atrium was paced at 40 beats/min above the heart rate recorded following myocardial stunning; dobutamine was infused intravenously at a 
rate of 4 JLg/kg/min. LV = left ventricular. Data at baseline and myocardial stunning have been expressed as absolute values. The data for atrial pacing 
and dobutamine have been expressed as absolute changes from the myocardial stunning values. All data have been presented as mean ± SD. *P<0.05 
myocardial stunning vs baseline; **P<0.01 myocardial stunning vs baseline; +P<0.05 vs myocardial stunning; 0P<0.05 dobutamine versus atrial pacing. 
Table 3: Coronary hemodynamics and the pressure-maximal coronary flow relationship in 12 swine before and after myocardial stunning (15 min 
ischemia and 30 min reperfusion) and following subsequent atrial pacing (n = 6) or intravenous dobutamine (n = 6). 
Coronary blood flow (ml/rnin) 
autoregulation 
during maximal vasodilation 
Coronary perfusion pressure (mmHg) 
autoregulation 
during maximal vasodilation 
Coronary flow reserve ratio 
Pressure-maximal coronary flow relationship 
slope (ml/rnin/mmHg) 
calculated flow at 40 mmHg (ml/rnin) 
calculated flow at 80 mmHg (ml/rnin) 
--
Baseline 
44 ± 12 
185 ± 61 
93 ± 16 
82 ± 16 
4.2 ± 1.0 
3.34 ± 1.03 
46 ± 21 
179 ± 57 
Myocardial stunning 
37 ± 13** 
167 ± 62 
80 ± 12** 
72 ± 12** 
4.7 ± 1.3* 
3.89 ± 1.33** 
40 ± 15 
195 ± 65* 
Absolute change from myocardial stunning 
Atrial pacing 
4 ± 4 
-18 ± 16 
-1 ± 2 
0 ± 2 
-0.8 ± o.s+ 
-0.18 ± 0.60 
-6 ± 8 
-13 ± 19 
Dobutarnine 
12 ± 9+ 
-14 ± 23 
-5 ± 7 
-7 ± 9 
-1.3 ± 0.6+ 
-0.04 ± 0.30 
7 ± 6° 
5 ± 12 
The left atrium was paced at 40 beats/min above the heart rate recorded following myocardial stunning; dobutarnine was infused intravenously at a 
rate of 4 p.gjkgjrnin. Data at baseline and myocardial stunning have been expressed as absolute values. The data for atrial pacing and dobutarnine 
have been expressed as absolute changes from the myocardial stunning values. All data have been presented as mean ± SD. *P<O.OS myocardial 
stunning; **P<0.01 myocardial stunning vs baseline; +P<O.OS vs myocardial stunning; 0P<0.05 dobutarnine versus atrial pacing. 
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was slightly smaller (Table 2), resulting in a reduction in systolic shortening in both 
myocardial layers. Post-systolic segment length and fractional post-systolic shortening 
were not affected by atrial pacing. In contrast, dobutamine doubled systolic shortening 
to 70% of baseline value in both myocardial layers. Furthermore, in the presence of 
dobutarnine post-systolic shortening was absent. 
Coronary blood flows and pressure-maximal coronary flow relationship 
Myocardial stunning decreased coronary blood flow during autoregulation by 20 
± 13% (P<0.01; Table 3). In the presence of adenosine coronary blood flow in stunned 
myocardium was not significantly different from baseline, despite the 10 ± 9 mm Hg 
(P < 0.01) drop in coronary perfusion pressure. Consequently, the calculated coronary flow 
reserve ratio increased from 4.2 ± 1.0 to 4.7 ± 1.3 (P< 0.05). Fig. 2 shows representative 
examples of the pressure-maximal coronary flow lines from an animal in each 
intervention group. Myocardial stunning increased the slope of the pressure-maximal 
CBF 
(ml/min) 
Figure 2: 
Atrial Pacing Dobutamine 
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Representative examples from two animals of pressure-maximal coronary flow 
relationships in the autoregulatory range. Presented are pressure-flow lines at 
baseline ( • ), following myocardial stunning ( + ), and during either atrial 
pacing at 40 beats/min above the intrinsic heart rate ( 0 , left panel) or 
intravenous infusion of 4 Jl.g/kg/min dobutamine infusion ( 0, right panel). 
CPP = mean coronary perfusion pressure, CBF = mean coronary blood flow. 
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coronary flow relationship from 3.34 ± 1.03 to 3.89 ± 1.33 ml/min/mm Hg (P<0.01, 
Table 3). The upward rotation of the pressure-flow line is also illustrated by calculating 
blood flows at two perfusion pressures: at 40 mm Hg coronary blood flows were 46 ± 
21 ml/min and 40 ± 15 ml/min (NS) before and after stunning, respectively and at 80 
mm Hg flows were 179 ± 57 and 195 ± 65 ml/min, respectively (P<O.OS). There was 
a poor correlation (r = 0.22; p = 0.5) between the percent change in subendocardial 
fractional systolic shortening and the percent change in the slope of the pressure-maximal 
coronary flow relationship (not shown). 
Although atrial pacing did not significantly increase coronary blood flow during 
autoregulation or reduce maximal coronary blood flow, the coronary flow reserve ratio 
was reduced. More important, the slope of the pressure-maximal coronary flow 
relationship was not affected by atrial pacing (Table 3). Dobutamine enhanced coronary 
blood flow during autoregulation by 30 %, while maximal coronary flow was unchanged. 
Consequently, the coronary flow reserve ratio decreased. As with atrial pacing, the slope 
of the pressure-maximal coronary flow relationship was unchanged during dobutamine. 
Discussion 
The main finding in the present study was that severe myocardial stunning, 
induced by 15 min of low flow ischemia and 30 min of reperfusion was associated with 
an increase in the maximal coronary conductance (defined by the slope of the pressure-
maximal coronary flow relationship) in the autoregulatory range. This increase in 
maximal coronary conductance could not be shown to be related to a change in 
contractile function, as it was affected neither by selective chronotropic (atrial pacing) 
nor combined inotropic and chronotropic (intravenous dobutamine) interventions. 
Other studies on coronary flow reserve measurements following brief periods of 
ischemia and reperfusion have shown variable results. In a number of studies in 
conscious (16) and anesthetized dogs (12, 25) it has been shown that the coronary blood 
flow responses to maximal doses of vasodilators are unchanged in reperfused "stunned" 
myocardium following single or multiple brief periods (5-10 min) of myocardial ischemia. 
Stahl et al. (25) found no change in coronary vasodilator response to intravenous 
dipyridamole and papaverine 90 min after 12 intermittent 5 min coronary artery 
occlusions in open-chest dogs. Jeremy et al. (12) using intracoronary adenosine in open-
chest dogs reported no change in flow reserve at 60 min of reperfusion following 10 min 
of ischemia. Similar observations were made with intravenous adenosine in conscious 
dogs by Laxson et al. (16) at 60 min of reperfusion following 3 intermittent 10 min 
coronary artery occlusions, separated by 30 min of reperfusion. In contrast with these 
findings, maximal coronary blood flow was reduced during reperfusion following 15 min 
of ischemia in open-chest dogs ( 4, 20). Nicklas and Gips (20), using intracoronary 
adenosine, found an attenuation of maximal coronary flow, at 1 hour of reperfusion. At 
4 hours ofreperfusion, Bolli et al. (4), using intravenous adenosine and papaverine, also 
observed an attenuated maximal coronary flow. The latter authors suggested that the 
longer duration of coronary artery occlusion, i.e. 15 min versus 10 min, could be 
responsible for the different observations. However, in a recent study in open-chest dogs, 
45 min of ischemia followed by 60 min reperfusion did not attenuate the vasodilator 
response to intracoronary nitroprusside (21). Also following 90 min of coronary artery 
occlusion and 150 min of reperfusion, maximal coronary flow assessed with intracoronary 
adenosine was maintained in post-ischemic viable myocardium (27). On inspection of 
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these studies, the length of reperfusion time does not seem to correlate with changes in 
coronary flow reserve. Furthermore, in all but two experimental protocols (21, 25) 
adenosine was used and therefore the discrepancies between the studies can not be 
ascribed to the use of different vasodilators. 
In the present study we found an increase in maximal coronary conductance 
following stunning, which seems in contrast with all previous studies. Laxson et al. (16) 
observed a small, yet non-significant, increase in maximal coronary blood flow from 63 
ml/min to 70 ml/min, following myocardial stunning, while arterial perfusion pressure 
decreased by 3 mm Hg, which was also not significant. As the slope of the pressure-
coronary flow line during maximal vasodilation is very steep (14, 18), the slight reduction 
in arterial perfusion pressure may have, at least in part, offset the increase in maximal 
flow. Nicklas and Gips (20) reported following stunning a non-significant reduction in 
diastolic arterial blood pressure of 5 mm Hg, while maximal coronary blood flow 
decreased from 179 ml/min to 136 ml/min. In our study a 5 mm Hg drop in perfusion 
pressure would result in a 15-20 ml/min drop in maximal coronary blood flow, which 
would account for almost half of the observed reduction in maximal coronary blood flow 
in their study (20). Although the small mean changes in perfusion pressure do not fully 
explain the findings of the different studies or their discrepancies, they do, however, 
illustrate the importance of determining the pressure-flow relationship when studying 
coronary flow reserve (14, 18). 
An explanation for the observed increase in maximal coronary conductance could 
be the loss of contractile function that occurs following ischemia and reperfusion. With 
the change in contractile function, extravascular compression may be altered which 
affects the pressure-maximal coronary flow relationship (14). To delineate between the 
effects on contractile function and the coronary vasculature, we studied and compared 
the effects of atrial pacing and dobutarnine on the maximal coronary conductance in 
stunned myocardium. Atrial pacing at 40 beats/min above intrinsic heart rate did not 
have an effect on the pressure-maximal coronary flow relationship. Bache and Cobb (3), 
have shown that atrial pacing in conscious dogs from 100 beats/min to 150 beats/min 
slightly reduced maximal subendocardial flow but had no significant effect on total 
transmural myocardial blood flow, and that only at heart rates of 200 beats/min and 250 
beats/min total transmural blood flow was reduced. The 40 beats/min (30%) increase 
in heart rate in our study, decreased the slope of the pressure-maximal coronary flow 
relationship in only two of the six animals and was apparently not large enough to 
consistently attenuate total transmural myocardial blood flow. Dobutamine, although not 
completely normalizing the contractile function, significantly improved contractile 
function with absolutely no effect on the maximal coronary conductance. This 
observation, taken together with the poor correlation between the degree of myocardial 
stunning and the change in maximal coronary conductance, strongly suggests that the 
increase in maximal coronary conductance is not related to the change in contractile 
function. The lack of effect of a change in contractile function on the pressure-maximal 
flow relationship seems in contradiction with an earlier study that showed an increase 
in maximal transmural blood flow when regional myocardial contractile function was 
abolished with lidocaine (17). However, other studies have shown the effects of changes 
in regional contractile function to be primarily on the transmural distribution of maximal 
coronary blood flow and minimal on maximal total transmural blood flow (6, 26). Several 
reasons can be forwarded to explain the lack of effect of a change in the contractile state 
of the myocardium on the pressure-maximal coronary flow relationship. Firstly, Doucette 
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et al. ( 6) showed that a loss of active contraction renders the myocardium more 
vulnerable to the compressive stress of left ventricular systolic pressure. A reduction in 
compressive stress due to a loss of active contraction may thus be partially offset by the 
increase in compressive stress due to the left ventricular systolic pressure generated by 
the normally contracting myocardium. A second explanation why an increase in 
contractility may not result in a reduction of maximal coronary conductance may be the 
duration of diastole. In our study, atrial pacing decreased the duration of diastole from 
42% of the cardiac cycle to 31%. In contrast, dobutarnine had no effect on the duration 
of diastole which was 45% and 46%, respectively, before and during dobutamine. Thus, 
relative to atrial pacing, dobutarnine increased the duration of diastole, an action that 
is due to an increase in velocity of contraction and relaxation (23). It could thus be that 
the effects of dobutarnine on systolic compression are counteracted by the increase 
diastolic perfusion time. Thirdly, in our study dobutarnine not only enhanced systolic 
function, it also enhanced early diastolic relaxation, as indicated by an almost complete 
reversion of post-systolic shortening. This may result in a reduction of diastolic 
compressive stress on the vasculature, thereby balancing the systolic compressive effects 
of dobutarnine on maximal coronary conductance. 
In summary, severe myocardial stunning, induced by 15 min of low flow ischemia 
and 30 min of reperfusion, was associated with an increase in the maximal coronary 
conductance in the autoregulatory range. The increase in maximal coronary conductance 
seems not related to the change in contractile function, as it was affected neither by 
selective chronotropic nor combined inotropic and chronotropic interventions. 
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Chapter 9 
The relationship between myocardial blood flow, metabolism and contractile function in 
regionally stunned myocardium during chronotropic and inotropic stimulation 
1Laboratory for Experimental Cardiology, Thoraxcenter, Erasmus University Rotterdam 
in preparation 
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Abstract 
Although stunned myocardium has been shown to retain normal functional reserve, 
the presence of coronary blood flow and metabolic reserve during increased myocardial 
demand following reperfusion has not been established. In 12 anesthetized swine, we 
occluded the left anterior descending coronary artery (LADCA) for 10 minutes and 
reperfused for 30 minutes for two successive cycles. The model has been previously shown 
to induce severe functional abnormalities in the absence of necrosis. At baseline, coronary 
blood flows in the control and LADCA regions were 1.49.±_0.43 and 1.48.±_0.42 ml/minjg, 
respectively. Thirty minutes following the second reperfusion period, control myocardial 
blood flow was 1.27.±_0.52 ml/min/g (NS) while LADCA flow was reduced to 0.94.±_0.27 
ml/min/ g (p < 0.05). Regional function was determined from segment length shortening 
(SLS) and the integral of the LV pressure-segment length loops (indices of work). At 
baseline, SLS in the control and LADCA regions were 13.2.±_3.7% and 18.3.±_5.2%, 
respectively and following reperfusion were 12.9.±_3.8% (NS) and 6.6.±_4.6% (p<0.05), 
respectively. Compared with baseline values, indices of work following reperfusion were 
reduced to 75.±_10% (NS) in the control region and 50.±_14% in the LADCA region 
(p < 0.05). Chronotropic and inotropic stimulation were then instituted following reperfusion. 
During atrial pacing and dobutamine, SLS was 10.2.±_3.5% in the control area and 
14.0.±_5.0% in the LADCA region (each 77% of baseline values). Although this suggested 
that post-ischemic function was fully recruited, index of work remained higher in the control 
region (116.±_48% vs 97.±_27%). Blood flow during the same intervention was 1.76.±_0.60 
mljminjg in control and 1.50.±_0.44 mljmin/g in the LADCA region, thus parallelling the 
small differences in recruitable work. Oxygen extraction was 75% both at baseline and 
following reperfusion and increased to 79 .±_11% (p < 0.05) during pacing. Lactate extraction 
was 40.±_14% and 8.±_11% (p < 0.05) at baseline and following reperfusion respectively and 
increased to 16.±_8% (p<0.05) with pacing and 19±9% (p<0.05) with dobutamine. In 
conclusion, coronary blood flow and metabolism are reduced with the functional 
abnormalities in this model of myocardial stunning. However, sufficient capacity to increase 
exists during augmented demands following reperfusion, thus emphasizing that neither are 
limiting factors for the contractile abnormalities .. The close relationship between changes 
in blood flow and recruitable work following reperfusion suggest that the two remain 
coupled. 
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Introduction 
In models of myocardial stunning induced by an ischemic period too brief to induce 
necrosis, the relationships between coronary blood flow, metabolism and contractile function 
have not been well characterized. Although the capacity to maximally vasodilate in response 
to exogenous vasodilators remains intact following stunning (1), basal coronary blood flow 
may be either lower (2-5) or unchanged (6-9) compared with pre-ischemic values. In support 
of the latter, myocardial oxygen consumption may be higher than expected based on the 
severe reductions in post-ischemic contractile function. A number of mechanisms including 
mitochondrial uncoupling, altered efficiency of energy utilization and an increased energy 
use for maintenance of cellular homeostasis (7) have been proposed to explain this apparent 
oxygen wastage. In support of the observation that blood flow is lower during myocardial 
stunning is the importance of the contractile state of the myocardium as a determinant of 
myocardial oxygen consumption. The latter suggests that blood flow would be metabolically 
down-regulated with reductions in post-ischemic function. 
We hypothesized that changes in blood flow in a model of myocardial stunning are 
metabolically related to changes in post-ischemic function and are not limited by the 
capacity to endogenously vasodilate. The design of these experiments was to assess the 
relationship between myocardial blood flow, metabolism and contractile function in 
regionally stunned myocardium during chronotropic (atrial pacing) and inotropic 
( dobutamine infusion during atrial pacing) stimulation. A model of stunning was used that 
has been shown to induce severe wall motion abnormalities in the absence of necrosis (10). 
Materials 
All experiments were performed in accordance with the Guiding Principles in the 
Care and Use of Animals as approved by the Council of the American Physiological Society 
(DREW Publication No. (NIH) 80-23, 1980) and under the regulations of the Animal Care 
Committee of the Erasmus University Rotterdam, Rotterdam, The Netherlands. 
Preparation 
On the day of the experiment, animals were sedated with an intramuscular injection of 
ketamine (20 mg/kg; AUV, Cuijk, The Netherlands), anesthetized with an intravenous 
injection ofmetomidate (5 mg/kg; Janssen Pharmaceutica, Beerse, Belgium), intubated and 
connected to a ventilator for intermittent positive pressure ventilation with a mixture of 
oxygen and nitrogen (1:2). Respiratory rate and tidal volume were set to keep arterial blood 
gases, measured with an AB1.3 (Radiometer, Copenhagen, Denmark) within the normal 
range: 7.35 < pH < 7.45; 35 mmHg < PC02 < 45 mmHg and 100 mmHg < P02 < 160 
mmHg. Catheters (7F) were placed in the superior caval vein for infusion of 10-15 mg/kg/h 
sodium pentobarbitone (Apharma, Arnhem, The Netherlands), haemaccel (Behringwerke 
A.G., Marburg, Germany) to replace blood withdrawn during sampling, and for infusion of 
dobutamine. Both femoral arteries were cannulated with 7F catheters, which were 
positioned in the descending aorta for measurement of central aortic blood pressure and for 
withdrawal of blood samples for blood gas analysis and calibration of the radioactive 
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microsphere method. A 7F Sensodyn micromanometer-tipped catheter (B.Braun Medical 
B.V., Uden, The Netherlands) inserted via the left carotid artery, was used to measure left 
ventricular pressure and its fust derivative (LVdP/dt). Rectal temperature was monitored 
throughout the experiment and maintained near 37 °C with external heating pads. 
Pancuronium bromide (4 mg; Organon Teknika B.V., Boxtel, The Netherlands) was given 
intravenously, and following a midline thoracotomy, the heart was suspended in a pericardia! 
cradle. The left manunary vessels were ligated and the second left rib was removed for ease 
of further instrumentation. The adventitia surrounding the aorta was dissected free and an 
electromagnetic flow probe (15 rom; Skalar, Delft, The Netherlands) was placed for 
measurement of ascending aortic blood flow. On the proximal third of the left anterior 
descending coronary artery (LADCA), a small segment was dissected free of its adventitia 
for subsequent positioning of the arterial clamp. 
Regional Myocardial Contractile Function 
To measure regional segment length changes in the area perfused by the LADCA, a pair 
of ultrasonic crystals (Triton Technology Inc., San Diego, CA, USA) was placed into the 
subendocardium, approximately 10 rom apart. Another pair of crystals was placed in the 
subendocardium of the area perfused by the left circumflex coronary artery (non-LADCA), 
remote from the myocardium perfused by the LADCA From the tracings the lengths at 
end-diastole (EDL; time of onset of positive LVdP/dt) and end-systole (ESL; time of peak 
negative LVdP/dt, see ref. 11) were obtained and systolic segment length shortening (SLS) 
calculated as: 
SLS (%) EDL- ESL x 100 
EDL 
Regional Myocardial Blood Flows 
To determine regional myocardial blood flows the left atrial appendage was catheterized for 
the injection of a batch of 1-2.106 radioactive microspheres, 15 ± 1 (SD) p,m in diameter 
(NEN Company, Dreieich, F.R.G.), labelled with either 95Nb, 103Ru, 113sn, 46sc or 141ce. 
Reference arterial blood samples were withdrawn from the descending aorta at a rate of 10 
ml/min, starting 15 seconds before and lasting until 1 minute after injection of the 
microspheres. At the conclusion of each experiment, the myocardium perfused by the 
LADCA was identified by injecting patent violet dye into the left atrium during LADCA 
occlusion and the heart was excised. Hearts were fixed in 10% formalin for 48 hours, and 
separated into LADCA and non-LADCA regions. Each region was then divided into 3 
layers of equal thickness (subendocardium, mesocardium and subepicardium). Vials 
containing either myocardial tissue or reference blood samples were then placed in a 
multichannel analyzer (Ganuna Counter-5000; Packard Instrument Inc.; USA) and the 
radioactivity was counted for the determination of regional myocardial blood flows. Full 
details of the procedures and the calculation of flow data using the reference sample 
technique have been reported earlier (12). 
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Determination of Oxygen Contents and Lactate Concentrations 
Blood samples were collected from the central aorta and from the cannulated vein 
accompanying the LADCA for the determination of oxygen and lactate contents. Oxygen 
saturation and hemoglobin concentrations were measured by an OSM2 system (Radiometer; 
Copenhagen, Denmark). These data together with oxygen tensions were used to calculate 
oxygen contents. Lactate contents were determined from aliquots of one ml of whole blood 
that were transferred into iced-plastic tubes containing 2 ml of 0.6 M HC104 and promptly 
vortexed. At the conclusion of each experiment, samples were centrifuged for later analysis 
by the enzymatic technique (13). Lactate extraction was calculated by the arterial-coronary 
venous differences divided by arterial levels X 100. Myocardial oxygen and lactate 
consumptions were calculated for the myocardium perfused by the LADCA from the 
product of regional transmural blood flow and the arterial coronary venous differences in 
oxygen and lactate, respectively. 
Experimental Protocol 
Following a 30-45 minute stabilization period, baseline recordings were made of aortic and 
left ventricular pressures, LV dP / dt, ascending aortic blood flow and myocardial segment 
length changes in the area's perfused by the LADCA and the non-LADCA. Arterial and 
coronary venous blood samples were obtained simultaneously for determination of oxygen 
content and lactate concentrations and a batch of radioactive microspheres was injected into 
the left atrium for regional myocardial blood flow measurements. Using a small clamp, the 
LADCA was then completely occluded for 10 minutes (occlusion-1) and reperfused for 30 
minutes (reperfusion-1). This sequence was then repeated (occlusion-2 and reperfusion-2). 
Throughout the two sequences of occlusion and reperfusion recordings were made of 
systemic hemodynamics and myocardial segment length changes. At the end of reperfusion-
2, all measurements (systemic hemodynamics, segment length changes, arterial and coronary 
venous blood sampling and injection of radioactive microspheres) were repeated. 
Subsequently, the heart rate was increased by 50 beats/min via left atrial pacing and 5 
minutes later all measurements were repeated. While atrial pacing was continued, an 
intravenous infusion of 2 J.Lg/kg/min dobutamine was started and after 10 min 
measurements were again obtained. In none of the experiments this dose of dobutamine 
caused an increase in heart rate exceeding the heart rate set by atrial pacing. All recordings 
were made at 50 rnm/s (Figure 1). 
Statistics 
Results are expressed as arithmetic means ..±. standard deviations. Changes were tested for 
significance at the p < 0.05 level by analysis of variance with repeated measurements 
(Fischer's PLSD plus F-test). In addition, changes in regional myocardial blood flows in the 
LADCA and non-LADCA regions were compared by unpaired student's t-test. 
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Representative tracing from an animal at baseline, during the first occlusion (10 
min), reperfusion-2 (30 min) and during chronotropic and inotropic stimulation 
following stunning. 
Results 
Systemic hemodynamics 
During the first coronary artery occlusion mean arterial blood pressure fell from 89 ± 13 
mmHg to 74 ± 20 mmHg (p < 0.05), because the increase in systemic vascular resistance was 
insufficient to compensate for the decrease in cardiac output from 2.90 ± 0.77 1/min to 2.24 
± 0.771/min (Table 1). The latter was due to a decrease in stroke volume as heart rate did 
not change. In view of the drop in arterial blood pressure and the increase in left ventricular 
end-diastolic pressure from 7 ± 2 mmHg to 12 ± 5 mmHg, the 20% decrease in 
LV dP / d~ax must have been responsible for the reduction in stroke volume. During the first 
reperfusion period there was a partial recovery of cardiac output and left ventricular end-
diastolic pressure, but the other systemic hemodynamic parameters were not significantly 
affected by the restoration of myocardial blood flow. During the second coronary artery 
occlusion cardiac output again decreased, but did not recover during the subsequent 
reperfusion period. The other parameters were only minimally affected by the second cycle 
of occlusion and reperfusion (Table 1). 
Table 1: Systemic hemodynamics during chronotropic and inotropic stimulation of stunned porcine myocardium. Stunning was induced by two sequences 
of complete occlusion (10 min) and reperfusion (30 min) of the left anterior descending coronary artery in 12 anesthetized swine 
Baseline Occlusion-! Reperfusion-1 Occlusion-2 
Mean arterial blood pressure 89 ± 13 74 ± 20* 76 ± 14* 77 ± 11* 
(mmHg) 
Cardiac output 2.90 ± 0.77 2.24 ± 0.77* 2.66 ± 0.67* 2.25 ± 0.59* 
(!/min) 
Heart rate 104 ± 13 103 ± 15 106 ± 19 102 ± 12 
(beats/min) 
LVdP/dtmax 2020 ± 440 1560 ± 400* 1630 ± 250* 1600 ± 310* 
(mmHg/s) 
LV-end diastolic pressure 7 ± 2 12 ± 5* 9 ± 4* 9 ± 3* 
(mmHg) 
Systemic vascular resistance 32.1 ± 7.7 35.4 ± 9.2* 37.0 ± 9.4* 36.1 ± 10.1* 
(mmHg.min/1) 
Stroke volume 27.4 ± 6.2 23.3 ± 5.4* 23.3 ± 5.1* 21.5 ± 5.5* 
(ml) 
Reperfusion-2 Atrial pacing Atrial pacing 
+ 
Dobutamine 
80 ± 11* 83 ± 10* 85 ± 10 
2.28 ± 0.68* 2.36 ± 0.72* 2.88 ± 0.93+ 0 
103 ± 15 153 ± 16*+ 153 ± 16*+ 
1550 ± 330* 1620 ± 300* 3320 ± 700*+ 0 
7 ± 2 7 ± 3 5 ± 3*+o 
38.0 ± 11.3* 37.6 ± 10.7* 31.7 ± 8.2+ 0 
22.1 ± 5.7* 15.3 ± 4.2*+ 18.7 ± 5.6*+ 0 
Hearts were paced at 50 beats/min above the heart rate measured at the end of Reperfusion-2. Dobutamine was infused intravenously at a rate of 2 
J.Lg/kg/min. LV = left ventricular. Data have been expressed as means ± sd; * P < 0.05 vs Baseline; + P < 0.05 vs Reperfusion-2; 0 P < 0.05 vs Atrial pacing 
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Atrial pacing had no effect on any of the systemic hemodynamic parameters, except 
for a decrease in stroke volume from 22.1 ± 5.7 ml to 15.3 ± 4.2 ml (p<0.05). During the 
additional intravenous infusion of dobutamine, stroke volume partially recovered to 18.7 ± 
5.6 ml (p<0.05) due to a doubling ofLVdP/dtmax and a 15% reduction in systemic vascular 
resistance (Table 1). 
Regional myocardial contractile function and work 
During the first coronary artery occlusion, the segment perfused by the LADCA became 
dyskinetic as systolic segment length shortening decreased from 18.3 ± 5.2% to -3.7 ± 2.5% 
(Table 2), while the non-LADCA perfused segment showed enhanced shortening during 
occlusion (from 13.2 ± 3. 7% to 15.4 ± 6.2%, p < 0.05). At 30 min of reperfusion, contractile 
function of the LADCA perfused area had only partially recovered (7.2 ± 5.0%, p<0.05 vs 
baseline). During the second cycle of occlusion and reperfusion similar values for systolic 
segment length shortening were observed, indicating little additional effect of the second 
cycle on contractile function. 
Atrial pacing reduced end-diastolic length in both the LADCA and the non-LADCA 
perfused areas, while the end-systolic lengths were minimally affected. As a result systolic 
segment length shortening decreased in both areas. Dobutamine increased systolic 
shortening from 4.3 ± 3.7% to 14.0 ± 5.0% (p<0.05) in the LADCA perfused area, but in 
the non-LADCA area the increase in systolic segment length shortening was only minor. 
Figure 2 shows an example of the left ventricular pressure-segment length 
relationship for both the LADCA and non-LADCA perfused areas. During the first 
occlusion the myocardium perfused by the LADCA did not perform any work (Table 3). By 
the end of the second period of reperfusion, there was a return to 50 ± 14% of baseline. 
At the same time, the work performed by the myocardium remote from the LADCA 
perfused area, was reduced to 75 ± 10% of baseline. Atrial pacing reduced work per 
minute, performed by both the LADCA and non-LADCA perfused myocardium by 15-30%, 
compared to the measurements obtained at the end of reperfusion-2. The additional infusion 
of dobutamine restored work in both segments to values measured at baseline (Table 3). 
Myocardial blood flow 
Two cycles of coronary artery occlusion and reperfusion, reduced transmural myocardial 
blood flow in the LADCA perfused area from 1.48 ± 0.42 ml/min/g to 0.94 ± 0.27 
ml/min/g (p<0.05), which was equally distributed over all layers (Table 4). In contrast, in 
the non-LADCA perfused area blood flow was reduced only in the subendocardial layers, 
as a result of which the subendocardial-subepicardial perfusion ratio decreased from 1.08 
± 0.13 to 0.94 ± 0.13 (p<0.05). The decrease in subendocardial perfusion of the LADCA 
area (0.51 ± 0.27 ml/min/g) was slightly larger than the decrease in subendocardial 
perfusion of the non-LADCA area (0.30 ± 0.43 mlfmin/g). In contrast to the transmural 
myocardial perfusion, the response of the subendocardial perfusion in the LADCA area was 
not significantly different from that in the non-LADCA area (p=0.08). 
Atrial pacing did neither affect transmural myocardial perfusion nor its distribution 
across the left ventricular wall. Dobutamine, infusion on the other hand, increased 
myocardial blood flow in both the LADCA and the non-LADCA perfused areas (Table 4). 
Table 2: 
LADCA area 
EDL (mm) 
ESL (mm) 
SLS (%) 
,..... 
w 
00 
Segment length changes during chronotropic and inotropic stimulation of stunned porcine myocardium. Stunning was induced by two sequences 
of complete occlusion (10 min) and reperfusion (30 min) of the left anterior descending coronary artery in 12 anesthetized swine 
Baseline Occlusion-1 Reperfusion-1 Occlusion-2 Reperfusion-2 Atrial pacing Atrial pacing 
+ 
Dobutamine 
12.2 ± 2.2 13.4 ± 2.3* 12.5 ± 2.3 13.3 ± 2.2* 12.6 ± 2.2 12.0 ± 2.0+ 11.7 ± 2.1*+ 
9.8 ± 1.9 13.9 ± 2.6* 11.6 ± 2.4* 13.9 ± 2.6* 11.8 ± 2.4* 11.6 ± 2.2* 10.0 ± 2.o+o 
18.3 ± 5.2 -3.7 ± 2.5* 7.2 ± 5.0* --4.1 ± 2.6* 6.6 ± 4.6* 4.3 ± 3.7* 14.0 ± 5.o•+o 
non-LADCA area 
EDL (mm) 10.7 ± 1.1 11.1 ± 1.1* 10.9 ± 1.2 11.2 ± 1.2* 10.8 ± 1.1 10.1 ± 1.1+ 9.8 ± 1.2*+ 
ESL (mm) 9.3 ± 1.1 9.4 ± 1.2 9.5 ± 1.1 9.6 ± 1.2 9.4 ± 1.0 9.3 ± 1.0 8.8 ± 1.o•+o 
SLS (%) 13.2 ± 3.7 15.4 ± 6.2* 13.2 ± 4.1 14.8 ± 4.9* 12.9 ± 3.8 8.2 ± 3.7*+ 10.2 ± 3.5*+ 0 
LADCA = left anterior descending coronary artery; EDL = end-diastolic length; ESL = end-systolic length; SLS = systolic segment length shortening. 
Hearts were paced at 50 beats/min above the heart rate measured at the end of Reperfusion-2. Dobutamine was infused intravenously at a rate of 2 
p.g/kg/min; Data have been expressed as means ± sd. * P<0.05 vs Baseline; + P<0.05 vs Reperfusion-2; 0 P<0.05 vs Atrial pacing. 
Figure 2: 
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Representative examples of LV pressure-segment length loops in both myocardial 
regions, at baseline, during occlusion-I, following reperfusion-2 and during atrial 
pacing and atrial pacing with dobutamine. 
Myocardial metabolism of the LADCA perfused area 
At the end of reperfusion-2, myocardial oxygen consumption was 70%, whereas 
lactate consumption was only 15% of their respective baseline values (Table 4). 
During atrial pacing myocardial oxygen consumption increased to 75% and lactate 
consumption to 30% of their respective baseline levels. During the additional dobutamine 
infusion, myocardial oxygen consumption returned to baseline but lactate consumption 
remained depressed at 40-45% of baseline (Figure 3). 
,_. 
""" 0 
Table 3: Normalized work during chronotropic and inotropic stimulation of stunned porcine myocardium. Stunning was induced by two sequences of 
complete occlusion (10 min) and reperfusion (30 min) of the left anterior descending coronary artery in 12 anesthetized swine 
Baseline Ocdusion-1 
LADCA area 
Normalized work (mmHg.mm/min) 1959 ± 556 28 ± 153* 
non-LADCA area 
Normalized work (mmHg.mm/min) 1692 ± 563 1560 ± 626 
Reperfusion-2 
968 ± 322* 
1246 ± 365 
Atrial pacing 
657 ± 508d 
1026 ± 393* 
Atrial pacing 
+ 
Dobutamine 
1926 ± 807+ 0 
1881 ± no+o 
LADCA = left anterior descending coronary artery. Hearts were paced at 50 beats/min above the heart rate measured at the end of Reperfusion-2. 
Dobutamine was infused intravenously at a rate of 2 J.Lg/kg/min. Data have been expressed as means ± sd; * P<O.OS vs Baseline; + P<O.OS vs 
Reperfusion-2; 0 P < 0.05 vs Atrial pacing. 
Table 4: Regional myocardial blood flows and metabolism during chronotropic and inotropic stimulation of stunned porcine 
myocardium. Stunning was induced by two sequences of complete occlusion (10 min) and reperfusion (30 min) of the left anterior 
descending coronary artery in 12 anesthetized swine 
Baseline Reperfusion-2 Atrial pacing Atrial pacing 
+ 
Dobutarnine 
Myocardial blood flow 
(mlfmin/g) 
LADCA area 
transmural 1.48 ± 0.42 0.94 ± 0.27* 1.07 ± 0.35* 1.50 ± 0.44+ 0 
endocardium 1.44 ± 0.44 0.93 ± 0.28* 1.05 ± 0.36* 1.44 ± 0.42+ 0 
epicardium 1.52 ± 0.42 0.94 ± 0.27* 1.08 ± 0.34*+ 1.56 ± 0.42+ 0 
endofepi 0.95 ± 0.13 0.99 ± 0.18 0.96 ± 0.12 0.92 ± 0.09 
non-LADCA area 
transmural 1.49 ± 0.43 1.27 ± 0.52 1.47 ± 0.64 1.76 ± 0.60*+ 0 
endocardium 1.54 ± 0.47 1.23 ± 0.53* 1.37 ± 0.60 1.65 ± 0.57+ 0 
epicardium 1.42 ± 0.41 1.32 ± 0.53 1.55 ± 0.28+ 1.91 ± 0.66.+ 0 
endo/epi 1.08 ± 0.13 0.94 ± 0.13* 0.88 ± 0.07* 0.87 ± 0.10* 
Myocardial metabolism 
LADCA area 
Oxygen content (flmolfml) 
arterial 4.45 ± 0.80 4.72 ± 0.88* 4.70 ± 0.89 4.68 ± 0.92 
arterial-venous difference 3.28 ± 0.47 3.48 ± 0.47* 3.62 ± 0.66*+ 3.20 ± 0.69+ 0 
Oxygen extraction (%) 75 ± 6 75 ± 10 79 ± u•+ 68 ± 12*+o 
Oxygen consumption 4.80 ± 1.40 3.24 ± 0.80* 3.84 ± 1.20*+ 4.70 ± 1.36+0 
(flmol/min/g) 
Lactate content (flmolfml) 
0.63*+ arterial 1.89 ± 0.92 1.91 ± 0.81 1.79 ± 0.68 1.60 ± 
arterial-venous difference 0.67 ± 0.22 0.16 ± 0.21* 0.27 ± 0.14* 0.30 ± 0.17*+ 
Lactate extraction (%) 40.0 ± 14.3 7.5 ± 10.6* 15.7 ± 8.3*+ 19.0 ± 9.o•+ 
Lactate consumption 1.02 ± 0.46 0.16 ± 0.21* 0.29 ± 0.20* 0.44 ± 0.27*+ 
(flmolfmin/g) 
...... 
LADCA ~ left anterior descending coronary artery. Hearts were paced at 50 beats/min above the heart rate measured at the end of Reperfusion-2. ""' ...... 
Dobutamine was infused intravenously at a rate of 2 f.Lg/kg/min. endo/epi ~ ratio of the normalized endocardial and epicardial blood flows. Data 
have been expressed as means ± sd. * P<0.05 vs Baseline; + P<0.05 vs Reperfusion-2; 0 P<0.05 vs Atrial pacing; (see table 1) 
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Figure 3: 
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(a) Oxygen and (b) lactate consumptions in the LADCA region at baseline, 
during repeifusion-2 (30 min) and with chronotropic and inotropic stimulation 
following stunning; data expressed as means+sd; n =12; *-p <0.05 vs baseline; 
#-p<0.05 vs reperfusion-2. 
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Discussion 
In this study, we have used a model of ischemia and reperfusion which induces 
severe changes in function following reperfusion without evidence of necrosis (10). We 
observed that at the end of reperfusion-2, myocardial blood flow was lower in the 
postischemic myocardium then in the control region. In view of the abundant evidence that 
the maximal vasodilatory capacity of the coronary vasculature is not or only minimally 
affected (5,8,9,14-16) in stunned myocardium, mechanical obstruction due to capillary 
plugging by neutrophils or edema formation, phenomena observed during prolonged periods 
of ischemia ( 17, 18), can be excluded as the cause for the reduction in myocardial blood flow. 
Furthermore, our data demonstrate that coronary blood flow which is reduced at a time 
when postischemic function is severely depressed, can return to preischemic levels when the 
myocardium is stimulated by chronotropic and inotropic stimulation. 
It has been suggested that the reduction in myocardial blood flow is metabolically 
regulated in accordance with the reduction in cardiac performance (19). That this reduction 
in blood flow is indeed the consequence, rather than the cause of the reduction in 
contractile function is also suggested by observations from other laboratories that contractile 
reserve is still present in stunned myocardium (20-22). However, in several studies using 
brief periods of ischemia and reperfusion myocardial blood flow has been shown to be 
similar to pre-ischemic values, despite significant reductions in contractile function ( 6-9). 
These observations suggest that myocardial oxygen consumption in regionally stunned 
myocardium is maintained due to either mitochondrial uncoupling, altered efficiency of 
energy utilization or an increased energy use for maintainance of cellular homeostasis (7). 
Our findings of a lower myocardial oxygen consumption are not necessarily inconsistent with 
these studies (6-9). The contractile state of the myocardium is an important determinant of 
myocardial oxygen consumption. With severe reductions in postischemic contractile function, 
the increase in oxygen consumption, due to mitochondrial uncoupling, altered efficiency or 
increased energy use for maintainance of cellular homeostasis may be masked by the 
attenuated oxygen demand due to the depression of contractile performance. Differences 
in studies may thus be explained by variable degrees of myocardial stunning. In the present 
study the changes in the index of myocardial work per minute parallelled the changes in 
blood flow following stunning, as well as following chronotropic and inotropic stimulation 
of the stunned myocardium with dobutamine. Another factor explaining the differences 
between our and previous studies (6-9) may be the response of systemic hemodynamics to 
ischemia and reperfusion. The index of myocardial work, used in the present study 
incorporates changes in heart rate and developed left ventricular pressure as well as changes 
in segment length shortening. This may explain the better prediction of blood flow and 
oxygen consumption by this index as compared to segment length shortening alone. During 
atrial pacing both systolic segment length shortening and the index of myocardial work 
decreased in both areas in the face of an increase in myocardial blood flow and oxygen 
consumption; an observation not readily explained. It could be that with atrial pacing 
activation of the myocardial contraction is not translated into myocardial work, because of 
an impaired filling of the left ventricle, which suggests that under these conditions a change 
in oxygen consumption is not solely governed by a change in myocardial work. Finally during 
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infusion of dobutamine myocardial blood flow and oxygen consumption returned to baseline 
levels however, myocardial substrate utilization was still altered, as reflected by a depressed 
lactate consumption. The mechanism leading to the altered substrate utilization can not be 
determined from the present study. In studies using longer periods of ischemia involvement 
of an increased production of lactate via enhanced uptake of substrates like glucose has 
been shown (23,24). In addition, a decreased oxidation of these substrates may play a role 
(25). From the data in Table 4, it becomes clear that the increase in oxygen consumption 
can not be explained by an increase in lactate consumption, suggesting an impairment in the 
lactate utilization capacity. Nevertheless, chronotropic and inotropic stimulation increased 
myocardial lactate consumption, indicating that this lactate utilization capacity was not 
exhausted. 
Conclusion 
In conclusion, we have shown in this model of myocardial stunning, that myocardial 
blood flow and myocardial oxygen consumption are reduced following reperfusion, parallel 
with a reduction in myocardial work. The observation that during chronotropic and inotropic 
stimulation with dobutamine blood flow and oxygen consumption increase, again in parallel 
with myocardial work, suggests that the lower blood flow in stunned myocardium is 
metabolically regulated and is not due to impairment of the vasodilatory capacity.] 
References 
1. Vanhaecke J, Flameng W, Borgers M, Jang I, Van de Werf F, De Geest H. Evidence 
for decreased coronary flow reserve in viable postischemic myocardium Circulation 
Research 1990;67:1201-1210. 
2. McFalls EO, Pantely GA, Ophuis TO, Anselone CH Bristow JD. Relation of lactate 
production to postischaemic reduction in function and myocardial oxygen consumption 
after partial coronary occlusion in swine. Cardiovasc Res 1987;21:856-62. 
3. Heyndrickx GR, Baig H, Nellers P, Levsen L, Fishbein MC, Vatner SF. Depression of 
regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 
1978;234:H653-9 
4. Bolli R, Zhu WX, Tbornby JI, O'Neill PG, Roberts R. Time-course and determinants 
of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 
1988;254:H102-H114. 
5. Bolli RJ, Triana F, Jeroudi MO. Prolonged impairment of coronary vasodilation after 
reversible ischemia. Circ Res 1990;67:332-43. 
6. Laxson DD, Romans DC, Dai X, Sublett E, Bach RJ. Oxygen consumption and 
coronary reactivity in postischemic myocardium Circulation Res 1989;64:9-20. 
145 
7. Dean EN, Shlafer M, Nicklas JM. The oxygen consumption paradox of "stunned 
myocardium" in dogs Basic Res Cardiol 1990;85:120-131. 
8. Nicklas JM, Gips SJ. Decreased coronary flow reserve after transient myocardial 
ischemia in dogs. JAm Coll Cardiol 1989;13:195-199. 
9. Jeremy RW, Stahl L, Gillinov M, Litt M, Aversano TR, Becker LC. Preservation of 
coronary flow reserve in stunned myocardium. Am J Physiol 1989;256:H1303-10. 
10. Schott RJ, Rohmann S, BraunER, Schaper W. Ischemic preconditioning reduces infarct 
size in swine myocardium. Circulation Research 1990;66:1133-1142. 
11. Guth BD, Schulz R, Reusch G. Evaluation of parameters for the assessment of regional 
myocardial contractile function during asynchronous left ventricular contraction during 
asynchronous left ventricular contraction. Basic Res. Cardiol. 1989;227-246. 
12. Saxena PR, Verdouw PD. Effects of methysergide and 5- Hydroxytryptamine on carotid 
blood flow distribution in pigs: further evidence for the presence of atypical 5-HT 
receptors. Br. J. Pharmacol. 1984;82:817-826. 
13. Clark LC, Noyes LK. Rapid electoenzymatic measurement of lactate in microsamples 
of spinal fluid. Clin Biochem. 1984;17:288-91. 
14. Johnson WB, Malone SA, Pantely GA, Anselone CA, Bristow JD. No reflow and extent 
of infarction during maximal vasodilation in the porcine heart. Circulation 
1988;78:462-72. 
15. McFalls EO, Duncker DJ, Krams R, Ward H, Gornick C and Verdouw, PD. 
Endothelial-dependent vasodilation following brief ischemia and reperfusion in 
anesthetized swine. Cardiovascular Research (in press) 
16. Duncker DJ, McFalls EO, Krams Rand Verdouw PD. Pressure-maximal coronary flow 
relationship in regionally stunned porcine myocardium. (submitted) 
17. Ambrosio G, Weisman HF, Mannisi JA, Becker LC.. Progressive impairment of regional 
myocardial perfusion after initial restoration of postischemic blood flow. 
Circulation1989;80:1846-61. 
18. Kloner RA, Ganote C.E, Jennings RB. The "no-reflow" phenomenon after temporary 
coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508. 
19. Schaper W, Ito BR. The energetics of "stunned" myocardium, in De Jong W (ed): 
Myocardial Energy Metabolism. Dordrecht/Boston/Lancaster, Martinus Nijhoff 
Publishing, 1988, pp203-213. 
146 
20. Stahl LD, Weiss HR, Becker LC. Myocardial oxygen consumption, oxygen 
supply f demand herogeneity, and microvascular patency in regionally stunned 
myocardium. Circulation 1988;77:86872. 
21. Ito BR, Tate H, Kobayashi M, Shaper W. Reversibly injured, postischemic canine 
myocardium retains normal contractile reserve. Circulation Res 1987;61:834-846. 
22. Becker LC, Levine JH, DiPaula AF, Guarnieri T, Aversano T. Reversal of dysfunction 
in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. 
J Am Coli Cardiol 1986;7:580-589. 
23. Schwaiger M, Neese RA, Araujo L, Wyns W, Wisneski JA, Sochor H, Swank S, Kulber 
D, Selin C, Phelps M, Schelbert HR, Fishbein MC, Gertz EW. Sustained nonoxidative 
glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am 
Coli Cardiol 1989;13:745-754. 
24. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine 
myocardium: quantitative considerations. Am J Physiol 1987;253:H107-H114. 
25. Renstrom R, Nellis SH, Liedtke JA. Metabolic oxidation of pyruvate and lactate during 
early myocardial reperfusion Circulation Research 1990;66:282-288. 
147 
Chapter 10 
Discussion 

149 
DISCUSSION 
This book is divided into three sections. The first presents the concept of coronary 
flow reserve with a specific application to patient care; the second presents experimental 
data from anesthetized swine to help define the relationships between myocardial blood 
flow, metabolism and function once autoregulation of blood flow is lost; the final section 
also includes experimental data from swine and characterizes how brief periods of ischemia 
and reperfusion further alter the relationships defined in section 2. 
Coronary flow reserve 
Coronary blood flow reserve, the ratio of maximal to resting coronary flow, has 
become a widely used clinical tool. In selected patients, it can supply valuable information 
for the diagnosis and management of abnormal pathophysiological states (2-4). Many 
invasive tools have become availiable to measure coronary flow reserve in patients and have 
been well validated experimentally (5). These techniques are limited however, because they 
can not quantitate blood flow or measure regional differences in coronary blood flow. In 
addition, they measure absolute flow reserve, which is not specific to changes in the 
coronary vasculature (10). 
Positron emission tomography (PET) is a non-invasive tool which measures the 
myocardial uptake of radioactive tracers, administered either intravenously or by inhalation. 
With rapid, high resolution scanning, tomographic slices of the entire heart can be acquired 
and time activity curves measured for the determination of regional myocardial blood flows. 
By comparing the maximal flow response between normal and abnormal regions, relative 
flow reserves can be determined which are a more independent measure of abnormal 
vasodilator capacity (10). In chapter 2, we showed how such measurements could be 
obtained in normal volunteers, and a group of patients with collateral-dependent 
myocardium. The results of the myocardial blood flows in both groups are consistent with 
flows acquired either from other techniques or from flows observed with radiolabeled 
microspheres in experimental animal preparations. The data show that coronary flow reserve 
in normal volunteers is greater than 4, which is also consistent with the findings of others 
(5). Myocardial blood flow in the distribution of completely collateralized myocardium in 
the patient group was normal at rest (0.8-1.1 mlfgfmin) but did not increase normally 
following infusions of dipyridamole. The relative flow reserve values correlated well with the 
length of time and the workload performed on standard exercise tests. Thus, this technique 
quantitatively demonstrates why patients with well developed intramyocardial collateral flow 
continue to have angina during high work loads. It emphasizes that colleral blood formation 
in patients can provide normal perfusion at rest, but have a limited capacity to maximally 
vasodilate. Thus, PET can provide a better understanding of the pathophysiology of 
collateral blood flow in humans. 
Chapter 3 addresses an important clinical question with the interpretation of flow 
reserve measurements in patients. That is, can the use of antiischemic therapies alter the 
results. In anesthetized swine, maximal coronary flow-pressure relationships were 
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characterized prior to and following 3 doses of either the selective beta-1 adrenoceptor 
antagonist metoprolol, the selective beta-1 partial agonist epanolol or the calcium antagonist 
nifedipine. Like relative flow reserve measurements, maximal flow-pressure lines accurately 
define changes in coronary vasculature and are minimally influenced by systemic 
hemodynamics (9). In this study, we showed that only nifedipine alters the maximal mean 
flow-pressure relationship. The data also support the hypothesis that calcium blockers are 
effective during ischemia by antagonizing endogenous adenosine and preventing 
redistribution of flow away from the subendocardium. 
Reserve during ischemia 
The purpose of the second section was to demonstrate how the myocardium adapts 
to acute ischemia. Autoregulation is the capacity of the myocardium to regulate resistance 
so that coronary blood flow remains constant over a wide range of perfusion pressures (11). 
It allows the myocardium to regulate its own flow according to myocardial oxygen demand, 
even in the presence of pathophysiological states such as coronary artery disease and 
ventricular hypertrophy. When perfusion pressure is reduced below a critical level, 
autoregulation is lost and ischemia develops. In chapter 4, we have shown that this 
"breakpoint" of the autoregulation curve in our model of anesthetized swine occurs at about 
50 mm Hg. This is consistent with the findings of other studies, however the type of 
anesthesia and the animal species used may account for significant differences (14). In 
addition, hemodynamic cha..'lges such as heart rate may also alter the absolute level of 
coronary driving pressure at which ischemia develops (15). 
Below this "breakpoint" of the autoregulatory curve, further reductions in perfusion 
pressure correlate in a near linear fashion with reductions in flow and transmural function 
and alterations in metabolism. Although these relationships have been well characterized 
in other models, the combil).ation of all parameters over a wide range of ischemic pressures 
has not been previously performed. We see from chapter 4, that the reserve to maintain 
normal function during ischemia is limited. As has been shown elsewhere (19), oxygen 
extraction can increase during flow reductions, however this accounts for only a small 
increase in overall oxygen delivery. The degree of anaerobic glycolysis increased relative to 
the degree of flow reductions and may be responsible for a slight increaase in ATP 
production at a time when aerobic oxidation of substrates has ceased ( 65). The chapter 
emphasizes that once flow is reduced, the degree of metabolic reserve to supply and 
preserve function is minimal. 
Because of differences in extravascular compression across the myocardial wall, the 
subendocardium is more vulnerable to reductions in perfusion pressure than the 
subepicardium (16). This probably accounts for differences in vasomotor tone across the 
wall, at a time when coronary blood flow is reduced. In chapter 4, we present a model of 
constant flow ischemia, with and without vasomotion intact. The data demonstrate that 
during moderate ischemia, vasomotor tone is greater in the subepicardial layers which when 
released with intracoronary adenosine, results in a reduction in subendocardial perfusion. 
This then causes a reduction in transmural function and an increase in the production of 
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lactate, at a time when overall oxygen consumption remains the same. This emphasizes 
another important component of myocardial reserve during ischemia which is the capacity 
to regulate vasomotor tone in different regions of the wall. 
It is clear that the capacity to regulate coronary flow during ischemia is the most 
efficient means of the myocardium to preserve function. In chapter 5, we show that 
intracoronary infusions of adenosine during ischemia can increase transmural coronary blood 
flow during the increased demand of tachycardia. This has been demonstrated in other 
models during basal states of ischemia (28-30) and suggests that pharmacological 
vasodilation is greater than endogenous vasodilation during moderate ischemia. Interestingly, 
minimal improvement in either function or metabolism is observed during this extra 
vasodilation, which implies that factors other than flow may be important regulators of 
function during ischemia. Some of these factors may include the intracellular accumulation 
of lactate, hydrogen ion or intracellular calcium (66). 
Reserve following ischemia and reperfusion 
In the third section, we have presented a model of myocardial stunning induced by 
brief ischemia (5-15 minutes) and reperfusion. This is an important model because such 
short periods of ischemic time induce substantial reductions in function at a time when 
necrosis would not be expected (37). Chapter 6 introduces stunning in swine induced by 
partial coronary occlusions and reperfusion. It confirms that post-ischemic reductions in 
function are related to the degree of flow reduction during ischemia, and shows that the 
functional losses are additive following sequential ischemic periods. It also shows that the 
functional abnormalities occur at a time when the distribution of coronary blood flow as 
measured by microspheres has returned to normal. 
The capacity to vasodilate in regionally stunned myocardium may be abnormally low 
(44). The mechanisms that could account for this include capillary plugging by neutrophils 
or edema formation as well as altered endothelial cell function (37-41). Many of these 
studies have been performed in models using extended ischemic times, when necrosis would 
also be expected. In chapters 7 and 8, we determined if the capacity to vasodilate was 
altered, in models of pure stunning. In the first study, we showed that the response of ATP, 
an endothelial-dependent vasodilator was not altered at a time when function was reduced 
following reperfusion. In the second study, we showed that slopes of the maximal coronary 
pressure-flow relationship with maximal intracoronary infusions of adenosine were not 
depressed, but actually were greater than preischemic baseline values. This enhanced flow 
reserve response supports the hypothesis that myocardial mechanical performance can be 
depressed following reperfusion, at a time when functional changes in the vasculature are 
normal. Because maximal flow was actually higher following reperfusion, it suggests that 
other factors may be responsible for the capacity to maximally vasodilate such as regional 
contractility. 
In chapter 9, we show that total coronary blood flow and oxygen consumption in the 
distribution of regionally stunned myocardium is lower than the non-ischemic regions. Other 
studies have indicated that coronary blood flow in the stunned myocardial region is not 
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lower following reperfusion ( 44,45). This discrepancy may be a result of differences between 
animal species (eg. the presence of collaterals in dogs), the variable degree of stunning 
between models or changes in hemodynamics during the experiment, making it difficult to 
interpret changes in post-ischemic flow and function. We have shown that with the 
recruitment of function following reperfusion, blood flow and oxygen consumption increase 
to similar degrees. This suggests that the reduced blood flow following stunning is 
metabolically regulated to the reductions in work performed, and not to an altered capacity 
to vasodilate. We have also shown that oxygen and lactate utilization are abnormal following 
reperfusion, but can increase during the higher demands, showing the presence of metabolic 
reserve. These findings emphasize the fact that blood flow and metabolic alterations may 
coexist with functional alterations, but are not the primary cause of the contractile 
abnormalities. 
Future perspectives 
The theme of these chapters has been myocardial reserve. In the first section, 
positron emission tomogrophy measurements of relative flow reserve provided both 
important clinical information as well as an understanding of human collateral blood flow. 
The tool offers the researcher an important means to understand coronary blood flow 
regulation in humans, and could be applied to a number of pathophysiological conditions 
such as hypertrophic cardiomyopathy and Syndrome X. In addition to coronary blood flow, 
it has the capacity to quantitate regional differences in myocardial metabolism and thus can 
be used to identify viable myocardium in patients considered for interventions. 
The second and third sections characterize myocardial reserve in swine during 
acute ischemia and following reperfusion. In the future, the most important impact in 
basic cardiovascular research will come from understanding the adaptive processes which 
occur as a result of chronic exposure to blood flow reductions and reperfusion. For 
instance, it is apparent that the myocardium has the potential to down-regulate its needs 
during severe ischemia, and prevent cellular death. This has been termed "hibernation" 
clinically (67), and involves different processes than those observed during the acute 
onset of ischemia outlined in the first section. Likewise, "stunning" may not be just a 
non-specific injury response which reduces oxygen consumption following reperfusion but 
rather an adaptation to maintain cellular homeostasis during stress. Recent evidence 
shows that the stunned myocardium undergoes a "preconditioned" state which protects it 
from subsequent prolonged periods of ischemia (68). These adaptations include changes 
in bioenergetics which improve energy supply (69) or may involve expression of different 
genes and the elaboration of new "stress" proteins which increase cellular resistance (70). 
The induction of these proteins may be protective to the heart, either by altering the 
metabolism or the vasculature. It is conceivable that they may explain some of our 
observations in the stunned myocardium, such as the improved coronary flow reserve 
measurements following reperfusion. A greater understanding of those mechanisms that 
allow the myocardium to adapt should provide the clinician with more therapies to 
improve function or maintain cellular viability with the ischemic syndromes. 
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SAMENVATTING 
Dit proefschrift is opgebouwd uit drie delen, betrekking hebbend op "myocardiale 
reserve". Het eerste deel gaat over bet concept van "coronaire flow reserve" en de specifieke 
toepassing daarvan in de patientenzorg. Het tweede deel behandelt de relaties tussen 
doorbloeding, metabolisme en functie van bet myocard, in situaties waarin autoregulatie van 
de doorbloeding ontbreekt. Het derde deel bespreekt hoe deze relaties veranderd zijn 
tijdens reperfusie volgend op een korte periode van ischemie. 
Coronary flow reserve 
De coronaire flow reserve, gedefineerd als de verhouding tussen de maximale 
doorbloeding van de kransslagaders en de doorbloeding in rust, is in de kliniek een veel 
gebruikt hulpmiddel geworden, waarmee kwantitatieve informatie wordt verkregen over de 
ernst van een kransslagadervernauwing. Voor bet meten van de coronaire flow reserve in 
patienten staan diverse invasieve meettechnieken ter beschikking, waaronder de 
intracoronaire Doppler-bloedstroom snelheidsmetingen. Een beperkingvan deze technieken 
is dat ze niet in staat zijn om de doorbloeding te kwantificeren of de regionale verschillen 
in doorbloeding te meten. Een ander nadeel van de coronaire flow reserve metingen is dat 
een hogere doorbloeding in rust, een lagere flow reserve oplevert zonder dat de maximale 
flow capaciteit is veranderd. 
Een non-invasieve meettechniek is de Positron Emission Tomography (PET). Met 
deze methode meet men de opname door bet myocard van radioactieve tracers na 
toediening via intraveneuze injectie of via inhalatie. Verder kan men tomografische coupes 
van bet hele hart verkrijgen, alsmede de "time-activity curve" waaruit men de regionale 
myocard doorbloeding kan bepalen. Door de normale en de abnormale geperfundeerde 
gebieden van bet myocard met elkaar te vergelijken, kan men de relatieve flow reserve (de 
verhouding tussen maximale doorbloeding van myocard geperfundeerd door een stenotische 
coronair arterie en de maximale doorbloeding van myocard geperfundeerd door een 
normale coronair arterie) vaststellen. Het voordeel van de relatieve flow reserve is dat deze 
niet wordt beinvloed door systemische hemodynamische veranderingen en niet afhankelijk 
is van de doorbloeding in rust. In bet tweede hoofdstuk hebben we Iaten zien, op welke 
wijze men dergelijke metingen kan verkrijgen bij normale vrijwilligers en bij een groep 
patienten, wier myocard voor de bloedvoorziening afhankelijk is van collateralen. Het bleek 
dat bij de normale vrijwilligers de doorbloeding van bet myocard na toediening van 
dipyridamole kan verviervoudigen, hetgeen in overeenstemming is met coronaire flow 
reserve waarden die via andere technieken verkregen waarden. Bij patienten waarvan in rust 
de myocard doorbloeding in rust afhankelijk van bet collaterale vaatbed, vindt geen toename 
in doorbloeding plaats na toediening van dipyridamole. Er bestaat een goede relatie tussen 
de waarden van de relatieve flow reserve en de hoeveelheid en duur van arbeid tijdens 
standaard belastingsproeven. Deze non-invasieve techniek is daarom zeer geschikt om 
potentieel ischemisch myocard te identificeren. 
Een probleem is dat de invloed van anti-ischemische medicamenten op de 
coronaire flow reserve, niet goed gedocumenteerd is. In hoofdstuk 3 zijn de coronaire druk-
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stroom relaties beschreven tijdens maximale vaatverwijding, geinduceerd door adenosine in 
geanaestheseerde varkens van 3 anti-ischemische stoffen: de selectieve Brblokker 
metoprolol, de selectieve 81 partieele agonist epanolol en de calcium antagonist nifedipine. 
Net als de metingen van de relatieve flow reserve zijn de maximale druk-stroom curves 
onafhankelijk van de basale doorbloeding en onafhankelijk van de coronaire perfusiedruk. 
In dit onderzoek hebben we aangetoond, dat aileen nifedipine de verhoudingen tussen 
maximale bloedstroom en druk verandert. 
Reserve tijdens ischemie 
Het myocard bezit het vermogen om de perfusie te autoreguleren, d.w.z. om de 
perfusie over een wijd bereik van de perfusiedruk hetzelfde te houden, bij een constant 
metabolisme. Valt de perfusiedruk beneden een kritisch niveau, dan gaat de autoregulatie 
verloren en treedt er ischemie op. Beneden bet kritiscbe punt van de autoregulatie curve 
neemt de perfusie met bet dalen van de perfusiedruk bijna lineair af. Hierbij treden tevens 
een vermindering in de contractiele functie en een verandering in bet metabolisme op. In 
hoofdstuk 4 hebben we aangetoond, dat bet vermogen om tijdens iscbemie een normale 
functie te bebouden beperkt is. Hoewel bet hart via toename zuurstofextractie en m.b.v. 
anaerobe glycolyse de ATP-productie tracht te bandbaven blijkt dat er slechts een zeer 
geringe metabole reserve bestaat om de functie te behouden wanneer er een vermindering 
in de doorbloeding optreedt. 
Vanwege de transmurale verscbillen in extravasculaire compressie van bet 
myocard, is bet subendocard kwetsbaarder voor een vermindering in de coronaire perfusie 
dan bet subepicard. In hoofdstuk 4 tonen we aan dat tijdens matige iscbemie de vaattonus 
in de subepicardiale lagen grater is dan in de subendocardiale lagen. Vermindert men de 
vaattonus in bet subepicard met behulp van een intracoronaire. infusie van adenosine, dan 
leidt dit tot een afname van de subendocardiale perfusie met een vermindering van de 
transmurale functie en een toename in lactaatproduktie. Dit benadrukt een andere 
belangrijke eigenscbap van bet myocard tijdens iscbemie, namelijk bet vermogen om de 
vaattonus te reguleren in de verschillende lagen van de wand. 
In boofdstuk 5 bescbrijven we, dat zelfs na verboging van de zuurstofbeboefte, de 
transmurale doorbloeding van emstig ischemiscb myocard kan stijgen door een 
intracoronaire toediening van adenosine. Dit betekent dat op een moment dat de endogene 
"vasodilator reserve" is uitgeput, bet nog mogelijk is om pbarmacologiscb bet vaatbed nog 
verder te verwijden. Interessant is echter, dat recrutering van de vasodilator reserve niet 
resulteert in een onmiddellijke verbetering van de contractiele functie en metabolisme van 
bet myocard. Het is dus waarscbijnlijk, dat naast de doorbloeding er nog andere factoren 
zijn, die een rol spelen bij de regulatie van de functie tijdens iscbemie. Hierbij kunnen we 
denken aan intracellulaire accumulatie van lactaat, protonen en calciumionen. 
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Reserve na ischemie en reperfusie 
In bet derde deel bebben we aspecten bestudeerd van "myocardiale stunning" ( = 
verdoving) in genarcotiseerde varkens. Stunning werd geinduceerd door een korte periode 
(5-15 min) van iscbemie, gevolgd door reperfusie. Dergelijke korte perioden van iscbemie 
resulteren in een substantiele afname in contractiele functie zonder dat necrose optreedt. 
In hoofdstuk 6 bebben we aangetoond, dat na 25 minuten reperfusie, op een moment dat 
de coronaire bloedstroom weer genormaliseerd is, de contractiele functie nog niet is 
bersteld. Op dat moment is er sprake van een verminderde coronaire bloedstroom naar en 
vertraaagde zuurstof consumptie door bet "gestunde" myocard in vergelijking met het 
controle myocard. Dit wordt niet altijd gevonden. Proefdier gebonden eigenscbappen 
(aanwezigheid collateralen), en mogelijk daarmee samenhangend, de mate van "stunning" 
en de veranderingen in systemiscb bemodynamiscbe parameters bemoeilijken ecbter bet 
interpreteren van de veranderingen in doorbloeding en contractie, functie en 
zuurstofconsumptie. Wat we wel zien is dat tijdens reperfusie, de bloedstroom en de zuurstof 
consumptie in dezelfde mate toenemen, als het hart wordt gestimuleerd door de 
hartfrequentie te verhogen en door toediening van dobutamine suggereert (hoofdstuk 7), dat 
de gevonden daling in doorbloeding tijdens "stunning" op metabole wijze gereguleerd wordt. 
Reductie in de verricbte arbeid en niet een veranderd vermogen tot vaatverwijden, lijken 
ten grondslag te liggen aan de gedaalde doorbloeding. Tevens blijkt uit hoofdstuk 7 dat bet 
gestunde myocard zowel voldoende functionele metabole als endogene 
vaatverwijdingsreserve bezit. 
Sommige onderzoekers bebben gesuggereerd, dat na korte periode van iscbemie 
gevold door bet vermogen tot maximaal verwijden van de vaten verminderd is. In de 
hoofdstukken 7 en 8 tonen we ecbter aan dat tijdens "myocardiale stunning", bet vermogen 
tot vasodilatatie in deze gebieden ecbter nog intact is. In het "gestunde" gebied treedt 
vasodilatatie op na toediening van zowel adenosine als de endotheel- afhankelijke 
vaatverwijder ATP. Met deze experimenten hebben we een onderscbeid kunnen maken 
tussen post-iscbemiscbe veranderingen in de contractie functie van bet myocard en de 
vaatresponsies. 
Vooruitzichten in de toekomst 
In dit proefschrift beeft bet onderwerp functionele en flow reserve van bet 
myocard centraal gestaan. In bet eerste deel is bescbreven hoe de coronaire flow reserve 
in patienten is gemeten met bebulp van de Positron Emissie Tomographie (PET). Met deze 
techniek is bet mogelijk de relatieve flow reserve te meten. Het toepassingsgebied van dit 
apparaat lijkt niet beperkt tot het kunnen identificeren van potentieel ischemisch myocard 
in patienten. Het vermogen om verscbillen in de regionale myocard perfusie op 
microcirculatoir niveau te meten, biedt de mogelijkbeid informatie te verstrekken over 
zeldzame iscbemiscbe syndromen, zoals syndroom X. De vraag is of er ook informatie 
verscbaft kan worden over regionale verscbillen in myocardiaal metabolisme. De 
mogelijkbeid om levend van dood myocard onderscheiden, is van belang bij bet selecteren 
van patienten die voor een operatie in aanmerking komen. 
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In bet tweede deel van dit proefschrift lag de nadruk op de acute adaptieve 
processen in bet myocard na een vermindering in perfusie. In de toekomst zal bet accent 
waarschijnlijk meer verschuiven in de richting van chronische aanpassingen van bet myocard. 
Er zijn recent aanwijzingen gevonden dat bet myocard zijn zuurstofbehoefte kan verlagen 
zodat ondanks langdurige vermindering in perfusie de myocyten overleven. Dit proces wordt 
"hibernation" ( = winterslaap) genoemd en is wezenlijk verschillend van processen die 
optreden tijdens acute ischemie. In deel 3 van dit proefschrift hebben we via interventies 
de functionele en flow reserve van "gestunned" myocard bestudeerd. In de nabije toekomst 
zal bet onderzoek zich waarschijnlijk meer richten naar de processen die dit "stunnen" 
veroorzaken, maar om inzicht te krijgen waarom bet myocard verminderd functioneert, 
terwijl bet wel een normale functie reserve bezit. Men moet "stunning" misscbien niet zien 
als een aspecifieke reactie op beschadiging ten gevolge van ischemie, die de zuurstof 
consumptie verlaagt gedurende de reperfusie, maar meer als een aanpassing om de 
homeostase van de eel onder stess te garanderen. Recent is aangetoond bewijs geleverd, dat 
"stunning" bet myocard beter hestand maakt tegen een volgende periode van ischemie. Dit 
proces ("preconditioning") wordt mogelijk verklaard door een geringere zuurstofbehoefte van 
bet myocard enjof geringere productie van lactaat, H+ etcetera. Mogelijk speelt ook de 
expressie van specifieke genen, die de vorming van "stress" eiwitten reguleren, zoals bet 
"heat-shock proteine", een rol. Deze eiwitten zouden bet hart dan beschermen via een 
overigens nog onbekend mechanisme. In de toekomst zullen we met bet beter begrijpen van 
processen als "hibernation" en "stunning" therapieen voor ischemische syndromen kunnen 
ontwikkelen die meer in overeenstemming zijn met de beschermingsmechanismen die bet 
hart zelf hanteert. 
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